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1 Introduction 
 
1.1 Signal Transduction 
During the development of complex organisms cells have to undergo both proliferation and 
differentiation events to finally generate a multi-cellular body composed of various tissues. 
Each cell of such an organism descends from a single progenitor cell, the zygote. The ability 
of differentiation, despite the common genome, is based on the temporally and spatially 
regulated expression of distinct subsets of genes. Cellular identity and perception of the 
environment is achieved by communication between cells mediated by the sending and 
receiving of signals. These signals are processed by molecular relay mechanisms that are 
called signal transduction pathways. One of the known modes of signal transduction includes 
an extra-cellular signal, the so-called ligand, which binds to its specific transmembrane 
receptor of a receiving cell. The receptor subsequently gets activated, for example by 
conformational changes in its cytoplasmic tail. Downstream components are activated in 
response to these actions. In turn, these components modify cytoplasmic transducers, which 
carry on the signal and finally activate transcription factors that subsequently alter target gene 
expression (reviewed in Gerhart, 1999). Despite the multiplicity of cellular processes an 
organism has to accomplish, only 17 different signal transduction pathways are known so far 
(reviewed in Gerhart, 1999). The wide variety of actions required for proper development of 
an organism can therefore only be achieved by crosstalk of different pathways, modulation of 
the intensity of the received signal and the history of a cell, the so-called cell´s competence 
(Pires-da Silva and Sommer, 2003). 
 
1.2 Protein modifications 
Signal transduction is often mediated by altering the state of signal transducing proteins by 
introducing post-translational modifications of amino acid side chains. Many of these 
proteins, including tyrosine kinases, histones and RNA polymerase II, are not only modified 
at a single amino acid, but display modifications at multiple sites (reviewed in Yang, 2005). 
Over 200 different forms of such modifications are known so far (reviewed in Yang, 2005). 
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1.2.1 Protein phosphorylation 
The major protein modification associated with signal transduction is phosphorylation. 
Protein kinases transduce the incoming signal by transferring phosphate groups to the 
hydroxyl side chain of tyrosine (Eckhart et al., 1979), serine or threonine residues (reviewed 
in McCubrey et al., 2000) of target proteins. Tyrosine phosphorylation is often required for 
signal transduction as shown for the Receptor Tyrosine Kinase (RTK) pathway and cytokine 
signaling (see also 1.4). Additionally, serine phosphorylation, for example, is required for full 
transcriptional activity of the Signal Transducer and Activator of Transcription (STAT) 1 
protein (Eilers et al., 1995). Furthermore, serine and threonine phosphorylation of histones 
contributes to transcriptional activation by chromatin remodeling (reviewed in Spencer and 
Davie, 1999). 
Phosphorylation is a reversible process. Phosphatases counteract the action of kinases by 
removing the introduced phosphate group of the modified proteins. As such, the change in 
protein function caused by phosphorylation can be regulated quickly and reversibly. The 
significance of the function of kinases and phosphatases is reflected in their large number in 
various genomes (Arena et al., 2005). For the human genome, at least 518 different genes 
coding for kinases are proposed constituting about 1.7% of all predicted genes (Manning et 
al., 2002). Additionally, about 180 phosphatases are known so far. The importance of both 
kinases and phosphatases becomes also apparent by mutations in these enzymes, which have 
frequently been associated with the onset of cancer (Arena et al., 2005). 
 
1.2.2 Protein methylation 
Another reversible post-translational modification involved in signal transduction is protein 
methylation of arginine, lysine, histidine, proline side chains and the C-terminal carboxyl 
group of the amino acid backbone. In general, the enzymes catalyzing methylation reactions 
are called methyltransferases. S-adenosylmethionine (SAM) provides the methyl group in the 
enzymatic reaction (reviewed in Chiang et al., 1996). Transfer of its methyl group results in 
S-adenosylhomocysteine and the methylated target. 
Reversible carboxy-methylation of glutamate side chains in receptor-transducer proteins, for 
example, is implicated in bacterial chemotaxis. Mutants lacking the methylating and 
demethylating enzymes exhibit an aberration in their motility pattern (reviewed in Chiang et 
al., 1996). Additionally, methylation of several lysine and arginine side chains in histones was 
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shown to contribute to both positive and negative regulation of transcription (reviewed in 
Stallcup, 2001; Lee et al., 2005). 
 
Arginine methylation 
Recently, arginine methylation and its role in signal transduction and transcriptional control 
has come into focus (reviewed in Stallcup, 2001). Protein Arginine Methyltransferases 
(PRMT) catalyze this modification by transferring methyl groups from the donor molecule 
SAM to the guanidino group of arginine residues of protein substrates. Arginine is a 
positively charged amino acid and often plays an important role in protein-protein interactions 
frequently mediated by hydrogen bonding. 
Methylation does not alter the charge of the arginine side chain, but rather increases its 
bulkiness and hydrophobicity. Arginine methylation mediated by PRMTs can have both 
negatively and positively regulating effects on protein function and protein-protein 
interactions (reviewed in Bedford and Richard, 2005; Boisvert et al., 2005). Recently, over 
200 new proteins were identified that are putatively arginine methylated implicating this post-
translational modification in many cellular processes including signal transduction, DNA 
repair, transcription, translation and apoptosis (Boisvert et al., 2003). The Co-activator 
Associated Arginine Methyltransferase (CARM) 1 methylates arginine residues in the CREB 
Binding Protein (CBP) and p300, which are transcriptional co-activators for a large number of 
transcription factors including cAMP Responsive Element Binding Protein (CREB), STAT1 
and nuclear receptors (Chevillard-Briet et al., 2002). Methylation of CBP/p300 occurs in 
distinct domains. Depending on the methylation site, this modification has an inhibitory effect 
on CREB mediated somatostatin expression by destabilizing the domain mediating CREB 
recruitment (Xu et al., 2001), whereas methylation of a distinct arginine residue was shown to 
have a positive influence on reporter gene transcription mediated by nuclear receptors 
(Chevillard-Briet et al., 2002). Arginine methylation of the transcription factor STAT1 has 
been reported to modulate Interferon (IFN) α/β signaling by affecting the interaction between 
STAT1 and the negative regulator Protein Inhibitor of Activated STAT (PIAS) (Mowen et al., 
2001). 
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1.3 Protein domains recognizing modified amino acid residues 
Transducing cellular signaling events by changing the activity of proteins through post-
translational modifications requires the ability to distinguish between unmodified and 
modified residues. Various protein modules exist which are known to bind modified amino 
acid side chains with high affinity (reviewed in Yang, 2005). Among these modules the Src-
homology 2 (SH2) domain (Sadowski et al., 1986) recognizes phosphorylated tyrosine 
residues of other proteins. Essential for binding of these phosphorylated tyrosine side chains 
is a highly conserved arginine residue, located at the base of the binding pocket. This arginine 
is conserved in the SH2 domain of various proteins, such as the kinases c-Src and c-Abl and 
the phospholipase PLCγ (reviewed in Koch et al., 1991). This residue is also evolutionary 
conserved within protein families in species ranging from Dictyostelium to human as shown 
for the transcription factor STAT (Kawata et al., 1997). At the edge of the binding pocket 
additional specific contacts are made between the SH2 domain and the tyrosine 
phosphorylated protein. These contacts are formed between various amino acid side chains of 
the SH2 domain and three flanking residues C-terminal to the phosphorylated tyrosine. The 
third residue is bound in the so-called phospho-tyrosine+3 pocket. In particular, this 
interaction contributes to the binding specificity of different SH2 domain containing proteins 
to tyrosine phosphorylated protein binding partners (Branden and Tooze, 1999). 
The interactions between phosphorylated and SH2 domain containing proteins are crucial 
events in signal transduction cascades, which use tyrosine phosphorylation to modify the 
function of pathway components (reviewed in Pawson, 2004). 
 
1.4 The JAK/STAT signal transduction pathway 
A signal transduction pathway using the principle of tyrosine phosphorylation and subsequent 
SH2 domain mediated recognition is the Januskinase (JAK) / Signal Transducer and Activator 
of Transcription (STAT) cascade. Numerous studies have led to the development of a 
canonical model of signal transduction (Fig. 1.1; reviewed in O'Shea et al., 2002; Rawlings et 
al., 2004b). In this model binding of an extra-cellular ligand to its transmembrane receptor 
results in receptor dimerization or conformational changes of pre-dimerized receptors 
(Heinrich et al., 2003). This way, the receptor associated JAK proteins are juxtaposed to each 
other, resulting in mutual phosphorylation, activation and subsequent phosphorylation of 
tyrosine residues of the receptors. 
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Fig. 1.1: Model of signal transduction by the JAK/STAT pathway (modified after 
O'Shea et al., 2002). (1) Pre-dimerized receptors (black) and associated JAK proteins (red). 
(2) Ligand (orange) binding to receptors results in conformational changes in the receptors, 
juxtaposing the JAK proteins to each other. (3) JAK proteins transfer a phosphate group 
(yellow) to tyrosine residues of JAKs and receptors. (4) This creates docking sites for STAT 
proteins (blue). At the receptor-JAK complex STAT proteins are phosphorylated at a 
conserved tyrosine residue by JAKs. (5) After phosphorylation STATs dissociate from the 
receptor complex and form homo- or heterodimers. (6) These dimers translocate to the 
nucleus, where they bind to palindromic DNA recognition sites present within promoters of 
pathway target genes and subsequently activate the expression of these genes. 
 
The phosphorylated receptor-JAK complex acts as a docking site for the SH2 domains of 
cytosolically localized STAT molecules. After recruitment to the receptor-JAK complex, the 
STAT proteins are themselves phosphorylated at an evolutionary conserved C-terminal 
tyrosine residue by the JAK proteins. These activated STAT molecules form homo- or hetero-
dimers, using their SH2 domains to bind the phosphorylated dimerization partner. The 
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resulting STAT dimers enter the nucleus by an importin α-5 and Ran dependent mechanism 
(Rawlings et al., 2004b), where they bind to palindromic DNA recognition sites present 
within the promoters of pathway target genes. Following DNA binding, STAT factors then 
stimulate transcription via direct or indirect interaction with the basal transcription machinery 
(reviewed in Darnell et al., 1994). 
 
1.4.1 JAK/STAT signaling in mammals 
In mammals the JAK/STAT pathway is a very complex system with a multiplicity of 
participating components. More than 40 different ligands including cytokines and growth 
factors are known (reviewed in Kisseleva et al., 2002). A corresponding variety of different 
receptors or combinations of these receptors bind these ligands (Hirano et al., 1997; Onishi et 
al., 1998). All different signals are transduced by only four receptor-associated tyrosine 
kinases, the JAK proteins JAK1-3 and Tyrosine Kinase (TYK) 2 (reviewed in Yamaoka et al., 
2004), and seven different STAT proteins, STAT1-4, STAT5A, STAT5B and STAT6 
(reviewed in Brierley and Fish, 2005). 
The JAK/STAT signal transduction cascade was originally identified as the primary mediator 
of IFNα and IFNγ induced signaling (reviewed in Darnell et al., 1994; Rawlings et al., 
2004b). Now it is known that a wide array of cytokines and growth factors, together with their 
respective receptors, use the JAK/STAT cascade for signal transduction. As expected, given 
the range of signals and receptors being used, JAK/STAT signaling plays an important role in 
many different processes. Among others, it affects proliferation, differentiation, migration and 
apoptosis of cells. Additionally, it is crucial for hematopoiesis, the immune response, 
mammary gland development and lactation, adipogenesis and sexually dimorphic growth 
(reviewed in Rawlings et al., 2004b). Multiple diseases related to these processes result from 
mutations in components of the JAK/STAT pathway (Schindler, 2002). Particularly, various 
blood cell malignancies including leukaemias, lymphomas and multiple myelomas caused by 
JAK/STAT mis-regulation highlight the central role of JAK/STAT signaling in hematopoiesis 
(Valentino and Pierre, 2006). 
 
Negative regulation of the JAK/STAT pathway 
JAK/STAT signaling is involved in multiple processes, and mis-regulation often has severe 
effects as outlined above. Therefore, JAK/STAT activity has to be tightly controlled at 
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multiple levels to ensure appropriate and controlled cellular responses (reviewed in Wormald 
and Hilton, 2004). Negative regulation of JAK/STAT activity is mediated by several classes 
of proteins, three of which are particularly well studied (reviewed in Carbia-Nagashima and 
Arzt, 2004; Wormald and Hilton, 2004). Among them, the PIAS family of proteins can bind 
to activated STAT dimers, thus blocking STAT DNA-binding activity. Furthermore, PIAS 
proteins have been shown to promote STAT1 SUMOylation, thereby inhibiting STAT1 
mediated transcription (Liu et al., 1998; Rogers et al., 2003; Ungureanu et al., 2003). In 
addition, protein phosphatases play an important role in negative regulation of JAK/STAT 
activity. In particular, members of the Protein Tyrosine Phosphatases (PTP) family of proteins 
reverse the activity of the JAK kinases, with SH2 containing protein tyrosine phosphatase 
(SHP) 1 as the first identified JAK/STAT phosphatase (David et al., 1995; Haque et al., 
1998). Finally, the Suppressors Of Cytokine Signaling (SOCS) family has eight members in 
mammals, SOCS1-7 and Cytokine-Inducible SH2-Containing Protein (CIS) (reviewed in Kile 
and Alexander, 2001; Larsen and Ropke, 2002). At least three mechanisms for negative 
regulation of JAK/STAT activity by SOCS proteins are known so far. These proteins can bind 
via their SH2 domain to phosphorylated receptors, thus blocking the recruitment of STAT 
proteins to the receptor complex (Yoshimura et al., 1995). Additionally, JAK kinase activity 
can be specifically inhibited by SOCS binding to JAK proteins (Yasukawa et al., 1999). 
Furthermore, an interaction of SOCS proteins with the elongin B/C complex was reported. 
This complex can bind an E3-like ubiquitin ligase suggesting the ubiquitination of JAKs and 
receptors to target them to the proteasome for degradation (Zhang et al., 1999). SOCS1 - 3 
and CIS expression is dependent on JAK/STAT activity. JAK/STAT signaling thus mediates 
the expression of signaling inhibitors to down-regulate its own activity. Hence, these SOCS 
proteins act together with the JAK/STAT pathway components in a classical negative 
feedback loop (reviewed in Larsen and Ropke, 2002). 
 
1.4.2 JAK/STAT signaling in Drosophila melanogaster 
The JAK/STAT pathway in Drosophila melanogaster is the most intensively studied example 
of an invertebrate JAK/STAT signaling cascade (reviewed in Luo and Dearolf, 2001; 
Hombría and Brown, 2002; Arbouzova and Zeidler, 2006). A single STAT-like gene termed 
stat92E is known (Hou et al., 1996; Yan et al., 1996). Additionally, a single JAK homologue 
called hopscotch (hop) was identified (Binari and Perrimon, 1994). The secreted glycoprotein 
Unpaired (Upd) (Harrison et al., 1998) and two closely related homologues Upd2 (Gilbert et 
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al., 2005; Hombría et al., 2005) and Upd3 (Agaisse et al., 2003) are the only pathway ligands 
known so far. They do not show sequence similarity to any vertebrate cytokine. However, 
they show structural features that are conserved throughout evolution and are reminiscent of 
mammalian cytokines (Boulay et al., 2003). The receptor Domeless (Dome) (Brown et al., 
2001) is the only JAK/STAT receptor described in Drosophila. It shows weak similarities to 
the vertebrate interleukin-6 receptor. Furthermore, the predicted gene CG14225 shows 
similarities to Dome, but no functional analysis has yet been done (Hombría and Brown, 
2002). Taken together, all components known from the vertebrate pathway are also present in 
Drosophila, with the big advantage of much less redundancy. 
In addition to the homology between vertebrate and Drosophila JAK/STAT pathway 
components, a number of developmental roles for JAK/STAT signaling have also been 
conserved (reviewed in Luo and Dearolf, 2001; Hou et al., 2002; Arbouzova and Zeidler, 
2006). These include its requirement for the development and differentiation of Drosophila 
hematopoietic cells (Hanratty and Dearolf, 1993; Harrison et al., 1995; Luo et al., 1995; Luo 
et al., 1997). Gain-of-function mutants of the kinase Hopscotch were shown to cause 
melanotic tumor formation and abnormalities in blood cell development (reviewed in Luo and 
Dearolf, 2001). JAK/STAT activity is also required for the response to bacterial infection 
(Agaisse et al., 2003; Agaisse and Perrimon, 2004). In addition, it functions in regulating 
cellular proliferation in wing imaginal discs (Mukherjee et al., 2005). Furthermore, loss of 
JAK/STAT signaling causes embryonic segmentation defects (Perrimon and Mahowald, 
1986; Binari and Perrimon, 1994; Hou et al., 1996; Harrison et al., 1998). JAK/STAT activity 
is also required for the induction of trachealess (trh) expression (Brown et al., 2001), which 
is essential for tracheal morphogenesis (Isaac and Andrew, 1996; Wilk et al., 1996). 
Furthermore, fore- and hindgut development (Johansen et al., 2003; Josten et al., 2004), the 
maintenance of stem cell renewal and development of both the adult testis and ovary 
(Hombría and Brown, 2002; Decotto and Spradling, 2005) have been shown to require 
JAK/STAT signaling. Development of the Drosophila eye is also dependent on JAK/STAT 
activity (Luo et al., 1999; Zeidler et al., 1999a; Zeidler et al., 1999b), as disruption of 
signaling results in a small eye phenotype (Luo et al., 1999). 
 
Negative regulation of the JAK/STAT pathway in Drosophila 
Negative regulators of JAK/STAT activity characterized in vertebrate systems are also 
present and functional in Drosophila as shown for a PIAS homologue (Mohr and Boswell, 
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1999; Betz et al., 2001; Hari et al., 2001). Additionally, genome-wide RNAi screens have 
identified Ptp61F among several other PTPs as negative regulator of Drosophila JAK/STAT 
signaling (Baeg et al., 2005; Müller et al., 2005). Furthermore, a family of SOCS proteins 
was also identified to regulate JAK/STAT activity (Callus and Mathey-Prevot, 2002; Karsten 
et al., 2002; Rawlings et al., 2004a). Three SOCS proteins are known in Drosophila: 
SOCS16D, SOCS36E and SOCS44A. It was shown that SOCS36E suppresses Drosophila 
JAK/STAT activity (Callus and Mathey-Prevot, 2002; Müller et al., 2005). socs36E is a 
transcriptional target of JAK/STAT signaling. Loss of pathway activity resulted in disruption 
of socs36E expression, whereas ectopic pathway activation induced ectopic socs36E 
expression (Karsten et al., 2002). This indicates that SOCS36E is part of a negative feedback 
loop as shown for vertebrate SOCS proteins (reviewed in Larsen and Ropke, 2002). 
SOCS44A is also a negative regulator of Drosophila JAK/STAT signal transduction, but its 
expression is regulated independently of JAK/STAT signaling (Rawlings et al., 2004a).  
 
1.5 Signal Transducer and Activator of Transcription 
The family of STAT proteins represents a central component of the JAK/STAT pathway 
(reviewed in Brierley and Fish, 2005). 
 
 
Fig. 1.2: Conserved domains of STAT proteins (modified after Chen et al., 1998). STAT1 
is shown as example. Size bar represents 100 amino acids. The N-terminal domain (NT) of 
STAT proteins is involved in protein-protein interactions. The coiled-coil (CC) and the SH2 
domain (SH2) have been implicated in receptor binding (Mikita et al., 1998; Zhang et al., 
2000). Furthermore, the SH2 domain is essential for STAT dimerization (Shuai et al., 1994). 
The DNA binding domain (DNA) as well as the Linker (LD) and the SH2 domain have been 
implicated in DNA binding (Mikita et al., 1998; Yang et al., 2002). The Transactivation 
domain (TA) is involved in transcriptional activation (Müller et al., 1993). Y701 of STAT1 
represents the conserved tyrosine residue, which is phosphorylated by JAK proteins and 
essential for STAT activation (Shuai et al., 1993b). 
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STAT proteins share a common protein structure (Fig. 1.2), which includes an N-terminal 
protein-protein interaction domain, followed by a coiled-coil domain involved in receptor 
binding (Zhang et al., 2000). A DNA binding domain (Horvath et al., 1995) is connected to a 
SH2 domain via a linker domain, which is also implicated in DNA binding (Yang et al., 
2002). The SH2 domain is responsible for dimerization and binding to the receptor complex 
(Shuai et al., 1994). A transcriptional activation domain is located at the C-terminus (Müller 
et al., 1993). Between these two domains a highly conserved tyrosine residue is situated. This 
tyrosine is the phosphorylation target of JAK proteins as it was first suggested for STAT1 and 
JAK1 (Shuai et al., 1993b). 
 
1.5.1 STAT function and control mechanisms of its activation 
Signal transduction mediated by STAT proteins plays a central role in developmentally 
important processes (reviewed in O'Shea et al., 2002). Therefore, it is not surprising that 
multiple regulatory mechanisms have evolved to control STAT activity. As outlined above, 
phosphorylation of a highly conserved tyrosine residue within the C-terminus of all STAT 
proteins is the key factor in their activation. This modification is required for the formation of 
STAT dimers via interactions between their SH2 domains and opposing phospho-tyrosine 
residues (Shuai et al., 1994). In addition to tyrosine phosphorylation, other post-translational 
modifications have been shown to regulate STAT function. These modifications include 
phosphorylation of a C-terminal serine residue of STAT1 increasing the potential of STAT1 
to activate transcription (Eilers et al., 1995). Serine phosphorylation was also shown for 
STAT3, STAT4, STAT5a and STAT5b (reviewed in Brierley and Fish, 2005). Additionally, 
PIAS mediated SUMOylation of STAT1 is implicated in the down-regulation of 
transcriptional activity (Rogers et al., 2003; Ungureanu et al., 2003). STAT1 and STAT3 
lysine acetylation was reported to stimulate sequence-specific DNA binding and 
transactivation activity (O'Shea et al., 2005; Wang et al., 2005; Yuan et al., 2005; Kramer et 
al., 2006). Furthermore, a number of contradictory reports have been published regarding the 
potential methylation of a conserved N-terminal arginine residue of STAT1 and STAT6 
affecting protein-protein interactions or transcriptional regulation (Mowen et al., 2001; Chen 
et al., 2004; Meissner et al., 2004; Komyod et al., 2005). However, the presence of these 
modifications in other STAT molecules, their roles in vivo and their contribution to the 
overall level of STAT activity are less clear and still subject of research. 
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Analysis of several artificially generated mutant STAT proteins has contributed to the 
understanding of STAT function (Mikita et al., 1998; Bromberg et al., 1999; Ariyoshi et al., 
2000; Daniel et al., 2000; Zhang et al., 2000; Yang et al., 2002; Meyer et al., 2004; Liddle et 
al., 2006). On the basis of these results, models for STAT protein action concerning receptor 
binding, phosphorylation, dimerization, DNA binding and transcriptional activation have been 
developed. The coiled-coil and SH2 domain, for example, have been implicated in receptor 
binding (Mikita et al., 1998; Zhang et al., 2000). Additionally, mutations in the DNA binding 
domain, as well as in the linker and SH2 domain, have been shown to affect DNA binding 
(Mikita et al., 1998; Yang et al., 2002). Furthermore, analysis of constitutive active STAT 
variants highlighted the essential role of a conserved tyrosine residue, phosphorylated by JAK 
proteins, for STAT function. Mutation of this residue completely abolished the transcriptional 
activity in the context of these constitutively active proteins (Bromberg et al., 1999; Ariyoshi 
et al., 2000; Daniel et al., 2000; Liddle et al., 2006). 
Structural analysis described that non-phosphorylated STAT1 also exists in dimers (Chen et 
al., 2003; Mao et al., 2005; Zhong et al., 2005). Dimerization of these non-active STAT1 
proteins is not mediated by their SH2 domain, but depends on interactions between the N-
terminal domains and also between the coiled-coil and the DNA binding domains of STAT1 
dimer partners. It was proposed that tyrosine phosphorylation induces structural 
rearrangements resulting in the active dimeric form, which is capable of inducing target gene 
expression. Another conformational rearrangement presenting the phosporylated tyrosine to 
nuclear phosphatases for dephosphorylation is proposed to be a prerequisite for STAT 
inactivation (Zhong et al., 2005). 
 
1.5.2 Drosophila STAT92E 
In Drosophila only a single STAT gene is known, stat92E (Hou et al., 1996; Yan et al., 
1996). Four different mRNAs are transcribed, which are translated into three different 
proteins (Fig. 1.3). Two transcripts, differing in their transcription start sites and 5´-UTRs, 
give rise to the same protein of approximately 87 kDa. Additionally, one closely related 
protein with an insertion of seven additional residues is translated from an alternatively 
spliced mRNA. Furthermore, a N-terminal truncated protein (ΔNSTAT92E) of approximately 
72 kDa is translated lacking 134 residues of the N-terminal domain. This variant acts as a 
negative regulator of JAK/STAT signaling. It was shown that over-expression of 
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ΔNSTAT92E is sufficient to suppress JAK/STAT-dependent transcriptional activation of the 
pair-rule gene even-skipped in vivo (Henriksen et al., 2002). 
 
 
Fig. 1.3: Protein structure of Drosophila STAT92E splice variants (modified after 
Henriksen et al., 2002). Two transcripts differing in the 5´-UTR give rise to identical 
proteins of ~87kD. Additionally, a protein, in which seven additional residues are inserted 
after residue 698 via a differential splice event between two exons, is translated. Furthermore, 
a N-terminal truncated version ΔNSTAT92E of ~72 kDa is also translated. This protein lacks 
134 amino acids of the N-terminal domain (NT). Y704/711 and Y577 represent the conserved 
tyrosine residue, essential for STAT activation (Shuai et al., 1993b). Size bar represents 100 
amino acids. CC: Coiled-coil domain, DNA: DNA binding domain, LD: Linker domain, SH2: 
SH2 domain, TAD: Transactivation domain. 
 
In vertebrates seven different STAT proteins participate in JAK/STAT signaling. Control of 
overall JAK/STAT activity involves post-translational modifications and interactions of 
different STAT proteins with co-regulators (reviewed in Brierley and Fish, 2005). However, 
STAT92E is sufficient to regulate multiple processes in Drosophila, which are regulated by 
different STAT proteins in vertebrates. It was shown that STAT92E exerts opposing roles in 
cellular proliferation analogous to the pro- and anti-proliferative roles of vertebrate STAT3 
and STAT1 (Mukherjee et al., 2005). Therefore, it is very likely that the regulation and 
control of Drosophila STAT92E activity requires a complex system of interactions with 
multiple co-regulators. One example is the repression of JAK/STAT-dependent expression of 
the genes trh, ventral veins lacking and knirps, which is mediated by DNA binding of the 
repressor Ken & Barbie to a subset of STAT92E recognition sites (Arbouzova et al., 2006). 
Furthermore, regulation of STAT92E activity by post-translational modifications, in addition 
to tyrosine phosphorylation, most likely also plays an important role for the control of 
Drosophila JAK/STAT signaling. 
For the better understanding of the regulatory mechanisms controlling STAT activity in vivo, 
this study characterized Drosophila STAT92E protein function by mutational analysis. Loss-
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of- and gain-of-function alleles of STAT92E were generated and analyzed for their function 
in cell culture and in vivo assays. This way, residues have been identified that are involved in 
the regulation of STAT92E sub-cellular localization and DNA binding activity and are also 
important for STAT92E function as a transcriptional activator. 
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2 Material & Methods 
 
2.1 Solutions 
Table 2-1: Composition of solutions used in this study. 
AP buffer 100 mM NaCl, 50 mM MgCl2, 0.1M Tris pH 9.5, 0.1% Tween20 
Binding buffer 20 mM HEPES pH 7.9, 1.4 mM MgCl2, 40 mM KCl, 0.1 mM EGTA, 
5% Glycerol, 0.5 mM DTT, 1 mM PMSF, 50 mg/ml Poly-dI-dC 
Cell resuspension 
buffer 
40 mM HEPES-KOH pH 7.9, 0.4 M KCl, 10% glycerol, 1 mM DTT, 
0.1 mM PMSF 
Cell rinse buffer 40 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.15M NaCl 
EB buffer 10 mM Tris-Cl pH 8.5 
Extraction buffer 0.1 M NaCl, 0.2 M sucrose, 0.1 M Tris-HCl pH 9.0, 50 mM EDTA, 
0.5% SDS 
Hybe 50% formamide, 5x SSC, 0.2 mg/ml sonicated salmon testis DNA, 0.1 
mg/ml tRNA, 50 µg/ml heparin 
Hybe B 50% formamide, 5x SSC 
Lysis buffer (for 
EMSA) 
10 mM HEPES pH 7.9, 10 mM KCl, 5 mM MgCl2, 1% Triton X-100, 
50% Glycerol, 1 mM DTT, 1 mM Na-O-vanadate, 1 mM PMSF 
PBS 130 mM NaCl, 7 mM Na2HPO4, 3 mM NaH2PO4 
PBT PBS with 0.1% Tween20 or 0.1% Triton X-100 
RIPA buffer 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM DTT, 0.1 mM PMSF, 
2.5 mM Na-O-vanadate, 0.1% NP-40, 10% glycerol, protease 
inhibitors (Complete EDTA-free, Roche Diagnostics, Mannheim) 
RNA fixative 10% paraformaldehyde in PBS, 50 mM EGTA (pH 7.0) 
4x SDS-gel buffer 1.5 M Tris-base, 0.4% SDS (pH 8.8) 
10x SDS-running 
buffer 
0.4 M Tris-base, 1.9 M glycin, 0.5% SDS 
0.5x TBE buffer 44.5 mM Tris-base, 44.5 mM boric acid, 1 mM EDTA (pH 8.0) 
TE buffer 10 mM Tris-HCl pH 8.0, 1 mM EDTA 
Transfer buffer 0.25 M Tris-base, 0.2 M glycin, 20% methanol 
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2.2 Bacterial culture 
Bacterial cells of E. coli strain XL1-blue (Stratagene, Amsterdam, The Netherlands) were 
grown either in LB+ medium with vigorous shaking (300 rpm) or on agar plates at 37°C. 
 
Solutions: 
LB- (per 1l of medium) 10 g bacto-tryptone, 5 g bacto-yeast extract, 10 g NaCl (pH 
7.0), autoclaved 45 min at 120°C 
LB+    LB- with 50 µg/ml ampicillin or 34 µg/ml chloramphenicol 
LB-agar   15g agar-agar, 1l of LB-, autoclaved and stored at RT 
 
To prepare plates LB-agar was melted, cooled down approximately to 50°C and 
supplemented with antibiotics to the same final concentration as in LB+. 
 
2.3 Nucleic acid manipulation 
2.3.1 Molecular cloning 
In the genomic region of socs36E (GenBank Scaffold: AE003657 & AE003658) fragments 
containing putative enhancer elements with potential STAT92E binding sites were amplified 
by PCR (see 2.3.2). To do so, sequence-specific primers for these regions were used, also 
introducing restriction sites for subsequent cloning (Table 2-2). After restriction (see 2.3.4) 
these fragments were sub-cloned (see 2.3.5) into the similar cut pW8ßE (see Table 2-4) or the 
pGL3-Promoter vector (Promega, Mannheim) to generate socs36E-lacZ or socs36E(I)-luc 
constructs as reporter for JAK/STAT activity, respectively. 
Fusion proteins, termed STAT92E-GFP, were generated for expression in Drosophila cells 
and as a tool to visualize JAK/STAT activity on the basis of STAT92E sub-cellular 
localization. The fusion protein consists of the full length stat92E ORF (Splice form CG4257-
RC; FlyBase, 2003) amplified with sequence-specific primers from STAT92E cDNA (Hou et 
al., 1996) and trimmed with restriction endonucleases Asp718 and BamHI. EGFP-fused 
constructs were produced in two steps: the stat92E ORF was first cloned into the pBS-
EGFPB vector (M. Zeidler, unpublished) and then re-cloned into the pUAST vector (Brand 
and Perrimon, 1993). pBS-EGFPB is a cassette based cloning system designed to generate C-
terminal fusions with EGFP (Clontech, Saint-Germain-en-Laye, France) and was generated 
by amplifying EGFP with sequence-specific primers. The PCR products were then trimmed 
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with BamHI and XbaI before cloning into a similarly cut pBS (KS+) vector (Stratagene, 
Amsterdam, The Netherlands). The resulting EGFP coding region includes a stop codon. The 
in frame cloning of STAT92E into pBS-EGFPB generates the amino acids N and P not 
originally present in either protein. pBS-STAT92E-GFP and pUAST-STAT92E-GFP were 
generated by M. Zeidler and have been described recently (Karsten et al., 2006). These 
constructs were used as a basis to generate several STAT92E-GFP mutants. Point mutations 
in STAT92E-GFP were introduced by site-directed mutagenesis (see 2.3.3). 
 
Table 2-2: Schemes for molecular cloning. 
Construct Primers Template 
Restriction 
sites in 
polylinker 
socs36E(I)-lacZ GTTAGGTACCGGGTCGCAGTATCGTTGGCG CGAAGGATCCCTGTCACTTCTCAGAAATCGGTC 
genomic 
DNA 
Asp718 
BamHI 
socs36E(II)-lacZ GATAGGTACCGTTCTTGTCTGCGCTCGTTTC GGATGGATCCCTACGAACC GCGAAATCAACAC 
genomic 
DNA 
Asp718 
BamHI 
socs36E(III)-lacZ CTAAGGTACCGTGCGGCATGGAGTCGTGCATG GCTAGGATCCCGCATCAGTTAGTGCTCCCC 
genomic 
DNA 
Asp718 
BamHI 
socs36E(IV)-lacZ GCGCGGTACCGATGAAATCCAATCAAGTAGTGAC GTAAGCGGCCGCGCTGCTCGGCAGCATATC 
genomic 
DNA 
Asp718 
NotI 
socs36E(I)-luc GTTAGGTACCCTGTCTTAGGTGTTTACCAC CGTTAGATCTGTGCGAGTACGAGTATCTTTG 
genomic 
DNA 
Asp718 
BglII 
pUAST-STAT92E-
GFP and mutant 
variants 
GAGGTACCGAGCATGAGCTTGTGGAAGCGC 
GTTCTAGATTACTTGTACAGCTCGTCCATGCCGAGAGTG 
pBS(KS+)-
STAT92E-
GFP 
Asp718 
XbaI 
 
2.3.2 Polymerase chain reaction 
Polymerase chain reaction (PCR) amplification of DNA fragments was used in this study for 
molecular cloning (see 2.3.1), site-directed mutagenesis (see 2.3.3) and the synthesis of 
templates for RNA in situ probes (see 2.3.7) and for double-stranded (ds) RNA used in RNAi 
experiments (see 2.4.4) 
 
PCR reactions were generally set up in a volume of 50 µl and composed of: 
 
1x PCR buffer (DNA polymerase-specific, supplied by manufactory) 
0.25 mM dNTPs (Roche Diagnostics, Mannheim) 
0.2 µM primers (MWG-Biotech AG, Ebersberg) 
2. Material & Methods 
 
 
17 
1U Taq (Fermentas, St. Leon-Rot) or 2.5U PfuTurbo DNA polymerase (Stratagene, 
Amsterdam, The Netherlands) 
50ng (plasmid) to 1µg (genomic) DNA 
 
General PCR cycling parameters were: 
Pre-denaturation 2 min at 95°C 
26 cycles of: denaturation 30 sec at 95°C 
   annealing 30 sec at appropriate temperature for the used pair of primers 
   synthesis 1 min per kb for Taq or 2 min per kb for PfuTurbo at 72°C 
10 min to complete synthesis at 72°C 
Primer annealing temperature was calculated from: Tannealing = Tmelting -5°C 
 
All primers used in PCR reactions are shown in Table 2-3 (for primers used in molecular 
cloning see Table 2-2): 
Table 2-3: Primers used for PCR. 
Primer name Primer sequence 
Primers for synthesis of templates for RNA in situ probes and for dsRNA used in RNAi 
experiments (T7 promoter marked red): 
trh-F GATTTCAGTGCCGACTCTCTG 
T7trh-R GAATTAATACGACTCACTATAGGGAGACTGATCCGTCTTGATGATGGT 
STAT92E-F TAATACGACTCACTATAGGGAGAAGCTGCTTGCCCAAAACTA 
STAT92E-R TAATACGACTCACTATAGGGAGCAGCTGAGAACCGATTAGCC 
T7DOME-F GAATTAATACGACTCACTATAGGGAGACCAGCTGCCTGACAAGCACC 
DOMET7-R GAATTAATACGACTCACTATAGGGAGACTGGACCCAGGCCCAATCCC 
SOCT7-F (socs36e) GAATTAATACGACTCACTATAGGGAGACCGCATCCACATCCGTGTCCAC 
SOCT7-R (socs36e) GAATTAATACGACTCACTATAGGGAGAAACGTGCCCTCCGGCTTG 
SamS-F TAATACGACTCACTATAGGGAGCGCTCAGATGTGTTCTGGTG 
SamS-R TAATACGACTCACTATAGGGAGATGGAGAGAGGCTCAGCAAG 
PRMT1-F TAATACGACTCACTATAGGGAGGGACAAGTGGCTGAAGAAGG 
PRMT1-R TAATACGACTCACTATAGGGAGGAAGTCCAGGTCACGGTTGT 
CG3675-F TAATACGACTCACTATAGGGAGATCTTGGATTCTGGCACGAT 
CG3675-R TAATACGACTCACTATAGGGAGGATCGGAGAGCACAAAGGAC 
CG5358-F TAATACGACTCACTATAGGGAGCCACGTGCTCAAGGAGTACA 
CG5358-R TAATACGACTCACTATAGGGAGCTTCCCCGGTATCACAGAGA 
CG6563-F TAATACGACTCACTATAGGGAGCCATCCATTCGGAAACTATGA 
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Primer name Primer sequence 
CG6563-R TAATACGACTCACTATAGGGAGTCAGCAATCCGCTGTTGTAG 
CG9882-F TAATACGACTCACTATAGGGAGCGGCGATGACTACGACTACC 
CG9882-R TAATACGACTCACTATAGGGAGGCAATCGTTTTCAGGCTGTT 
CG9927-F TAATACGACTCACTATAGGGAGAACCAAAAATTGCCCTTCCT 
CG9927-R TAATACGACTCACTATAGGGAGCCATCCATTCGGAAACTATGA 
CG9929-F TAATACGACTCACTATAGGGAGAGGAGGTGATCTTTGCCAGA 
CG9929-R TAATACGACTCACTATAGGGAGCATCCCAAGCTCTCCGATTA 
CG10061-F TAATACGACTCACTATAGGGAGCGGCGTCTAAACAAAACTGC 
CG10061-R TAATACGACTCACTATAGGGAGGTTGAGATCGTCGAGCTGTG 
CG16840-F TAATACGACTCACTATAGGGAGTGCGATATTGGGGAATAAGG 
CG16840-R TAATACGACTCACTATAGGGAGCTTGCGGATTCAGCTGTGTA 
CG32152(2)-F TAATACGACTCACTATAGGGAGTAGTGTGGCAGAGCGAAAGA 
CG32152(2)-R TAATACGACTCACTATAGGGAGTCATGACCGTGATCACACCT 
Primers for sequencing: 
STAT-S1 CAGGGCATAGGACCTATCCAC 
STAT-S2 CGCGCAGAAGAACCTGGT 
STAT-S3 CCGACCGCGTTACCTGGG 
STAT-S4 CCGTTTCTCCGACAGCGAG 
STAT-S5 CTCCACCGAGCTCGCTG 
STAT-S6 CTCCGCAAATGCATTGTCCC 
STAT-S7 CAGCTGAGAACCGATTAGCC 
STAT-S8 GGGTGTGACCATACCGAGGG 
Primers for site-directed mutagenesis (mutations introduced in STAT92E-GFP are shown in red): 
M647H-F CGAAAATGGACTGGTCACCCACCTAGCGCCATGGACTGC 
M647H-R GCAGTCCATGGCGCTAGGTGGGTGACCAGTCCATTTTCG 
Y711F-F (Y704F) CTAGATCCTGTGACCGGTTTCGTGAAGAGCACATTACATG 
Y711F-R (Y704F) CATGTAATGTGCTCTTCACGAAACCGGTCACAGGATCTAG 
STATR30A-F GGAGAAGGGTATGCTCGAGCTGGCCCTCTGCTTGGCACCC 
STATR30A-R GGGTGCCAAGCAGAGGGCCAGCTCGAGCATACCCTTCTCC 
STATR30E-F GGAGAAGGGTATGCTCGAGCTGGAGCTCTGCTTGGCACCC 
STATR30E-R GGGTGCCAAGCAGAGCTCCAGCTCGAGCATACCCTTCTCC 
STATR30K-F GGAGAAGGGTATGCTCGAGCTGAAGCTCTGCTTGGCACCC 
STATR30K-R GGGTGCCAAGCAGAGTTCCAGCTCGAGCATACCCTTCTCC 
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2.3.3 Site-directed mutagenesis 
Point mutations in pBS-STAT92E-GFP were generated using the QuickChange in vitro 
mutagenesis technique (Stratagene, Amsterdam, The Netherlands). Two or three successive 
rounds of mutagenesis were performed to generate double or triple mutations, respectively. 
All constructs were sequenced before they were sub-cloned into the inducible Drosophila 
germline transformation vector pUAST (Brand and Perrimon, 1993). 
To generate point mutations at positions R30, M647 and Y704 of STAT92E-GFP, specific 
primers were designed carrying nucleotide substitutions (see Table 2-3). These point 
mutations converted the triplets CGC into GCC, GGC, GAG for R30A, R30E, R30K 
substitutions, ATG into CAC for M647H substitution and TAT into TTC for Y704F 
substitution, respectively. Following 7-10 cycles of PCR amplification (see 2.3.2) of pBS-
STAT92E-GFP by PfuTurbo (Stratagene, Amsterdam, The Netherlands) using those primers, 
the resulting mixture containing the template and the newly synthesized plasmid was treated 
with DpnI (Stratagene, Amsterdam, The Netherlands), a restriction endonuclease recognizing 
a 4 bp methylated DNA site. DpnI digestion destroyed the methylated parental template. The 
newly synthesized mutated plasmid was transformed into bacteria. The resulting clones were 
analyzed, and stat92E ORFs carrying the desired mutations were re-cloned into the pUAST 
vector (Brand and Perrimon, 1993). 
 
2.3.4 Endonuclease restriction 
For molecular cloning or analysis of generated constructs restrictions were normally carried 
out for 1h at 37°C in 20 - 30 µl volume using 1 - 10U of the designated restriction enzyme 
and the respective buffer (Fermentas, St. Leon-Rot or New England Biolabs, Frankfurt a. M.). 
Restriction and PCR products were analyzed by electrophoresis on 0.8 - 1.5% agarose gels in 
0.5x TBE buffer. The DNA fragments were stained with ethidium bromide and visualized 
with an UV-transilluminator (Raytest, Straubenhardt) at 366nm. The GeneRuler DNA Ladder 
Mix (Fermentas, St. Leon-Rot) was used to control fragment sizes. 
DNA fragments were purified by either ethanol precipitation (salting agent 500 mM NaCl), 
air-dried and dissolved in EB buffer (Qiagen, Hilden), or the desired band was excised from 
the gel and purified using the Gel Extraction Kit (Qiagen, Hilden). 
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2.3.5 Ligation 
For ligation cut and purified fragments were mixed with similar cut vector DNA (see 2.3.4) in 
a ratio of approximately 4:1. Ligation reactions were carried out in a total volume of 20 µl o/n 
at 16°C in 1x ligation buffer using 1U of T4 DNA ligase (Roche Diagnostics, Mannheim). 
 
2.3.6 Heat shock transformation of bacterial cells 
Plasmids were introduced into chemical competent E. coli XL1-Blue cells by heat shock 
transformation. Plasmids or ligation samples were mixed with 100 µl competent cells and 
incubated 45 min on ice. A 45 - 55 sec heat shock at 42°C followed. After two min chilling on 
ice cells recovered in 900 µl LB- medium for 1h at 37°C, were then spread on agar plates 
supplemented with the appropriate antibiotic and grown o/n at 37°C. 
Colonies containing the desired plasmid DNA were used to inoculate in 5 ml LB+ medium 
and grown o/n at 37°C. 1 ml of the bacterial suspension was used for analytical DNA 
preparation by the QIAprep Spin Miniprep Kit (Qiagen, Hilden). Presence of the cloned DNA 
fragments was tested by analytical restriction digests (see 2.3.4) and, if necessary, confirmed 
by DNA sequencing. The bacterial colonies containing the desired DNA constructs were used 
to inoculate in 100 - 150 ml LB+ medium and grown o/n at 37°C. Plasmid DNA preparation 
was performed using the Plasmid Maxiprep Kit (Qiagen, Hilden). 
 
Table 2-4: Plasmids used. 
Construct Remarks Reference 
pUC18-Act-Gal4 constitutively expresses Gal4  
pUAST vector for Gal4 mediated transgene expression (see 2.7.4) Brand and Perrimon, 
1993 
pAct-Renilla constitutively expresses Renilla luciferase Müller et al., 2005; 
Karsten et al., 2006 
pAct-Upd-GFP constitutively expresses Upd-GFP Müller et al., 2005 
pAct-HopTuml constitutively expresses HopTuml Müller et al., 2005 
2xDrafSTATwt-
TATA-luc 
JAK/STAT-dependent luciferase reporter construct 
containing 2 STAT92E binding sites of the Draf promoter 
Kwon et al., 2000 
6x2xDrafLuc multimerized form of 2xDrafSTATwt-TATA-luc Müller et al., 2005 
pW8ßE vector for P-element-mediated germ line transformation, 
includes lacZ ORF 
modified after Klemenz 
et al., 1987 
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2.3.7 RNA probe labeling for in situ hybridization 
For RNA in situ hybridization experiments (see 2.8.1.2) anti-sense RNA probes were labeled 
with DIG-coupled UTPs using the DIG-Labeling Kit (Roche Diagnostics, Mannheim). 
Genomic DNA or plasmids containing the corresponding cDNA were used as template (see 
Table 2-5). The labeling reaction was performed according to the manufacturer´s instructions. 
The labeled probe was subsequently mixed with 10 µl of 20 mg/ml non-specific tRNA 
(Sigma-Aldrich, Taufkirchen) in a final volume of 200 µl (adjusted with DEPC-treated H2O). 
The RNA was precipitated by ethanol (salting agent 400 mM LiCl) for at least 2h at –80°C, 
subsequently centrifuged at 13000 rpm for 15 min, washed twice with 70% ethanol, air-dried 
and dissolved in 100 µl of DEPC-treated H2O for 30 min at 37°C. 
The efficiency of labeling was tested by dot-blot hybridizations. 1 µl of serial dilutions of the 
probes (1:10, 1:100, 1:1000) and control RNA (1 ng/µl, 100 pg/µl, 10 pg/µl, 1 pg/µl) were 
spotted onto a nylon membrane (Amersham Biosciences, Freiburg). When fully dried, the 
nucleic acids were cross-linked to the membrane by UV-light for two min. The membrane 
was afterwards washed two times for five min with PBS, blocked with PBS supplemented 
with 10 µg/ml BSA and 5% sheep serum for 30 min and hybridized with anti-DIG alkaline 
phosphatase (AP)-conjugated antibody (1:5000 dilution, Roche Diagnostics, Mannheim) for 
30 min at RT to detect incorporated DIG-coupled UTP in the synthesized probes. The 
membrane was then washed three times for ten min with PBS to remove unbound antibodies. 
After two washing steps with AP-buffer of ten min each, colorimetric detection of the alkaline 
phosphatase was performed using NBT/BCIP solution (20 µl of stock solution (Roche 
Diagnostics, Mannheim) per 1 ml AP-buffer). This reaction was stopped by several washes 
with PBS. The intensity of the experimental spots was compared with the control, and the 
approximate concentration of the labeled probe was estimated (suggested working 
concentration 1 ng/ml). 
For DEPC-treatment 1 ml DEPC (Sigma-Aldrich, Taufkirchen) per 1l H2O was constantly 
mixed for 1h at 37°C or o/n at RT and autoclaved afterwards. 
 
Table 2-5: Scheme for RNA probe preparation. 
Probe Template Restriction enzyme / primers Polymerase 
socs36E pOT2A-socs36E EcoRI SP6 
lacZ pBS-KS-ßgal NotI T3 
trh genomic DNA trh-F, T7trh-R (see Table 2-3 for primer sequences) T7 
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2.3.8 Isolation of genomic DNA from flies 
For genomic DNA isolation approximately 50 flies per sample were frozen and ground in 400 
µl DNA extraction buffer using a plastic pestle. Additional 400 µl DNA extraction buffer can 
help to rinse the pestle. The homogenate was incubated for 30 min at 65°C. After the addition 
of 120 µl 8 M K-acetate the sample was incubated for 30 min on ice. After centrifugation at 
13000 rpm for five min the supernatant was transferred into a fresh tube. The DNA was 
purified by ethanol precipitation. After centrifugation the pellet was washed with 70% 
ethanol, dried and resuspended in 400 µl TE buffer. RNAs were removed by RNAse 
treatment (final concentration 2 µg/ml) for 30 min at 37°C. The DNA was subsequently 
purified by phenol/chloroform extraction followed by ethanol precipitation. Finally, the DNA 
was dissolved in 50 µl TE buffer with an approximate DNA concentration of 1 µg/µl. 
 
2.4 Drosophila cell culture & cell culture based assays 
2.4.1 Maintenance of cultured cells 
S2 (Schneider, 1972), Kc167 (Echalier and Ohanessian, 1969) and S2R+ (Yanagawa et al., 
1998) cultured Drosophila cells were grown in 75cm2 flasks (BD Biosciences, Heidelberg) 
containing 10 ml Schneider’s Drosophila medium (Gibco Invitrogen, Karlsruhe) 
supplemented with 10% fetal calf serum (Sigma-Aldrich, Taufkirchen) and 
penicillin/streptomycin (0.1 mg/ml, PAA Laboratories, Pasching, Austria GmbH) at 25°C. 
 
2.4.2 Transfections 
JAK/STAT pathway components were ectopically expressed in cultured cells for functional 
analysis of this signal cascade. To do so, cells were seeded three to six h before transfection. 
In general, 3x104 cells per well of a 96-well plate, 5x105 per well of a 6-well plate and 1x106 
(5x106) cells onto 60mm (100mm) dishes were seeded. 
Transfections were performed using the Effectene Transfection Reagent (Qiagen, Hilden) 
according to the manufacturer´s instructions except using 11 µl instead of 22 µl Effectene 
Reagent per 1 µg DNA. 
Methylation in cultured cells was inhibited to assess its role for JAK/STAT signaling. For this 
purpose, cultured cells were treated with 5´-deoxy-5´(methylthio)adenosine (MTA, Sigma-
Aldrich, Taufkirchen), which was dissolved in Schneider’s Drosophila medium (Gibco 
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Invitrogen, Karlsruhe). MTA was added 6h after transfection in the final concentration of 0.1 
or 0.5 mM and was incubated with the cells until lysis. 
For inhibition of protein tyrosine phosphatases for EMSA analysis (see 2.5.3) sodium-ortho-
vanadate (Sigma-Aldrich, Taufkirchen) was used. 50 µl sodium-ortho-vanadate (1M) and 55 
µl H2O2 (31% stock) were incubated in 1 ml Schneider’s Drosophila medium (Gibco 
Invitrogen, Karlsruhe) for five min at RT. This mixture was added to the transfected cells in a 
final concentration of 100 µM sodium-ortho-vanadate and 1 µM H2O2 for 45 min before lysis. 
 
2.4.2.1 Transfections for dual luciferase reporter assays 
For dual luciferase reporter assays cultured cells were seeded in 96-well plates. Transfections 
were performed as described in 2.4.2. Transfection mixtures (200 ng DNA per well) were set 
up in replicates. 65 ng reporter construct, 35 ng pAct-Gal4 and 5 ng pAct-Renilla was 
transfected per well. Additionally, to test the effect of STAT92E-GFP variants, 55 ng pUAST-
STAT92E-GFP was co-transfected with 40 ng pUAST-Hop(Tuml) or Act-Hop(Tuml). For mock or 
non-stimulation transfections pUAST and pAct constructs were substituted for equal amounts 
of each of the respective empty pUAST- and pAct constructs. For transfection in replicates 
plasmid mixtures were prepared in the respective multiple amounts of DNA specified above. 
Before addition to the cells, the transfection mixtures were split to transfect 200 ng DNA in 
total per well. Cells were lysed 72h after transfection according to the Dual-Luciferase Assay 
Kit (Promega, Mannheim). Lysates were then used in a dual luciferase assay for measurement 
of luciferase activities (see 2.4.3.2). 
 
2.4.2.2 Transfections for EMSA and Western blotting experiments 
For EMSA and Western Blotting experiments cultured cells were seeded in 60mm (100mm) 
tissue culture dishes. Transfections were performed as described in 2.4.2 with 500 (750) ng 
pAct-Gal4 and 2 ng pUAST-luc as normalization control. To express STAT92E-GFP variants, 
500 (750) ng pUAST-STAT92E-GFP was co-transfected with 500 ng pUAST-Hop(Tuml) or Act-
Hop(Tuml). For mock or non-stimulation transfections pUAST and pAct constructs were 
substituted for equal amounts of each of the respective empty pUAST and pAct constructs. 
Cells were lysed 72h after transfection (see 2.5.1 for immunoprecipitation and Western 
blotting or 2.5.3 for EMSA analysis). 
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2.4.2.3 Transfections for immuno-staining and sub-cellular localization assays 
For immuno-staining and sub-cellular localization experiments cultured cells were seeded in 
6-well plates on glass coverslips. Transfections were performed as described in 2.4.2 with 300 
ng pAct-Gal4. To express STAT92E-GFP variants, 500 ng pUAST-STAT92E-GFP was co-
transfected with 200 ng pUAST-Hop(Tuml) or Act-Hop(Tuml). For mock or non-stimulation 
transfections pUAST and pAct constructs were substituted for equal amounts of each of the 
respective empty pUAST and pAct constructs. Cells were fixed and mounted 72h after 
transfection (see 2.8.2). 
 
2.4.3 Luciferase assays 
Firefly and Renilla luciferase activities were measured on a Wallac Victor Light 1420 
luminescence counter (PerkinElmer, Rodgau-Jügesheim) using the Dual-Luciferase Reporter 
Assay (Promega, Mannheim). 
 
2.4.3.1 Firefly luciferase activity measurement 
Firefly luciferase activity was used for normalization of the relative transfection efficiency of 
cells prepared for EMSA experiments (see 2.5.3). Firefly luciferase was consitutively 
expressed in cultured cells (see 2.4.2.2), and its activity in cell lysates was determined 
according to the manufacturer´s instructions. Measurements were performed in non-
transparent 96-well reading plates. 25 µl LAR-II solution (luciferase assay reagent, Promega, 
Mannheim) was injected into each well containing 5-10 µl of the lysate (see 2.4.2.2). After a 
delay of two sec, the luminescent signal was measured for ten sec. 
 
2.4.3.2 Dual luciferase reporter assay 
2xDrafSTATwt-TATA-luc (Kwon et al., 2000) or 6x2xDrafLuc (Müller et al., 2005) reporter 
activation dependent on JAK/STAT activity results in firefly luciferase expression. Renilla 
luciferase was ubiquitously expressed using the actin5.1 promoter to assay for transfection 
efficiency and as a control suitable for normalization. Both firefly and Renilla luciferase 
activities were analyzed using the Dual-Luciferase Reporter Assay (Promega, Mannheim). 20 
µl of the lysates of transfected cells (see 2.4.2.1) were used for measuring. 25 µl LAR-II 
solution (Promega, Mannheim) containing the substrate for the firefly luciferase were added 
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to the cell lysates. After a delay of three sec, measurement of the luminescent signal was 
performed for ten sec. Afterwards, the reaction was quenched, and the Renilla luciferase 
reaction was started simultaneously by addition of 25 µl Stop&Glo solution (Promega, 
Mannheim). After another delay of three sec, the luminescent signal of Renilla luciferase was 
measured for ten sec. Relative reporter activity was calculated from the ratio of firefly to 
Renilla luciferase activity. Reporter activation values in experimental samples were 
normalized to mock transfected cells. 
 
2.4.4 RNA interference 
The dual luciferase reporter system (see 2.4.3.2) was also used in RNAi assays to identify 
genes that interact with the JAK/STAT pathway. Candidate gene expression was knocked 
down in cultured cells by the addition of sequence-specific dsRNA. The effect of the resultant 
reduced candidate gene expression on JAK/STAT signaling was detected using the dual 
luciferase reporter assay. dsRNA targeting candidate genes was generated from DNA 
fragments covering 400 - 600bp of the respective gene. These fragments were amplified by 
PCR on genomic DNA (see 2.3.2) using gene-specific primers introducing a T7 RNA 
polymerase promoter (see Table 2-3). The gene specific region of the primers was directed 
against single exons of the candidate genes. One-tenth of the PCR sample was used for 
subsequent generation of dsRNA in an in vitro transcription reaction using T7 RNA 
polymerase: 
 
 PCR template 
1x transcription buffer (Fermentas, St. Leon-Rot) 
10 mM DTT (Sigma-Aldrich, Taufkirchen) 
 1 mM NTPs (Roche Diagnostics, Mannheim) 
 60U RNAse inhibitor (Fermentas, St. Leon-Rot) 
10U T7 RNA polymerase (Fermentas, St. Leon-Rot) 
 
This reaction was carried out for at least 2h at 37°C. Afterwards, DNA was degraded by 
DNAse treatment (15U, Fermentas, St. Leon-Rot) for 15 min at 37°C. The RNA was then 
purified by ethanol precipitation, air-dried and dissolved in RNAse-free H2O. Formation of 
dsRNA was achieved by heating the RNA for one min to 95°C and subsequent cooling down 
to RT. 
2. Material & Methods 
 
 
26 
For RNAi interaction assays 1.5 µg dsRNA / 1x105 cells were added to cultured cells 2h after 
transfection to specifically knock down candidate gene expression. The cells were incubated 
with dsRNA until lysis for the dual luciferase reporter assay (see also 2.4.2.1). 
 
2.5 Protein biochemistry 
2.5.1 Immunoprecipitation 
Immunoprecipitation (IP) and Western Blotting experiments were performed to monitor post-
translational modifications of STAT92E-GFP variants, which were expressed in cultured cells 
(see 2.4.2.2). To obtain crude cell lysates, cells were rinsed several times in cell rinse buffer, 
transferred into 1 ml cell rinse buffer and centrifuged at 13000 rpm for two min at RT. The 
cell pellet was then resuspended in 400 µl cell resuspension buffer and subjected to three 
cycles of freezing in liquid nitrogen and thawing. Cellular debris was removed by 
centrifugation at 13000 rpm for five min at 4°C. The supernatent was stored at -80°C. 
For IP RIPA buffer was added to the crude cell lysates to a total volume of 470 µl. Lysates 
were then mixed with anti-GFP antibody (1:500, Abcam, Cambridge, UK) and rocked for 3h 
at 4°C. 50 µl of 50% Protein-A agarose beads (Calbiochem, Bad Soden) were washed in 
RIPA buffer three times for five min at 4°C, added to the lysates and incubated on a rocking 
platform o/n at 4°C. The beads were washed in RIPA buffer five times for 20 min, 
centrifuged, mixed with 15 µl of 2x Laemmli buffer (Laemmli, 1970) and boiled for five min. 
The eluted proteins were resolved by SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
and analyzed by Western blotting (see 2.5.2). 
 
2.5.2 SDS-Polyacrylamid Gel Electrophoresis & Western Blotting 
Discontinous gels were composed of 8% polyacrylamide for the separating gel and 5% 
polyacrylamide for the stacking gel. Electrophoresis was performed in 1x SDS-running buffer 
at 35mA constant current. Pre-stained SDS-PAGE Standards (New England Biolabs, 
Frankfurt a. M.) were used as molecular weight control. 
For Western Blotting the unstained gel was rinsed with transfer buffer immediately after 
electrophoresis and put onto a piece of nitrocellulose membrane (Schleicher & Schuell, 
Dassel) moistened with transfer buffer. The protein transfer apparatus was assembled in a way 
that the membrane was oriented to the anode, while the gel faced the cathode to allow the 
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transfer of the negatively charged SDS-coated proteins onto the membrane. Western Blotting 
was carried out at 150mA per gel for 1h at 4°C. Afterwards, the membrane was rinsed in PBS 
and subsequently blocked in PBS with 10 mg/ml BSA for 1h at RT or o/n at 4°C. Primary 
antibody incubation was carried out o/n at 4°C (for an overview of the antibodies, see Table 
2-6). Unbound antibody was removed by washing with PBS four times for ten min. The 
membrane was then incubated with species-specific horseradish peroxidase (HRP)-conjugated 
secondary antibody (Perbio Science, Bonn, see Table 2-6) in PBS with 10 mg/ml BSA for 1 - 
2h at RT. Subsequent washing steps were performed similar to the ones after primary 
antibody incubation. The coupled peroxidase was incubated with the SuperSignal West Pico 
Chemiluminescent Substrate (Perbio Science, Bonn) for five min at RT. Luminescence was 
detected either on a Fujifilm Luminescent Image Analyser LAS-1000 CH or using BioMax 
XAR films (Kodak, Stuttgart). 
 
Table 2-6: Antibodies used. 
Primary antibodies 
rabbit polyclonal antibody to GFP 1:5000 (Western blotting) 
1:500 (IP) 
Abcam ab290-50 
Mouse monoclonal (7E6) to Arginine (mono- and di-methyl) 1:500 (Western blotting) 
1:100 (IP) 
Abcam ab412-200 
Secondary antibodies 
Goat anti-mouse HRP conjugated 1:8000 Pierce #1858412 
Goat anti-rabbit HRP conjugated 1:8000 Pierce #1858415 
 
2.5.3 Electro Mobility Shift Assay 
Electro Mobility Shift Assays (EMSA) were used to test for the ability of STAT92E-GFP 
variants to bind radio-labeled oligonucleotides containing a STAT92E consensus recognition 
site (Yan et al., 1996). 
 
DNA probe labeling and cold oligonucleotides synthesis for EMSA 
Single-stranded DNA oligonucleotides with partly complementary sequences were designed 
containing a STAT92E consensus or a mutated recognition site (for sequences see Table 2-7). 
5pmole of each oligonucleotide were mixed with Restriction Buffer 2 (New England Biolabs, 
Frankfurt a. M.) in a final volume of 100 µl, denatured for ten min at 95°C and let cool down 
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to RT to allow the annealing of the single-stranded oligonucleotides. The resulting dsDNA 
fragments with the calculated concentration of 5 µM contained 3’-overhangs, which were 
filled by Klenow with dNTPs containing 32P-dCTP. The composition of the labeling reaction 
in a volume of 50 µl was as followed: 
 
1x Restriction buffer 2 (New England Biolabs, Frankfurt a. M.) 
0.5 µM annealed oligonucleotides 
0.4 mM each dATP, dTTP and dGTPs (Roche Diagnostics, Mannheim) 
0.33 µM 32P-dCTP (Hartmann Analytic, Braunschweig) 
2U Klenow fragment (Roche Diagnostics, Mannheim) 
The reaction was incubated for 20 min at 37°C. 
 
The synthesized probe was purified using the Nucleotide Removal Kit (Qiagen, Hilden) 
according to the manufacturer´s instructions. When eluted in 100 µl EB buffer, the calculated 
concentration of the probe was 250 nM. The labeling efficiency was measured on Bioscan 
QC-4000 XER. Generally, 1 µl of the probe gave 100000 – 700000 cpm (counts per min). 
10000 cpm are sufficient for one EMSA reaction. 
Synthesis of cold oligonucleotides was performed similarly, except that the labeling reaction 
was carried out in a volume of 100 µl, the annealed oligonucleotides were added in 10x 
higher concentration, and 32P-dCTP was replaced with dCTP with the final concentration of 
0.5 mM for each dNTP. When eluted in 100 µl EB buffer, the calculated concentration of cold 
oligonucleotides was 2.5 µM. 
 
Table 2-7: Sequence of oligonucleotides used for STAT92E probe labeling. Nucleotides 
essential for STAT92E binding are depicted in red. 
Oligonucleotide Probe Sequence 
wtSTAT-top GGATTTTTCCCGGAAATG 
wtSTAT-bottom 
WT: oligonucleotide containing a 
STAT92E recognition site GACCATTTCCGGGAAAAA 
mutSTAT-top GGATTTTTGCCGCAAATG 
mutSTAT-bottom 
mut: oligonucleotide containing a 
mutated STAT92 recognition site  GACCATTTGCGGCAAAAA 
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EMSA 
Cultured cells were incubated five min on ice in lysis buffer three days after transfection (see 
2.4.2.2). Following centrifugation (13000 rpm, five min at 4°C) to remove cell debris, the 
supernatant was used for EMSA and Western Blotting analysis to normalize for transfection 
efficiency. Radio-labeled or unlabeled STAT92E probes containing the consensus STAT92E 
recognition sequence (Yan et al., 1996) or a mutated recognition sequence were generated 
(see above) to detect the DNA binding activity of STAT92E-GFP variants. 2 µl (16.67 nM) 
STAT92E probe and protein extract normalized for firefly luciferase activity (see 2.4.3.1) 
were allowed to bind for 30 min at RT in binding buffer. For supershift experiments anti–GFP 
antibody (1:3000, Abcam, Cambridge, UK) was added to the binding reaction. For cold 
oligonucleotide competition assays unlabeled STAT92E probes were added to the binding 
reaction in a 10x, 50x and 100x excess. Complexes were resolved by native polyacrylamide 
gel electophoresis in a 5% continous gel, 0.5x TBE before drying and autoradiography. 
 
2.6 Computional analysis 
For identification of potential protein arginine methyltransferases (PRMT), Basic Local 
Alignment Search Tool (BLAST) searches of the Drosophila proteome were performed 
(blastp at http://www.ncbi.nlm.nih.gov/BLAST/; Altschul et al., 1990). 
Protein alignments were performed using the clustal alignment algorithm of MegAlign 
software (DNASTAR Inc.; Higgins and Sharp, 1989). 
Identification of conserved domains in candidate proteins was performed using InterProScan 
(http://www.ebi.ac.uk/InterProScan/; Zdobnov and Apweiler, 2001). 
Sequence identities of proteins used for BLAST searches and alignments: STAT5A (Homo 
sapiens): NP_003143, STAT5A (Mus musculus): NP_035618, STAT5B (Gallus gallus): 
NP_990110, STAT5.1 (Danio rerio): NP_919368, STAT5 (Xenopus laevis): AAK94906, 
STAT (Spodoptera frugiperda): AAL37477, STAT92E (Drosophila melanogaster): 
NP_996242, STAT (Anopheles gambiae): CAA09070, STAT (Caenorhabditis elegans): 
AAY18583, PRMT1 (Homo sapiens): AAH19268. Potential PRMTs in Drosophila 
melanogaster: CG6554/Dart1: NP_650017, CG3675/Dart2: NP_608821, CG6553/Dart3: 
NP_650434, CG5358/Dart4: NP_649963, CG9927/Dart6: NP_650322, CG9882/Dart7: 
NP_611753, CG16840/Dart8: NP_609478, CG9929/Dart9: NP_650321, CG32152: 
NP_730116. 
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2.7 Fly work & genetics 
2.7.1 Fly stocks 
The following fly stocks were used: 
OreR (Oregon R, Drosophila wild type strain), w1118, y w P{w+, GMR-updΔ3´}/FM7, P{w+, 
Ubp-GFP} (Bach et al., 2003), w; P{w+, ey-Gal4} (Halder et al., 1995), w; P{w+, Nullo-
Gal4} (Kunwar et al., 2003, kindly provided by W. Gehring), y w; P{w+, UAS-GFP} (Karsten 
et al., 2006), w; P{w+, UAS-domeΔCYT}/TM3 (Brown et al., 2001), w; P{w+, UAS-HopTuml} 
(Harrison et al., 1995), M(2)21AB1/CyO, P{ry+t7.2=ftz/lacZ}USC1 (Bloomington stock 
#6305), y1; P{y+mDint2w(BR.E.BR)=SUPor-P}Art1KG09631, ry506 (Bloomington stock #15202). 
 
2.7.2 Fly handling and feeding 
The handling and feeding of Drosophila melanogaster was performed according to Ashburner 
(Ashburner, 1989). All embryos, larvae and flies were grown at 25°C on standard 
cornmeal/agar food, unless otherwise specified. 
 
2.7.3 Genetic interaction assay 
To test for genetic interaction of JAK/STAT signaling and components of the methylation 
machinery, y w P{w+, GMR-updΔ3´}/FM7, P{w+, Ubp-GFP} virgins were crossed to males of 
following genotypes: M(2)21AB1/CyO, P{ry+t7.2=ftz/lacZ}USC1 and y1; 
P{y+mDint2w(BR.E.BR)=SUPor-P}Art1KG09631, ry506. As negative control, y w P{w+, GMR-
updΔ3´}/FM7, P{w+, Ubp-GFP} virgins were crossed to OreR males. Crosses were set up in 
parallel on the same batch of food. For GMR-updΔ3´ interactions any deviation from the size 
of the overgrown GMR-updΔ3´/+ adult eye was scored as potential JAK/STAT pathway 
interaction. 
 
2.7.4 Ectopic expression using the Gal4/UAS system 
The Gal4/UAS system is based on the yeast transcription factor Gal4 and its recognition site 
UAS (upstream activating sequence) (Brand and Perrimon, 1993). Using this system, any 
cloned gene can be ectopically expressed in defined tissues. A driver line carries either a 
tissue-specific or inducible enhancer sequence upstream of the Gal4 gene. An effector line is 
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composed of an upstream UAS promoter and a downstream gene of interest. When crossed to 
the driver, the target transgene is expressed in the same tissue- and stage specific pattern as 
the transcription factor Gal4. 
In this study, the driver ey-Gal4 (Halder et al., 1995) was used for expression in the eye 
imaginal disc during Drosophila eye development. For expression in all somatic tissues 
during Drosophila embryogenesis at blastoderm stage the nullo-Gal4 driver (Kunwar et al., 
2003) was used. 
 
2.7.5 Preparing DNA for subsequent injection into Drosophila embryos 
DNA constructs destined to be injected in Drosophila embryos (see 2.3) were extracted with 
the MidiPrep DNA purification Kit (Qiagen, Hilden). Subsequently, they were additionally 
purified by phenol/chloroform extraction and precipitated with ethanol (salting agent 300 mM 
Na-acetate, pH 5.5). Following centrifugation the resulting pellet was washed with 70% 
ethanol, air-dried and dissolved in TE buffer for five min at 60°C. 
12 µg of the purified DNA construct was mixed with 4 µg “helper DNA” coding a 
transposase and co-precipitated by ethanol (salting agent 300 mM Na-acetate, pH 5.5). The 
precipitate was centrifuged, washed twice with 70% ethanol, air-dried and dissolved in 20 µl 
H2O for five min at 60°C. DNA concentration was adjusted to 400 ng/µl. 
 
2.7.6 P-element-mediated generation of transgenic flies 
Transgenic flies were generated as described by Rubin and Spradling, 1982. Purified DNA 
constructs (see 2.7.5) intended to be integrated into the fly genome were injected into 
preblastoderm embryos of the Drosophila w- strain. Each hatched fly was crossed to w- 
mutant flies. Integration of the transgene into the genome could be detected by a reversion of 
the mutant phenotype to red eye color by introduction of the mini-white gene on the transgene 
construct. 
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Table 2-8: Transgenic lines generated. 
Genotype Eye phenotype (upon over-expression 
using ey-Gal4) and remarks 
w; P{w+, UAS-STAT92E-GFP}1a.2/(CyO) no change 
w; P{w+, UAS-STAT92EY704F-GFP}1b.3/(TM3) no change 
w; P{w+, UAS-STAT92EM647H-GFP}1/(CyO) reduced size and rough structure 
w; P{w+, UAS-STAT92EM647H-GFP}2.1/(TM3, Sb) slightly reduced size and rough structure 
w; P{w+, UAS-STAT92EM647H-GFP}4.1/(TM3, Sb) slightly reduced size and rough structure 
w; P{w+, UAS-STAT92EM647H-GFP}6.0/(CyO) slightly reduced size and rough structure 
w; P{w+, UAS-STAT92EM647H-GFP}11.0/(TM3, Sb) slightly reduced size and rough structure 
w; P{w+, UAS-STAT92ER30A-GFP}1.0.3/(TM3,Sb) strongly reduced size and rough structure 
w; P{w+, UAS-STAT92ER30A-GFP}2.0.1/FM6 varies from moderate to strong size 
reduction 
w; P{w+, UAS-STAT92ER30E-GFP}3.III/(TM3) varies from dramatically reduced size to 
complete loss, rough structure. Eyes are 
not equally affected. 
w; P{w+, UAS-STAT92ER30E-GFP}2.1.3/(TM3) reduced size and rough structure 
w; P{w+, UAS-STAT92ER30E-GFP}3.1.II/(CyO) slightly reduced size and rough structure 
w; P{w+, UAS-STAT92ER30K-GFP}1.II/(CyO) reduced size and rough structure 
w; P{w+, UAS-STAT92ER30A,M647H-GFP}2.1.3/(TM3, Sb) varies from strong size reduction to 
complete loss 
w; P{w+, UAS-STAT92ER30E,M647H-GFP}1.2/(CyO) varies from strong size reduction to 
complete loss  
w; P{w+, UAS-STAT92ER30E,M647H-GFP}1.0.2/(CyO) strongly reduced size and rough structure 
w; P{w+, UAS-STAT92ER30K,M647H-GFP}2.1.2/(CyO) reduced size and rough structure 
w; P{w+, UAS-STAT92ER30A,Y704F-GFP}3.0.2/(CyO) no change 
w; P{w+, UAS-STAT92ER30A,Y704F-GFP}7.0.2/(CyO) no change 
w; P{w+, socs36E(I)-lacZ}/(CyO) 
w; P{w+, socs36E(II)-lacZ}/(CyO) 
w; P{w+, socs36E(III)-lacZ}/TM3 
w; P{w+, socs36E(IV)-lacZ}/(CyO) 
transgenic flies carrying lacZ reporter 
constructs dependent on fragments of the 
socs36E genomic region containing 3 -5 
potential STAT92E binding sites 
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2.8 Histology 
2.8.1 Drosophila embryo manipulations 
For embryo collections flies were kept on apple juice agar plates holding baker´s yeast as 
extra food. To collect embryos of all stages, flies were allowed to lay eggs for 20h at 25°C. 
 
2.8.1.1 Embryo fixation 
Embryos were washed off the apple juice agar plates with H2O, cleansed of the yeast, 
transferred to a fine sieve and dechorionated in 50% DanKlorix bleach (Colgate-Palmolive, 
Hamburg) for five min. The dechorionated embryos were rinsed several times with H2O, 
transferred to a glass vial and fixed in 1 ml RNA fixative and 6 ml heptane for 20 min with 
vigorous shaking. The lower phase containing the fixative was replaced with 6 ml of 
methanol. Afterwards, the vitelline membrane of the embryos was removed by vigorous 
shaking for one min. Devitellinated embryos sank to the bottom of the vial. The upper phase 
was discarded. Embryos were washed several times in methanol, collected in Eppendorf tubes 
and stored at -20°C. 
 
2.8.1.2 Whole-mount RNA in situ hybridization 
Gene expression can be analyzed by RNA in situ hybridization using DIG labeled RNA 
probes (see 2.3.7). This way, the expression pattern of genes can be detected. To do so, 
embryos stored in methanol (see 2.8.1.1) were re-hydrated in 50% methanol/PBS and 
afterwards post-fixed in 500 µl PBT and 500 µl RNA fixative for 20 min. After several 
washes with PBT, embryos were treated with Proteinase K (50 µg/ml, Sigma-Aldrich, 
Taufkirchen). This treatment was stopped after 90 sec by the addition of glycine (2 mg/ml). 
The embryos were then rinsed two times with PBT and post-fixed once again in 500 µl PBT 
and 500 µl RNA fixative for 20 min. Embryos were washed several times in PBT and 
afterwards equilibrated in a mixture of PBT/hybridization buffer (Hybe) B (1:1) and in Hybe 
B alone. Hybe B was replaced with Hybe, and embryos were pre-hybridized for 1h at 70°C. 
Afterwards, the embryos were hybridized with RNA in situ probes (see 2.3.7) in a minimal 
solution of Hybe (around 50 µl) o/n at 70°C. The next day 500 µl Hybe were added, replaced 
with Hybe B and washed two times for 15 min at 70°C with pre-warmed Hybe B. Then 500 
µl PBT was added. After several rinses and washing steps of 15 and 20 min in PBT at RT, 
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incubation with anti-Dig AP-conjugated antibody (1:2000, Roche Diagnostics, Mannheim) 
for 1h followed. Embryos were rinsed several times in PBT, then washed for 20 and 30 min in 
PBT to remove unbound antibodies followed by two short washing steps in AP buffer. 
Colorimetric detection of the alkaline phosphatase was performed using NBT/BCIP solution 
(20 µl of stock solution (Roche Diagnostics, Mannheim) per 1 ml AP-buffer). The staining 
reaction was stopped by several rinses with PBT and a subsequent 20 min washing step. 
The stained embryos were dehydrated in an ethanol dilution series (30%, 50%, 70%) and left 
in 70% ethanol o/n at 4°C. The next day embryos were dehydrated in 100% ethanol and 
mounted in a 1:1 mixture of Canada Balsam (Sigma-Aldrich, Taufkirchen) and methyl 
salicylate (Sigma-Aldrich, Taufkirchen). Mounted embryos were photographed using a Zeiss 
Axioskop2 MOT microscope. 
 
2.8.1.3 Whole-mount antibody detection of proteins 
To specifically detect protein expression in embryos, whole-mount antibody stainings were 
undertaken. To do so, embryos stored in methanol (see 2.8.1.1) were re-hydrated in 
methanol/PBS dilution series (4:1, 3:2, 2:3, 1:4). Unless otherwise specified, all procedures 
were performed at RT. The fully re-hydrated embryos were washed in PBT three times for 20 
min, blocked in PBT with 2% sheep serum and, finally, incubated with anti-lacZ primary 
antibody (1:3000, Cappel, Durham, NC, USA) o/n at 4°C. The embryos were washed in PBT 
three times for five min, then two times in PBT with 2% sheep serum. Following incubation 
with preabsorbed species-specific biotin-conjugated secondary antibody (1:500 dilution, 
Vectastain ABC Elite Kit, Vector Laboratories, Peterborough, UK) in PBT with 2% serum for 
2h at RT, embryos were washed four times for ten min in PBT. 
For detection the embryos were incubated with a complex of avidin/biotinylated HRP 
(preformed for 30 min, Vector Laboratories, Peterborough, UK) for 30 - 90 min. The embryos 
were then washed thoroughly four times for 20 min. Colorimetric detection of the HRP 
enzyme activity was performed by addition of 30 µl diaminobenzidine tetrachloride (10 
mg/ml stock) and 10 µl H2O2 (37% stock) to the embryos in 0.5 ml PBT resulting in brown 
staining. Coloring can be achieved very fast and should be monitored under a microscope. To 
stop the reaction, the embryos were washed several times in PBT. Finally, the embryos were 
dehydrated in ethanol dilution series (10%, 30%, 50%, 70%, 90%), washed twice in 100% 
ethanol, clarified in 0.5 ml methyl salicylate (Sigma-Aldrich, Taufkirchen) and mounted in 
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Canada balsam (Sigma-Aldrich, Taufkirchen). Embryos were imaged with Zeiss Axioskop2 
MOT microscope. 
 
2.8.2 Immuno-staining and sub-cellular localization of STAT92E-GFP 
variants 
Transfected cells (see 2.4.2.3) were washed in PBS, fixed in PBS + 5% formaldehyde three to 
four days after transfection and then mounted in VectaShield Mounting Medium with DAPI 
(H-1200, Vector Laboratories, Peterborough, UK). The cells were analyzed for the sub-
cellular localization of STAT92E-GFP variants using a Zeiss Axioskop microscope, Axiocam 
and Openlab software (Improvision, Tübingen). 
For immuno-stainings cells were fixed as described above. Afterwards, they were incubated 
with anti-phospho-STAT92E antibody (1:200, Cell Signaling Technologies, Danvers, MA, 
USA) for 1h in PBT with 2% sheep serum. After washing with PBS, incubation for 1h with 
Cy3-conjugated secondary antibody (1:200, Jackson Immuno Research Labs, 
Cambridgeshire, UK) followed. After another washing step with PBS, cells were mounted in 
VectaShield Mounting Medium (Vector Laboratories, Peterborough, UK). Images were 
captured on a Leica TCS SP2 confocal microscope using sequential scans. 
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3 Results 
 
3.1 Tools for the analysis of Drosophila JAK/STAT pathway activity 
In order to analyze and visualize Drosophila JAK/STAT pathway activity in general and the 
function of STAT92E variants in particular, cell culture and in vivo assays have been 
established. 
 
3.1.1 Transcriptional control of socs36E 
SOCS proteins act as negative regulators of the JAK/STAT pathway, and several SOCS genes 
are transcriptional targets of this signaling cascade (reviewed in Starr and Hilton, 1998). This 
was also shown for Drosophila socs36E (Callus and Mathey-Prevot, 2002; Karsten et al., 
2002). Expression of this gene is dependent on upd expression, the Drosophila JAK/STAT 
pathway ligand. upd and socs36E expression were detected in a complex, almost identical 
pattern during embryogenesis (Karsten et al., 2002; Fig. 3.1). 
 
 
Fig. 3.1: Expression of socs36E during embryogenesis in Drosophila (modified after 
Karsten et al., 2002). socs36E RNA in situ hybridization using a DIG labeled antisense probe 
with wild type embryos of all stages (see Material & Methods 2.8.1.2). Unless otherwise 
noted, embryos are shown anterior to the left and dorsal up. Embryonic staging was carried 
out according to Campos-Ortega and Hartenstein (1997). (A) Stage 5 embryo showed staining 
in the dorsal anterior head region and throughout most of the trunk. (B) & (C) The same stage 
6 embryo focused laterally (B) and internally (C) showed socs36E expression in the head 
region, in two stripes flanking the presumptive cephalic furrow and in seven diffuse stripes 
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through the trunk region. Additionally, socs36E expression was detected in the invaginating 
mesoderm (arrow in C). (D) Early stage 9 embryo showed staining anterior to the ventral 
cephalic furrow, in the head region and in 14 stripes. (E) During stage 10 expression was 
transiently detected in three neuroblasts per-hemisegment. Additionally, socs36E began to be 
expressed in the leading edge cells (arrow in E). (F) Ventral view of a late stage 10 embryo 
showed a ring of expression surrounding the tracheal pits (arrow in F). (G) Stage 12 embryos 
showed expression in the trachea, the clypeolabrum and the hindgut (out of focus). socs36E 
expression in the leading edge cells (arrow in G) was strong and not detected using upd 
probes (not shown). (H) & (I) Expression in stage 14 embryos was detected in the 
clypeolabrum, proventriculus and hindgut. Expression in the anterior spiracle (arrow in I) and 
tracheal pits was maintained as stripes at more medial layers. 
 
socs36E expression is first visible at stage 5 in a head stripe and a broad central domain (Fig. 
3.1A). This pattern resolves first into seven and then 14 stripes (Fig. 3.1B - D). After transient 
expression in the presumptive mesoderm (Fig. 3.1C, arrow) and a subset of neuroblasts (Fig. 
3.1E), socs36E expression is up-regulated in the developing tracheal pits (Fig. 3.1F, arrow) 
and the leading edge cells during dorsal closure (Fig. 3.1G, arrow). During stages 14/15 
expression is limited to the inner clypeolabrum, the proventriculus, the hindgut and the 
anterior and medial spiracles (Fig. 3.1H & I). 
 
 
Fig. 3.2: The genomic organization of the socs36E gene region (after Karsten et al., 
2002). Intron/exon structure for socs36E as shown here is based on sequence analysis of the 
EST clones LD22121 and SD04320. The 3´ located gene kelch is shown as predicted by the 
Berkeley Drosophila genome project (FlyBase, 2003). Scale bar represents 1 kb. Coding 
sequences of socs36E are indicated in grey, untranslated sequences in white. Red crosses 
mark potential STAT92E DNA binding sites (as in silico determined). Regions I - IV cloned 
into a lacZ-reporter construct (socs36E(region)-lacZ) are marked by bars. 
 
In the genomic region of socs36E covering 15.5 kb 22 potential STAT92E binding sites 
sharing the consensus sequence TTCNNNGAA (Yan et al., 1996) were found (Karsten et al., 
2002; Fig. 3.2). To test, which of these potential sites STAT92E can bind and subsequently 
activate target gene expression in vivo, the genomic region was divided into several parts 
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containing three to five of the potential STAT92E binding sites (Fig. 3.2). These putative 
enhancer elements could then be used to mediate the expression of a reporter gene in order to 
monitor JAK/STAT pathway activity in vivo or in cultured cells. Therefore, the selected 
regions containing STAT92E recognition sites were cloned into a Drosophila transformation 
vector and fused to a basal promoter and the lacZ gene to produce a potential socs36E-lacZ 
reporter for JAK/STAT activity (see Material & Methods 2.3.1). Transgenic flies expressing 
lacZ under the control of the respective genomic sub-regions were generated. lacZ reporter 
gene expression in several transgenic lines was analyzed. 
Anti-lacZ-antibody staining and RNA in situ hybridization using an antisense lacZ probe with 
embryos of all developmental stages were performed (see Material & Methods 2.8.1.3 & 
2.8.1.2) to determine the transactivation activity of those genomic regions. It could be shown 
that different enhancer regions are active at distinct time points during embryogenesis. In 
addition, these different enhancer elements were also responsible for gene expression in 
different tissues. In none of the generated transgenic w; P{w+, socs36E-lacZ} embryos the 
lacZ reporter gene was expressed in the complete wild type expression pattern of socs36E 
(compare Fig. 3.3 to Fig. 3.1). Unfortunately, due to technical difficulties it was not possible 
to assess the regulatory function of the entire region spanning 15.5 kb. Therefore, it cannot be 
ruled out that other regulatory elements inside and/or outside of this region contribute to the 
expression pattern of socs36E. In w; P{w+, socs36E(I)-lacZ} embryos, region I containing 
five potential STAT92E binding sites was sufficient for lacZ expression in 14 stripes at stage 
9 of development (Fig. 3.3A, panel 1). Expression was also visible in a subset of cells, 
presumably in the central nervous system (CNS) (Fig. 3.3, panel 2). Additionally, expression 
was detected during late embryogenesis in the tracheal pits and the fore- and hindgut 
primordium (Fig. 3.3, panel 3). A similar expression pattern could be detected in transgenic 
w; P{w+, socs36E(II)-lacZ} embryos (Fig. 3.3B). During stage 9 lacZ expression could be 
observed in 14 stripes in the epidermis (Fig. 3.3B, panel 1), later also in the CNS (Fig. 3.3B, 
panel 2) and the hind- and foregut primordium (Fig. 3.3B, panel 3). The enhancer region III, 
comprising five putative STAT92E binding sites, was sufficient for lacZ expression in the 
leading edge cells during dorsal closure (Fig. 3.3C, panel 1 & 2) and also later during stages 
13/14 in the fore- and hindgut in transgenic w; P{w+, socs36E(III)-lacZ} embryos (Fig. 3.3C, 
panel 3). In w; P{w+, socs36E(IV)-lacZ} embryos only a weak lacZ expression was detected, 
presumably in the CNS and the tracheal pits (Fig. 3.3D, panel 1 & 2). Taken together, regions 
I to IV contributed to the majority of expression domains of socs36E during embryogenesis. 
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However, the very early expression pattern of endogenous socs36E (see Fig. 3.1A - C) could 
not be detected in any of the transgenic w; P{w+, socs36E-lacZ} embryos. 
 
 
Fig. 3.3:Transcriptional control of socs36E. anti-LacZ antibody staining and lacZ RNA in 
situ hybridization using a DIG-labeled antisense probe with socs36E-lacZ transgene embryos 
of all stages (see Material & Methods 2.8.1.2). Embryos are shown anterior to the left in 
lateral or dorsal view. Embryonic staging was carried out according to Campos-Ortega and 
Hartenstein (1997). (A) In w; P{w+, socs36E(I)-lacZ} embryos lacZ expression dependent on 
region I was detected in 14 stripes during stage 9 (panel 1) and the CNS (panel 2). At stage 14 
lacZ expression was detected in tracheal pits and the fore- and hindgut (panel 3). (B) lacZ 
expression in w; P{w+, socs36E(II)-lacZ} embryos dependent on region II was detected in 14 
stripes during stage 9 (panel 1) and the CNS (panel 2). At stage 14 lacZ expression was 
detected in the fore- and hindgut (panel 3). (C) lacZ expression in w; P{w+, socs36E(III)-
lacZ} embryos dependent on region III was detectable in cells of the leading edge at stages 10 
- 12 (panel 1 & 2) and the fore- and hindgut at stage 14 (panel 3). (D) lacZ expression in w; 
P{w+, socs36E(IV)-lacZ} embryos dependent on region IV was detected in a subset of CNS 
cells (panel 1) and the tracheal pits (panel 2). 
 
3.1.2 A luciferase reporter system to monitor JAK/STAT activity in 
cultured cells 
The genomic region I was already shown to be sufficient for induction of lacZ reporter gene 
expression in vivo and to recapitulate major components of endogenous socs36E expression 
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(Fig. 3.3A). Furthermore, a bioinformatics survey concerning the number and spacing of the 
putative binding sites within the genomic region of socs36E resulted in a high probability that 
the sites of region I contribute to endogenous socs36E expression in vivo (Ho-Ryun Chung, 
personal communication). Therefore, region I containing five consensus STAT92E binding 
sites (Fig. 3.2) was the most promising candidate to generate a luciferase reporter construct to 
detect JAK/STAT pathway activity in cultured cells. For this purpose, region I was inserted 
into the pGL3-Promoter vector, which includes the firefly luciferase gene as inducible 
reporter for JAK/STAT activity (see Material & Methods 2.3.1). Alternatively, the 
2xDrafSTATwt-TATA-luc reporter (Kwon et al., 2000) based on the Drosophila raf (Draf) 
gene promoter was tested. Draf is a transcriptional target of the JAK/STAT pathway and its 
promoter contains two consensus STAT92E recognition sites. The genomic region containing 
these binding sites was fused to the firefly luciferase gene (Kwon et al., 2000). JAK/STAT 
activation by over-expression of the Drosophila JAK kinase Hopscotch (Hop) in cultured 
cells could be detected using this reporter construct (Kwon et al., 2000). Renilla luciferase 
was constitutively expressed and used as normalization control. For this purpose, the coding 
region of Renilla luciferase was sub-cloned into the pAc5.1 vector to generate pAct-Renilla 
(Müller et al., 2005; Karsten et al., 2006). Three to four days after transfection, cells were 
lysed and luciferase activities were measured (see Material & Methods 2.4.3). Changes in the 
relative luciferase activity are a measure for JAK/STAT activity. 
As shown in Fig. 3.4, the reporter system based on the socs36E enhancer region I did not 
respond to an activation of the JAK/STAT pathway in S2 cells (Schneider, 1972), neither by 
co-expressed Hop nor by the constitutively active allele HopTumorous-lethal (HopTuml). Co-
expression of a STAT92E-GFP fusion protein (see 3.1.3.1) together with the kinase did not 
result in the induction of firefly luciferase reporter gene expression (Fig. 3.4, compare column 
1 to 2 & 3). By contrast, co-expression of STAT92E-GFP and Hop or HopTuml resulted in 
pathway activation detectable by the 2xDrafSTATwt-TATA-luc reporter (Kwon et al., 2000). 
A three-fold increase in the relative reporter activity was observed after stimulation by both 
Hop and HopTuml (Fig. 3.4, compare column 4 to 5 & 6). Using this reporter, relative 
luciferase activity could be increased to an eight-fold induction upon pathway stimulation in 
later experiments (see also Fig. 3.8). Therefore, in all following luciferase assays the reporter 
2xDrafSTATwt-TATA-luc (Kwon et al., 2000) or the modified version 6x2xDrafLuc (Müller 
et al., 2005) were used to monitor JAK/STAT pathway activity in cultured Drosophila cells. 
The modified reporter version was constructed by multimerization of the genomic region 
comprising two STAT92E binding sites from the reporter 2xDrafSTATwt-TATA-luc and 
3. Results 
 
 
41 
yielded approximately 50-fold induction of relative luciferase activity upon pathway 
stimulation (see Fig. 3.9). 
 
 
Fig. 3.4: A cell culture reporter assay for JAK/STAT activity using the socs36E based 
reporter or the 2xDrafSTATwt-TATA-luc reporter plasmid (Kwon et al., 2000). S2 cells 
(Schneider, 1972) co-expressing the indicated proteins (Wt: wild type), reporter plasmids and 
Renilla luciferase as normalization control. Lysates were used for dual luciferase reporter 
assays as described in Material & Methods 2.4.3.2. Relative activity (Firefly luciferase 
reporter activity / Renilla luciferase activity) is plotted. Mock-transfected cells were allocated 
the relative activity 1. Error bars represent standard deviations of four experiments. Induction 
of relative reporter activity was not detectable using the reporter construct based on the 
socs36E enhancer region I (columns 1 - 3), whereas co-expression of STAT92E-GFP and 
Hop or HopTuml resulted in a three-fold increase of relative reporter activity (colums 4 - 6) 
using the 2xDrafSTATwt-TATA-luc reporter construct (Kwon et al., 2000). 
 
3.1.3 Drosophila STAT: STAT92E 
STAT92E plays a central role in the Drosophila JAK/STAT pathway. This protein is 
responsible for the signal transduction from the membrane-associated ligand/receptor/kinase-
complex through the cytoplasm into the nucleus. For this purpose, it has to leave the 
cytoplasm and enter the nucleus to subsequently accomplish its function in activating target 
gene expression. 
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3.1.3.1 Sub-cellular localization of STAT92E-GFP 
In order to follow the sub-cellular localization of STAT92E, the fusion protein STAT92E-
GFP was generated (see Material & Methods 2.3.1). Following activation STAT dimers 
accumulate in the nucleus of mammalian cells (Brierley and Fish, 2005). Therefore, an 
accumulation of STAT92E-GFP in the nucleus of transfected cultured Drosophila cells 
should be detectable upon pathway stimulation with the constitutively active kinase HopTuml. 
 
 
Fig. 3.5: Sub-cellular localization of STAT92E-GFP. Kc167 cells (Cherbas et al., 1977) 
expressing the indicated proteins. Columns 1 & 3 show GFP fluorescence and DAPI staining 
of DNA reflecting the localization of GFP fusion proteins (green) and the nuclei (blue), 
respectively. Columns 2 & 4 show columns 1 & 3 overlaid on a brightfield image of the cells. 
Scale bars represent 20 µM. (A) EGFP is distributed throughout the cells and (B) does not 
respond to stimulation by HopTuml. (C) STAT92E-GFP protein is localized in the cytoplasm 
and the nucleus of non-stimulated Kc167 cells (arrows). (D) Pathway stimulation by co-
expression with HopTuml resulted in an accumulation of STAT92E-GFP in the nucleus and 
depletion from the cytoplasm (arrows). 
 
STAT92E-GFP was ectopically expressed via the Gal4/UAS system (Brand and Perrimon, 
1993) in Drosophila Kc167 cells (Cherbas et al., 1977). These cells were analyzed for the sub-
cellular localization of the GFP signal using a fluorescence microscope. As a control, EGFP 
alone was expressed. It was distributed throughout the cell (Fig. 3.5A) including nuclear 
localization, which was probably due to unrestricted transport because of the little molecular 
weight of EGFP (30 kDa). Stimulation of the JAK/STAT pathway by co-expression with 
HopTuml did not alter the localization of EGFP (Fig. 3.5B) showing that this protein did not 
respond to JAK/STAT signaling. In non-stimulated cells STAT92E-GFP was distributed 
throughout the cell (arrows in Fig. 3.5C). Additionally, STAT92E-GFP was not excluded 
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from the nucleus. This suggests a low basal level of STAT92E activation or activation-
independent transport into the nucleus similar to other STAT proteins (reviewed in Meyer and 
Vinkemeier, 2004). STAT92E-GFP, activated by co-expressed HopTuml, accumulated in the 
nucleus, mainly visible by the clearance of the cytoplasm (arrows in Fig. 3.5D). The detected 
fluorescence reflected the putative activation state of STAT92E-GFP, a finding consistent 
with activation-dependent nuclear accumulation of vertebrate STATs (Brierley and Fish, 
2005). 
 
3.1.3.2 Activation-dependent phosphorylation of STAT92E-GFP 
Phosphorylation of a conserved C-terminal tyrosine residue is essential for the function of 
STAT proteins (Shuai et al., 1993a). Therefore, the phosphorylation state of the conserved 
tyrosine residue Y704 of Drosophila STAT92E was tested using the STAT92E phospho-
specific antibody pSTAT92E (Li et al., 2003). 
 
 
Fig. 3.6: Phosphorylation state of STAT92E-GFP. S2 cells (Schneider, 1972) expressing 
the indicated proteins, visualized by GFP fluorescence (green) and anti-pSTAT92E indirect 
immunofluorescence (red). Columns 1 & 3 show the overlay of the EGFP and anti-
pSTAT92E signal. Columns 2 & 4 show the anti-pSTAT92E signal alone. Scale bars 
represent 16 µM. (A) In cells expressing EGFP pSTAT92E staining was not detectable under 
non-stimulated conditions. (B) Co-expression of EGFP with Hop did not alter levels of 
pSTAT92E staining. (C) In cells expressing STAT92E-GFP alone pSTAT92E staining was 
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not detectable under non-stimulated conditions. (D) STAT92E-GFP and Hop co-expression 
resulted in increased levels of pSTAT92E (arrows). 
 
In Drosophila S2 cells (Schneider, 1972) expressing EGFP the anti-pSTAT92E antibody 
showed a low level of background staining (Fig. 3.6A). In cells co-expressing EGFP and Hop 
no increase in anti-pSTAT92E staining was detectable compared to the non-stimulated state 
(Fig. 3.6, compare A to B). This suggested that endogenous STAT92E was not present or 
detectable in these cells by this assay. STAT92E-GFP expression alone did not result in anti-
pSTAT92E staining above background level (Fig. 3.6, compare A to C) as expected for an 
antibody displaying STAT92E phospho-Y704-specific binding activity. However, when 
STAT92E-GFP was activated by co-expressed Hop, an increased level of pSTAT92E could 
be detected (arrows in Fig. 3.6D). Thus, activation of JAK/STAT signaling by the kinase Hop 
caused Y704 phosphorylation of STAT92E-GFP in cultured Drosophila cells. 
 
3.1.3.3 DNA binding ability of STAT92E-GFP 
It is known that STAT proteins bind to specific DNA sequences in promoters of target genes 
(Stark et al., 1998). The DNA binding ability of the fusion protein STAT92E-GFP to its 
consensus DNA recognition site TTCCCGGAA (Yan et al., 1996) was tested in an electro-
mobility shift assay (EMSA, see Material & Methods 2.5.3). In this approach the presence of 
STAT92E-GFP dimers, competent to bind DNA in vitro, can be detected with high 
sensitivity. Therefore, whole lysates of S2 cells (Schneider, 1972) ectopically expressing 
STAT92E-GFP alone or together with Hop were tested for their ability to bind double-
stranded radio-labeled oligonucleotides containing the STAT92E consensus DNA recognition 
site TTCCCGGAA. Lysates of non-transfected cells did not show any binding activity (Fig. 
3.7A, lane 1). Thus, the S2 cells used in this experiment did not provide endogenous levels of 
JAK/STAT activity detectable by this assay. This was also supported by the fact that in 
lysates of cells expressing STAT92E-GFP alone no mobility shift was detectable (Fig. 3.7B, 
lane 1). Hence, the upstream components of the pathway were either not present or not 
endogenously activated to a detectable extent in these cells, as already shown in 3.1.3.2. 
However, in lysates of S2 cells co-expressing STAT92E-GFP together with Hop DNA 
binding activity was detectable as manifested by a shifted band in this EMSA experiment 
(Fig. 3.7A, lane 2). This band could be super-shifted by addition of an anti-GFP antibody 
(arrow in Fig. 3.7A, lane 3) showing the existence of GFP in this complex. This demonstrated 
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that the shifted band represented STAT92E-GFP bound to the radio-labeled oligonucleotide 
containing the STAT92E recognition site. The specificity of the binding process could be 
confirmed in a competition assay. Addition of increasing amounts of excess unlabeled 
oligonucleotides containing the consensus binding site resulted in an attenuation of the shifted 
band (Fig. 3.7B, compare lane 2 to lanes 3 - 5). In contrast, oligonucleotides containing a 
mutated binding site (TTGCCGCAA) were not able to compete with the radio-labeled wild 
type binding site. Even when double-stranded oligonucleotides in 100x excess were added, 
the signal of the shifted band was not affected (Fig. 3.7B, compare lane 2 to lanes 6 - 8). This 
indicated that STAT92E-GFP specifically bound the STAT92E DNA consensus recognition 
site. 
 
 
Fig. 3.7: DNA binding ability of STAT92E-GFP. Indicated proteins were co-expressed in 
S2 cells (Schneider, 1972). Crude cell lysates were tested for DNA binding ability to radio-
labeled oligonucleotides containing the STAT92E consensus DNA recognition site 
TTCCCGGAA (see Material & Methods 2.5.3). (A) STAT92E-GFP bound to the STAT92E 
consensus DNA recognition site TTCCCGGAA when co-expressed with Hop (lane 2). This 
shifted band could be super-shifted by an anti-GFP antibody (arrow head in lane 3). Extra 
bands at the top of lanes 2 & 3 were loading artifacts. (B) Unlabeled double-stranded 
oligonucleotides containing the STAT92E consensus recognition site TTCCCGGAA (WT) 
could compete with radio-labeled double-stranded oligonucleotides for binding (lanes 3 - 5) 
while double-stranded oligonucleotides containing a mutated consensus recognition sequence 
TTGCCGCAA (mut) did not compete (lanes 6 - 8). Oligonucleotides were added in 10x, 50x, 
100x excess. 
 
Taken together, I could demonstrate that STAT92E-GFP complexes, which show binding 
specificity for the previously determined DNA recognition site (Yan et al., 1996), can be 
detected in EMSA experiments. Furthermore, I could show that STAT92E-GFP mediated 
DNA binding to this site occurred only after activation by Hop in these cells. STAT92E-GFP 
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did not show any specific DNA binding activity to its DNA recognition site under non-
stimulated conditions. 
 
3.1.3.4 Transcriptional activation by STAT92E-GFP 
Although tyrosine phosphorylation, nuclear translocation and DNA binding are required for 
STAT activity, the key role for a transcription factor is its ability to elicit the expression of 
pathway target genes. To test the functionality of STAT92E-GFP and its ability to induce 
target gene expression compared to wild type STAT92E, the luciferase reporter assay for 
JAK/STAT activity described above (see 3.1.2) was used. 
 
 
Fig. 3.8: JAK/STAT pathway activity transduced by STAT92E or the fusion protein 
STAT92E-GFP. S2 cells (Schneider, 1972) co-expressing the indicated proteins, the 
2xDrafSTATwt-TATA-luc reporter (Kwon et al., 2000) and Renilla luciferase as 
normalization control. Lysates were used for dual luciferase reporter assay as described in 
Material & Methods 2.4.3.2. Relative activity (Firefly luciferase reporter activity / Renilla 
luciferase activity) is plotted. Mock-transfected cells were allocated the relative activity 1. 
Error bars represent standard deviations of three experiments. Expression of each Hop, 
STAT92E or STAT92E-GFP alone did not result in (columns 3 & 4) or only in mild 
induction of relative reporter activity (column 2). Co-expression of Hop and STAT92E or 
STAT92E-GFP resulted in a seven- to eight-fold increase of relative reporter activity 
(columns 5 & 6). 
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Using the 2xDrafSTATwt-TATA-luc reporter (Kwon et al., 2000) in S2 cells (Schneider, 
1972), it was shown that expression of Hop resulted in a slight induction of luciferase reporter 
activity (Fig. 3.8, column 2) suggesting low levels of endogenous STAT92E present in these 
cells which was activated by ectopic expressed Hop. No firefly luciferase activity above 
background levels was detectable after expression of STAT92E or STAT92E-GFP alone (Fig. 
3.8, columns 3 & 4). This indicated that no detectable endogenous pathway activity was 
present in these cells. However, co-expression of STAT92E or STAT92E-GFP together with 
Hop resulted in a seven- to eight-fold response (Fig. 3.8, columns 5 & 6). This clearly showed 
that the C-terminal GFP-tag did not alter the function of STAT92E in this assay system. Both, 
STAT92E and the fusion protein STAT92E-GFP were able to activate reporter gene 
expression (Fig. 3.8, compare columns 5 & 6) with no significant difference. 
 
3.1.3.5 RNAi as a tool to identify potential JAK/STAT pathway interactors 
In further experiments a modified form of the reporter, 6x2xDrafLuc, was also used to detect 
JAK/STAT activity. In this vector the STAT92E binding sites were multimerized to result in 
a reporter with 12 binding sites (Müller et al., 2005). Activation of the JAK/STAT pathway 
by expression of an Upd-GFP fusion protein (Müller et al., 2005) resulted in an 
approximately 50-fold induction of luciferase reporter activity (Fig. 3.9, column 6). 
It was shown that addition of dsRNA is a potent tool to sequence-specifically silence gene 
expression (Fire et al., 1998). During this procedure dsRNA is internalized by the cells and 
recognized by the Dicer enzyme. This enzyme cleaves dsRNA into precisely sized fragments 
of ∼22 nucleotides, so called small interfering RNAs (siRNAs). These siRNAs join the RNA-
induced silencing complex (RISC) and guide this complex to homologous mRNA substrates, 
which then are specifaclly degraded (reviewed in Hannon, 2002). 
This method of gene silencing was used to knock down endogenous mRNA of pathway 
interacting genes in cultured cells (see Material & Methods 2.4.4). For this purpose, cells 
expressing Upd-GFP were incubated with dsRNA added to the culture medium covering 
about 500bp of the ORF of the respective target genes. Treatment with Dome and stat92E 
dsRNA decreases the relative luciferase reporter activity back to less than half the stimulated 
level (Fig. 3.9, compare column 6 to 8 & 9). This showed the important role of these proteins 
for Upd signal transduction to the nucleus. Furthermore, another component of the pathway, 
the negative regulator SOCS36E, was tested for its effect on JAK/STAT signaling in this 
luciferase assay. When socs36E mRNA was knocked down by addition of dsRNA, a clear 
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increase of reporter activity was detected in both non-stimulated and Upd stimulated cells 
(Fig. 3.9, columns 5 & 10). This suggested a low level activity of the JAK/STAT pathway in 
these cells, which is normally counteracted by SOCS36E. Addition of lacZ dsRNA as a 
negative control did not alter the luciferase activity (Fig. 3.9, columns 2 & 7). 
 
 
Fig. 3.9: Transcriptional activation of the JAK/STAT pathway via Upd-GFP. Kc167 cells 
(Cherbas et al., 1977) co-expressing the indicated proteins, the 6x2xDrafLuc reporter (Müller 
et al., 2005) and Renilla luciferase as normalization control. Cells were incubated with the 
indicated dsRNA (1.5 µg/105 cells) until lysis. Lysates were used for dual luciferase reporter 
assays as described in Material & Methods 2.4.3.2. Relative activity (Firefly luciferase 
reporter activity / Renilla luciferase activity) is plotted. Mock-transfected cells were allocated 
the relative activity 1. Error bars represent standard deviations of four experiments. 
Expression of Upd-GFP (Müller et al., 2005) resulted in a 50-fold increase of relative reporter 
activity (column 6). Knocking down dome or stat92E mRNA repressed relative reporter 
activity (columns 8 & 9) showing the importance of these genes for JAK/STAT signaling. 
SOCS36E acted as repressor of JAK/STAT signaling. Knocking down socs36E mRNA 
resulted in a strong increase of relative reporter activity (columns 5 & 10). 
 
In summary, these results showed that changes in JAK/STAT signaling activity were 
responsible for the alteration of the firefly luciferase reporter activity. STAT92E-GFP was 
fully functional and the 2xDrafSTATwt-TATA-luc reporter (Kwon et al., 2000) and its 
modified version 6x2xDrafLuc (Müller et al., 2005) can be used to detect JAK/STAT activity 
in cultured Drosophila cells (Fig. 3.8, Fig. 3.9 and see also Fig. 3.4). Additionally, it was 
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shown that RNAi could be used to alter luciferase reporter activity by silencing expression of 
JAK/STAT pathway components or regulators. This provides a tool to test for the interaction 
of candidate genes with this signaling cascade. Knocking down negative regulators resulted in 
an increase, whereas knocking down positive regulators led to a decrease of luciferase 
reporter activity as it was shown for socs36E, dome and stat92E, respectively (Fig. 3.9). 
 
3.2 A constitutive active allele of STAT 
Ariyoshi and colleagues described a gain-of-function allele of mouse STAT5A (Ariyoshi et 
al., 2000), which contains an asparagine to histidine substitution (N642H) in its SH2 domain. 
This mutant STAT5AN642H-Flag fusion protein was identified by conferring autonomous cell 
growth on interleukin-3-dependent Ba/F3 cells. The gain-of-function characteristic was 
presumably due to constitutive phosphorylation of the conserved residue Y694 and thereby 
activation of STAT5AN642H-Flag (Ariyoshi et al., 2000). 
 
 
Fig. 3.10: Alignment of the C-terminal region containing the SH2 domain of several 
STAT proteins. Identical amino acids are shaded black. Protein sequence identities are listed 
in Materials & Methods 2.6. Residues aligning to N642 of mouse STAT5A (M647 of 
Drosophila STAT92E) and to the conserved tyrosine residue (Y704 of Drosophila STAT92E) 
are marked by the pound sign (#) and the asterisk (*), respectively. Hu = Homo sapiens, Mm 
= Mus musculus, Gg = Gallus gallus, Dr = Danio rerio, Xl = Xenopus laevis, Sf = Spodoptera 
frugiperda, Dm = Drosophila melanogaster, Ag = Anopheles gambiae, Ce = Caenorhabditis 
elegans. 
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Analysis of mutant pathway components can help to give an insight into the mode of signal 
transduction and also to characterize pathway co-regulators. Activation of signaling by 
constitutive active alleles of STAT, independent of classical pathway stimulation via ligand 
binding, can be used to classify pathway regulators in up- or downstream effectors of STAT 
by the analysis of epistatic effects. 
In order to generate a constitutively active allele of Drosophila STAT92E, the residue 
corresponding to N642 of mouse STAT5A was identified. For this purpose, protein 
alignments of several STAT proteins were performed using the clustal alignment algorithm of 
MegAlign software (DNASTAR Inc.; Higgins and Sharp, 1989). These alignments showed 
that methionine at position 647 (M647) of STAT92E corresponds to N642 of STAT5A (Fig. 
3.10). Interestingly, STATs of lower organisms like the nematode Caenorhabditis elegans 
and the mosquito Anopheles gambiae already have a histidine at this position. So far no JAK-
like proteins have been identified in those organisms. This suggests an alternative mode of 
pathway activation independent of phosphorylation by JAK proteins. 
 
3.2.1 Generation of mutant STAT92E-GFP variants 
Having shown that the STAT92E-GFP fusion protein is fully functional in cell culture assays, 
such fusion proteins were used to analyze various STAT92E mutants. Residue M647 of 
STAT92E-GFP was mutated to a histidine (M647H) in order to generate a constitutively 
active allele of Drosophila STAT92E corresponding to STAT5AN642H-Flag (Ariyoshi et al., 
2000). Furthermore, the conserved tyrosine residue Y704, target of JAK-mediated 
phosphorylation, was mutated to phenylalanine (Y704F) to generate a non-functional 
STAT92E-GFP. In addition, the double mutant STAT92EM647H,Y704F-GFP was generated (see 
Material & Methods 2.3.3). These STAT92E-GFP mutant proteins were analyzed for their 
function using the assays described above. 
 
3.2.2 Sub-cellular localization of STAT92E-GFP variants 
STAT92E-GFP accumulated in the nucleus after stimulation with Hop (see Fig. 3.5). The 
mutant STAT92EY704F-GFP protein was localized throughout the cell similar to non-
stimulated STAT92E-GFP (arrows in Fig. 3.11C, compare to Fig. 3.5C). However, after 
stimulation by HopTuml, STAT92EY704F-GFP was not able to accumulate in the nucleus, but 
remained localized throughout the cell (arrows in Fig. 3.11D) in contrast to STAT92E-GFP 
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(see Fig. 3.5D). This result emphasized the importance of the conserved tyrosine residue 
Y704, mutation of which abolished activation-dependent nuclear accumulation. 
 
 
Fig. 3.11: Sub-cellular localization of STAT92E-GFP variants. Kc167 cells (Cherbas et al., 
1977) co-expressing the indicated proteins. Columns 1 & 3 show GFP fluorescence and DAPI 
staining of DNA reflecting the localization of GFP fusion proteins (green) and the nuclei 
(blue), respectively. Columns 2 & 4 show columns 1 & 3 overlaid on a brightfield image of 
the cells. Scale bars represent 20 µM. (A) STAT92EM647H-GFP accumulated in the nuclei of 
non-stimulated cells (arrows). (B) In cells co-expressing HopTuml STAT92EM647H-GFP was 
also located in the nuclei of the cells (arrows). (C) & (D) STAT92EY704F-GFP did not 
accumulate in the nuclei of the cells under both non-stimulated and stimulated conditions 
(arrows). Y704F mutation abolished nuclear translocation of STAT92E-GFP. (E) & (F) 
Double mutant STAT92EM647H,Y704F-GFP did also not accumulate in the nuclei of the cells 
under both non-stimulated and stimulated conditions (arrows). Y704F mutation was sufficient 
to abolish nuclear translocation of STAT92EM647H-GFP. 
 
Strikingly, expression of STAT92EM647H-GFP resulted in fluorescence that was nuclear 
enriched even in the absence of co-expressed HopTuml when compared to non-stimulated 
STAT92E-GFP (arrows in Fig. 3.11A, compare to Fig. 3.5C). This effect was even stronger 
under stimulated conditions, when almost no fluorescence was detectable in the cytoplasm 
anymore (arrows in Fig. 3.11B). Thus, the mutation M647H of STAT92E-GFP enabled 
nuclear enrichment of this protein even without activation by co-expressed HopTuml. This 
result was a first indication that STAT92EM647H-GFP is a constitutively active allele of 
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STAT92E as it was shown for the corresponding mouse STAT5AN642H-Flag (Ariyoshi et al., 
2000). In the double mutant STAT92EM647H,Y704F-GFP, Y704F mutation was sufficient to 
prevent the nuclear enrichment of the protein, as it was shown for the single mutant 
STAT92EY704F-GFP (arrows in Fig. 3.11E & F). This demonstrated the essential role of this 
tyrosine residue for the sub-cellular localization of STAT92EM647H-GFP. 
 
3.2.3 Phosphorylation state of STAT92E-GFP variants 
After stimulation by Hop, phosphorylated STAT92E-GFP could be detected with anti-
pSTAT92E antibodies (see Fig. 3.6; Li et al., 2003). 
Strikingly, STAT92EM647H-GFP was inherently phosphorylated on Y704 even under non-
stimulated conditions as indicated by elevated levels of anti-pSTAT92E staining (arrows in 
Fig. 3.12A, compare to Fig. 3.6C). Co-expression with Hop resulted in an even stronger 
signal (Fig. 3.12, compare A to B). These results suggested that STAT92EM647H-GFP was, at 
least partly, constitutively phosphorylated on Y704. Additionally, this phosphorylation was 
independent of activation by Hop. However, stimulation by Hop could also contribute to 
Y704 phosphorylation of STAT92EM647H-GFP as shown by the increased level of pSTAT92E 
under stimulated conditions (Fig. 3.12, compare A to B). These results were consistent with 
the gain-of-function characteristics of mouse STAT5AN642H-Flag (Ariyoshi et al., 2000). 
STAT92E-GFP mutants containing the Y704F substitution were not phosphorylated to an 
extent detectable by anti-pSTAT92E antibody (Fig. 3.12C – F). An increased level of 
pSTAT92E staining could not be observed after pathway stimulation by Hop, neither for the 
STAT92EY704F-GFP single nor for the STAT92EM647H,Y704F-GFP double mutant (Fig. 3.12D 
& F). This confirmed that Y704 is a target of Hop. Together with the results showing defects 
in the activation-dependent nuclear accumulation for STAT92E-GFP Y704 mutants (see Fig. 
3.11C - F), this demonstrated that Y704 phosphorylation is essential for proper sub-cellular 
localization of STAT92E-GFP. 
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Fig. 3.12: Phosphorylation state of STAT92E-GFP variants. S2 cells (Schneider, 1972) 
expressing the indicated proteins. STAT92E-GFP fusion proteins were visualized by GFP 
fluorescence (green) and anti-pSTAT92E indirect immunofluorescence (red). Columns 1 & 3 
show the overlay of EGFP and anti-pSTAT92E signal. Columns 2 & 4 show anti-pSTAT92E 
signal alone. Scale bars represent 16 µM. (A) In cells expressing STAT92EM647H-GFP raised 
levels of pSTAT92E staining were detectable under non-stimulated conditions (arrows). (B) 
Co-expression of STAT92EM647H-GFP and Hop resulted in increased levels of pSTAT92E 
compared to (A). (C) - (F) Elevated levels of pSTAT92E could not be detected in cells 
expressing either STAT92EY704F-GFP single or STAT92EM647H,Y704F-GFP double mutant both 
under non-stimulated and stimulated conditions. 
 
3.2.4 DNA binding ability of STAT92E-GFP variants 
In EMSA experiments STAT92E-GFP could specifically bind radio-labeled oligonucleotides 
containing the STAT92E consensus DNA recognition site TTCCCGGAA after stimulation by 
Hop (see Fig. 3.7). 
Before testing the DNA binding ability of the STAT92E-GFP mutants, the relative protein 
levels were examined by Western blotting of whole cell lysates (see Material & Methods 
2.5.2). The results showed that all STAT92E-GFP variants were expressed in S2 cells 
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(Schneider, 1972) in comparable levels and were stable with no major degradation products 
detected (Fig. 3.13A, lower panel). Using NIH Image software the luminographs of these 
Western blots were quantified, and protein levels were normalized before EMSA analysis was 
performed. 
 
 
Fig. 3.13: DNA binding ability of STAT92E-GFP variants. S2 cells (Schneider, 1972) 
expressing the indicated proteins. Crude cell lysates were tested for DNA binding ability to 
radio-labeled oligonucleotides containing the STAT92E consensus DNA recognition site 
TTCCCGGAA (see Material & Methods 2.5.3). (A) STAT92E-GFP mutants, co-expressed 
without or with Hop, bound to radio-labeled oligonucleotides containing the STAT92E 
consensus DNA recognition site TTCCCGGAA. Expression of Hop or STAT92E-GFP alone 
was not sufficient for detecting a band shift (lane 1 or 2) whereas co-expression of both 
proteins together resulted in a shifted band (lane 3). Mutation of Y704 in the single or the 
double mutant abolished DNA binding completely (lanes 4 & 5, 8 & 9). STAT92EM647H-GFP 
mutant proteins could bind to DNA even in the absence of Hop stimulation (lane 6). 
However, DNA binding was stronger when Hop was co-expressed (lane 7). Extracts used for 
EMSA were also analyzed by Western blotting using anti-GFP antibody. Proteins were stable 
and equally loaded (lower panel). (B) STAT92E-GFP mutants co-expressed without or with 
Hop or treated with 0.1 mM sodium-ortho-vanadate for 45 minutes before cell lysis. Binding 
to radio-labeled oligonucleotides containing the STAT92E consensus DNA recognition site 
TTCCCGGAA was visualized by the shifted band. STAT92E-GFP could be stimulated to 
bind DNA in the absence of Hop following treatment with sodium-ortho-vanadate (lane 6) 
3. Results 
 
 
55 
and gave a signal similar to that produced by the STAT92EM647H-GFP mutant under non-
stimulated conditions (lane 7). Y704F mutant proteins could not be stimulated by sodium-
ortho-vanadate (lanes 10 & 11). 
 
Expression of neither Hop (Fig. 3.13A, lane 1) nor STAT92E-GFP (Fig. 3.13A, lane 2) alone 
resulted in a detectable shifted band. Thus, the S2 cells used in this experiment did not 
provide endogenous levels of Hop activity and did not express levels of STAT92E detectable 
by this assay. STAT92E-GFP DNA binding activity was only detectable upon stimulation by 
Hop (Fig. 3.13A, lane 3). In contrast, the STAT92EM647H-GFP mutant yielded a clear band 
shift even under non-stimulated conditions (Fig. 3.13A, lane 6). This result indicated that this 
protein could constitutively bind DNA even in the absence of Hop stimulation. Moreover, this 
band migrated at the same position as the band shifted by STAT92E-GFP suggesting that 
STAT92EM647H-GFP was also likely to bind DNA as a dimer like wild type STAT92E. Co-
expression of STAT92EM647H-GFP together with Hop increased the strength of the shifted 
band (Fig. 3.13A, lane 7). This was consistent with augmented Y704 phosphorylation of 
STAT92EM647H-GFP after stimulation by Hop (see Fig. 3.12, compare A & B), indicative for 
a raised proportion of activated STAT92E. However, both STAT92EY704F-GFP and 
STAT92EM647H,Y704F-GFP mutants did not show any DNA binding activity (Fig. 3.13A, lanes 
4, 5 & 8, 9), whether stimulated or not. This again displayed the importance of Y704 for 
proper functioning of STAT92E-GFP. 
Y704 phosphorylation of STAT92E-GFP was required to produce dimers capable of DNA 
binding. In addition, endogenous Hop activity was not detectable in the S2 cell line used. On 
this account, the question arose regarding the mechanism, by which STAT92EM647H-GFP was 
phosphorylated. Inhibition of protein phosphatases is sufficient for phosphorylation and 
subsequent activation of STAT proteins independent of external pathway stimulation and 
JAK activity (Haque et al., 1995). In an attempt to mimic Hop independent STAT92EM647H-
GFP phosphorylation, cultured cells expressing wild type STAT92E-GFP were treated with 
the phosphatase inhibitor sodium-ortho-vanadate (see Material & Methods 2.4.2). It was 
already pointed out that co-expression of STAT92E-GFP with Hop was sufficient to stimulate 
STAT92E-GFP DNA binding (see Fig. 3.13A). When non-stimulated S2 cells expressing 
STAT92E-GFP were treated with sodium-ortho-vanadate, a similar effect could be observed 
(Fig. 3.13B, lane 6). However, the intensity of the detected shifted band was not as strong as 
the intensity of the band caused by binding of STAT92E-GFP stimulated by Hop (Fig. 3.13B, 
compare lanes 5 & 6). Rather, it was similar to the one produced by non-stimulated 
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STAT92EM647H-GFP (Fig. 3.13B, compare lanes 6 & 7). A possible explanation for this is that 
low levels of tyrosine kinase activity are endogenously present in S2 cells and capable of 
phosphorylating both alleles of STAT92E-GFP. Furthermore, these results suggested that 
normally the activity of endogenous protein phosphatases counteract this STAT92E 
phosphorylation under non-stimulated conditions. However, phosphatases were incapable of 
dephosphorylating STAT92EM647H-GFP to the same degree as STAT92E-GFP. 
When considered in combination, STAT92EM647H-GFP fulfilled the characteristics expected 
of activated STAT92E-GFP following stimulation by Hop. Furthermore, the activity of 
STAT92EM647H-GFP was dependent on the integrity and phosphorylation of the conserved 
tyrosine residue Y704. This suggested that both tyrosine phosphorylation and dimerization of 
STAT92EM647H-GFP are reminiscent of normal STAT activation. As such, STAT92EM647H-
GFP represented a constitutive gain-of-function allele like the previously described 
STAT5AN642H-Flag (Ariyoshi et al., 2000) as judged by the three criteria of sub-cellular 
localization, Y704 phosphorylation and DNA binding. 
 
3.2.5 Transcriptional activation by STAT92E-GFP variants 
The key role of a transcription factor is the ability to induce target gene expression. 
STAT92EM647H-GFP acted as a gain-of-function mutant as judged by the three criteria of sub-
cellular localization, Y704 phosphorylation and DNA binding (see 3.2.2, 3.2.3 & 3.2.4). 
Similar to mouse STAT5AN642H-Flag (Ariyoshi et al., 2000), STAT92EM647H-GFP should be 
able to induce luciferase reporter gene expression in a JAK/STAT activity assay 
constitutively. Surprisingly, this was not the case. Expression of constitutively phosphorylated 
and DNA-bound STAT92EM647H-GFP alone was not sufficient to induce expression of the 
luciferase reporter in cultured cells (Fig. 3.14, column 3, blue bar). Strikingly, even co-
expression with Hop did not result in an increase in luciferase activity (Fig. 3.14, column 3, 
red bar). In contrast to STAT92E-GFP, STAT92EM647H-GFP was incapable of activating 
transcription in this assay. STAT92EY704F-GFP was also not able to induce reporter gene 
expression (Fig. 3.14, column 4). Additionally, the double mutant STAT92EM647H,Y704F-GFP 
was not capable of activating transcription after pathway stimulation (Fig. 3.14, column 5). 
Taken together, the integrity of Y704 was critical for JAK/STAT signaling. 
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Fig. 3.14: Transcriptional activation by STAT92E-GFP variants. S2R+ cells (Yanagawa 
et al., 1998) co-expressing the indicated proteins, the 2xDrafSTATwt-TATA-luc reporter 
(Kwon et al., 2000) and Renilla luciferase as normalization control. Lysates were used for 
dual luciferase reporter assays as described in Material & Methods 2.4.3.2. Relative fold 
activation (Firefly luciferase reporter activity / Renilla luciferase activity) of the luciferase 
reporter in lysates of cells not expressing Hop is shown in blue, relative activation in lysates 
of cells co-expressing Hop is shown in red. Mock-transfected cells were allocated the relative 
activity 1. Error bars represent standard deviations of four experiments. In contrast to wild 
type STAT92E-GFP (column 2), STAT92E-GFP mutant variants were not able to induce 
relative reporter activity both under non-stimulated and stimulated conditions (columns 3 - 5). 
 
These results showed that STAT92EM647H-GFP is not a constitutively active allele of 
STAT92E, as it was expected from its gain-of-function characteristics of constitutive 
phosphorylation (see 3.2.3), nuclear accumulation (see 3.2.2) and DNA binding (see 3.2.4). 
Drosophila STAT92EM647H-GFP was not able to act as transcriptional activator in cell culture 
assays, thus functioning in a different way to mouse STAT5AN642H-Flag (Ariyoshi et al., 
2000). Therefore, STAT92EM647H-GFP function was analyzed in vivo. For this purpose, 
transgenic flies were generated, in which STAT92E-GFP variants could be expressed via the 
Gal4/UAS system (Brand and Perrimon, 1993). 
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3.2.6 Analysis of STAT92E-GFP variants in vivo 
3.2.6.1 The JAK/STAT pathway during Drosophila eye development 
JAK/STAT signaling is required for a range of developmental processes during the 
embryonic, larval and adult life of Drosophila melanogaster (reviewed in Zeidler et al., 2000; 
Luo and Dearolf, 2001). This includes proliferation of cells within the eye imaginal disc, the 
larval tissue that gives rise to the adult compound eye (Bach et al., 2003). 
 
 
Fig. 3.15: JAK/STAT signaling during eye development of Drosophila. Eyes in (A) - (C) 
are shown in lateral view, eyes in (D) - (F) in dorsal view. (A) & (D) Eyes of an adult wild 
type fly. (B) & (E) Eyes of an adult fly mutant of Upd (allele Updos1) are smaller than wild 
type eyes (compare to A and D). Loss of ventral eye tissue is marked by an arrow in (B). (C) 
& (F) Ectopic expression of the pathway ligand Upd under the control of the GMR element in 
the developing eye resulted in overgrown adult eyes (Bach et al., 2003), particularly 
observable in the dorsal region of the eye (arrows in C & F). 
 
Loss of JAK/STAT activity during eye development resulted in a small-eye phenotype (Tsai 
and Sun, 2004) as shown in Fig. 3.15B & E for a fly mutant of the pathway ligand Upd 
(compare to wild type eye in Fig. 3.15A & D). Although the structure of the eye was not 
affected, a loss of ventral eye tissue was observable (arrow in Fig. 3.15B). Ectopic pathway 
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activation in the eye imaginal disc resulted in an overgrowth of the adult eye compared to the 
wild type eye (Fig. 3.15, compare A & C, see also 3.3.7), particularly observable in the dorsal 
regions of the eye (Bach et al., 2003, arrows in Fig. 3.15C & F). Thus, changes in JAK/STAT 
pathway activity could be assayed on the basis of the variation of eye size and morphology. 
Therefore, STAT92E-GFP variants were expressed in the developing eye to assess their 
function in vivo in the context of Drosophila eye development. 
 
Mis-expression of STAT92E-GFP variants during eye development 
JAK/STAT components were expressed within the complete imaginal eye disc using the eye 
disc-specific driver line eyeless-Gal4 (ey-Gal4) (Halder et al., 1995). Expression of EGFP 
during eye development had no effect on either the size or the morphology of the resulting 
adult eye (Fig. 3.16A). However, expression of a dominant-negative allele of the pathway 
receptor Domeless lacking the cytoplasmic domain (Dome∆Cyt, Brown et al., 2001) resulted 
in a strong reduction of the overall volume of the eye and a loss of ventral tissue (arrow in 
Fig. 3.16B). Conversely, ectopic pathway activation by mis-expression of the constitutively 
active kinase HopTuml caused overgrowth of the adult eye (Fig. 3.16C & D). This showed that 
modulation of JAK/STAT activity interferes efficiently with eye development of Drosophila. 
Although expression of STAT92E-GFP resulted in an occasional mild roughening of the 
posterior equatorial regions, no discernable change in eye size was observed as compared to 
the EGFP expressing eye (compare Fig. 3.16A & E). Similarly, expression of the non-
functional STAT92EY704F-GFP did not have a visible effect on the eye morphology or size 
(Fig. 3.16G). By contrast, expression of STAT92EM647H-GFP was sufficient to produce 
roughening and reduction of eye volume, readily identifiable by the loss of ventral eye tissue 
(arrow in Fig. 3.16F), an effect analogous to that produced by the dominant-negative 
Dome∆Cyt (Fig. 3.16B). These results, confirmed by testing eight independent transgenic fly 
lines, suggested that mis-expression of STAT92EM647H-GFP produced developmental defects 
consistent with its function as a dominant-negative allele in vivo. In the double mutant 
STAT92EM647H,Y704F-GFP disruption of Y704 was sufficient to abrogate the phenotype 
produced by STAT92EM647H-GFP (Fig. 3.16H), indicating that STAT92EM647H-GFP required 
Y704 to exert the dominant-negative effect. 
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Fig. 3.16: Effect of mis-expression of STAT92E-GFP variants on the developing 
Drosophila eye. Adult eyes emanating from eye imaginal discs expressing the indicated 
control or STAT92E-GFP fusion proteins under the control of ey-Gal4 (Halder et al., 1995). 
Unless otherwise noted, all eyes are anterior to the left, dorsal up and show the lateral view. 
(A) Expression of GFP did not alter the size or morphology of the eye. (B) Expression of a 
dominant-negative receptor variant that lacks its cytoplasmic domain resulted in loss of 
ventral eye tissue (arrow) and a rough eye. (C) & (D) Expression of HopTuml led to an 
overgrowth of the eye as shown in lateral (C) and dorsal view (D). (E) Expression of 
STAT92E-GFP had no effect on size or morphology of the eye. (F) Expression of 
STAT92EM647H-GFP resulted in loss of ventral eye tissue (arrow) and a rough eye similar to 
the dominant-negative phenotype shown in (B). (G) & (H) Expression of STAT92EY704F-GFP 
(G) or STAT92EM647H,Y704F-GFP (H) did not alter eye size or morphology. 
 
3.2.6.2 The JAK/STAT pathway during Drosophila tracheal development 
To test whether the mutation M647H affects other aspects of STAT92E activity besides 
cellular proliferation in the eye imaginal disc, the effect of STAT92EM647H-GFP on expression 
of the JAK/STAT pathway target gene trachealess (trh) (Brown et al., 2001) was analyzed. 
trh is one of the first markers of tracheal development in Drosophila and encodes a protein 
required for the development of the embryonic and larval tracheal system (Isaac and Andrew, 
1996; Wilk et al., 1996). Previous studies have shown that loss of Dome or STAT92E is 
sufficient to ablate trh expression (Brown et al., 2001). Therefore, the expression of this gene 
was used as a molecular marker for JAK/STAT activity. STAT92E-GFP variants were 
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ubiquitously expressed during embryogenesis using the Gal4/UAS-system (Brand and 
Perrimon, 1993) and the nullo-Gal4 line (Kunwar et al., 2003). 
 
The effect of mis-expression of STAT92E-GFP variants on the expression of 
the pathway target gene trh 
In wild type embryos of stage 10/11 trh is expressed in the developing tracheal placodes (Fig. 
3.17A; Isaac and Andrew, 1996; Wilk et al., 1996). Ectopic expression of STAT92E-GFP did 
not affect trh expression (Fig. 3.17B). However, despite the presence of endogenous 
STAT92E activity in the developing tracheal placodes, mis-expression of STAT92EM647H-
GFP was sufficient to strongly reduce the levels of trh expressed (Fig. 3.17C). No tracheal 
pits formed in these embryos. This effect was very similar to that caused by the mis-
expression of a dominant-negative splice from of STAT92E (∆NSTAT92E) lacking its N-
terminal domain (Fig. 3.17D; Henriksen et al., 2002). These results indicated at the molecular 
level that STAT92EM647H-GFP acted as a dominant-negative allele capable of preventing the 
function of endogenous STAT92E in vivo. 
 
 
Fig. 3.17: Effect of STAT92E-GFP variants on the expression of JAK/STAT pathway 
target gene trh. trh RNA in situ hybridization using a DIG labeled antisense probe (see 
Material & Methods 2.8.1.2). Embryos are shown with their anterior to the left and dorsal up. 
Embryonic staging was carried out according to Campos-Ortega and Hartenstein (1997). (A) 
trh expression in stage 10/11 wild type embryos was strong and localized within the ten 
tracheal placodes and in the presumptive salivary gland primordia (arrow). (B) Expression of 
STAT92E-GFP in w; P{w+, Nullo-Gal4} / w; P{w+,UAS-STAT92E-GFP} embryos did not 
change the wild type pattern shown in (A). (C) By contrast, trh expression was almost 
completely ablated in w; P{w+, Nullo-Gal4} / w; P{w+,UAS-STAT92EM647H-GFP} embryos of 
the same stage. (D) Expression of a dominant-negative form of STAT92E (Henriksen et al., 
2002) in w; P{w+, Nullo-Gal4} / w; P{w+,UAS-ΔNSTAT92E} embryos abolished trh 
expression in the tracheal placodes. Note that while expression of trh in the salivary gland 
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primordium does not require STAT92E (Brown et al., 2001), ubiquitous mis-expression of 
dominant-negative STAT92E variants was sufficient to prevent expression in this tissue (C) 
& (D). 
 
3.3 Involvement of other post-translational modifications of 
STAT92E in JAK/STAT signaling 
In summary, the results described so far differed from the previous report, which identified 
the analogous mutant STAT5AN642H-Flag as a constitutive active allele (Ariyoshi et al., 2000). 
The mutation M647H of Drosophila STAT92E changed this protein into a dominant-negative 
allele in vivo (see Fig. 3.16 & Fig. 3.17). In contrast to mouse STAT5AN642H-Flag (Ariyoshi et 
al., 2000), expression of the Drosophila mutant protein was sufficient to prevent target gene 
expression (see Fig. 3.17). Consequently, the question arose why constitutively 
phosphorylated STAT92EM647H-GFP was not able to activate target gene expression. The only 
difference between STAT92E-GFP and STAT92EM647H-GFP is a single residue within the 
SH2 domain. In lower organisms like C. elegans a histidine is already incorporated at this 
position (see Fig. 3.10). Therefore, it appears very unlikely that this mutation was responsible 
for a complete loss of the ability to activate target gene expression. However, it also seems 
unlikely that a constitutively active STAT protein, whose activity is not controlled, exists in 
C. elegans. Therefore, a conceivable model could be that additional regulation of STAT 
activity aside from phosphorylation might be necessary for complete STAT activation. 
 
3.3.1 CG9882, a protein with potential arginine methyltransferase activity 
 Dr. Steve Brown (Manchester University) identified a potential protein arginine 
methyltransferase (PRMT) annotated as CG9882 (FlyBase, 2003) as an interaction partner of 
both the receptor Dome and the kinase Hop in Yeast Two Hybrid (Y2H) assays (personal 
communication). Therefore, a potential role of arginine methylation in JAK/STAT signal 
transduction as additional regulatory mechanism was taken into consideration. 
 
3.3.2 CG9882 genomic organization and expression 
The gene CG9882, identified in Y2H assays to interact with Dome and Hop, is located on the 
right arm of the 2nd chromosome at band 59C3. Its transcript is 2224 bases in length and 
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encodes a protein of 705 amino acids with predicted protein arginine methyltransferase 
activity (FlyBase, 2003). Its genomic organization is shown in Fig. 3.18. 
 
 
Fig. 3.18: The genomic organization of the CG9882 region. Intron/exon structure for 
CG9882/Dart7 is shown as predicted by the Berkeley Drosophila genome project (FlyBase, 
2003). CG9882/Dart7 consists of three exons and two introns. Coding sequences are 
indicated in grey, untranslated sequences in white. Scale bar represents 100bp. 
 
To investigate a potential involvement of CG9882 in JAK/STAT signaling, its expression 
pattern was determined. During embryogenesis expression could not be detected by RNA in 
situ hybridization (data not shown). However, these results could not exclude a maternal 
protein contribution. 
 
3.3.3 The role of arginine methylation in JAK/STAT signaling 
Further evidence for an involvement of PRMTs in the JAK/STAT signaling cascade has been 
shown: PRMT1 binds to the cytoplasmic tail of the human IFNAR chain in the type I 
interferon receptor, which is involved in JAK/STAT signaling (Abramovich et al., 1997). 
Moreover, PRMT1 associates with and methylates mouse STAT1 at a conserved arginine 
residue modulating IFNα/β-induced transcription (Mowen et al., 2001). Arginine methylation 
has also been reported to be important for murine STAT6 function. Inhibition of methylation 
impaired phosphorylation and DNA binding activity of STAT6 (Chen et al., 2004). 
To assess the effect of arginine methylation on Drosophila JAK/STAT signal transduction, 
cell culture based experiments were performed. 
 
3.3.4 Inhibition of methylation events by MTA 
Protein methyltransferases can be inhibited by 5´-deoxy-5´(methylthio)adenosine (MTA) 
(Williams-Ashman et al., 1982). It was reported that this inhibition did not affect transcription 
or translation in general, but had specific effects on JAK/STAT signaling (Mowen et al., 
2001). Therefore, MTA was used to inhibit methylation in cultured Drosophila cells (see 
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Material & Methods 2.4.2). The effect on JAK/STAT signaling was examined in a luciferase 
activity assay (Fig. 3.19). Effects on the general regulation of transcription were measured by 
co-transfection of a JAK/STAT-independent Renilla luciferase expression vector under the 
control of the actin5.1 promoter. 
 
 
Fig. 3.19: Effect of MTA on JAK/STAT signaling in cultured Drosophila cells. S2 cells 
(Schneider, 1972) co-expressing the indicated proteins, the 2xDrafSTATwt-TATA-luc 
reporter (Kwon et al., 2000) and Renilla luciferase as control to assay JAK/STAT-
independent effects of MTA. Lysates were used for dual luciferase reporter assays as 
described in Material & Methods 2.4.3.2. Cells were treated with the indicated concentration 
of MTA. Luciferase activity values (in RLU = relative light unit) of the same experiment are 
plotted. Firefly luciferase activity is shown in blue, Renilla luciferase activity in red. Error 
bars represent standard deviations of three experiments. MTA tratment of cultured cells 
adversely affected both JAK/STAT-dependent firefly and JAK/STAT-independent Renilla 
luciferase activities (columns 1 - 6). 
 
Unlike the previous report, in which cells were treated with 0.3 mM MTA (Mowen et al., 
2001), an apparently non-specific effect on JAK/STAT signaling was observed. Under non-
stimulated and stimulated conditions both luciferase activities were affected (Fig. 3.19). 
Firefly luciferase reporter activity decreased at increasing MTA concentrations (Fig. 3.19, 
blue bars). However, the JAK/STAT-independent Renilla luciferase activity also decreased 
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when cells were treated with increasing MTA concentrations (Fig. 3.19, red bars). These 
results suggested an overall non-specific effect of MTA on transcription or translation. If 
arginine methylation plays a role specifically in this signaling cascade, it is unverifiable in 
this approach because of the broadly effects caused by inhibition of methyltransferases. 
 
3.3.5 BLAST search for Drosophila PRMTs 
Apparently, methylation events affect multiple processes in a cell (reviewed in Chiang et al., 
1996), which makes it difficult to specifically uncover the role of arginine methylation in 
JAK/STAT signaling. To distinguish between effects of methylation on transcription or 
translation in general and a potential specific involvement in JAK/STAT signaling, I searched 
for putative PRMTs in Drosophila that may modulate JAK/STAT pathway activity using 
basic local alignment search tool (BLAST, Altschul et al., 1990) searches of the Drosophila 
proteome. Mouse PRMT1 was reported to interact with the type I interferon receptor 
(Abramovich et al., 1997) and to methylate STAT1 (Mowen et al., 2001). Therefore, the 
sequence of this protein was used as query sequence for the BLAST search. Besides CG9882 
eight other potential PRMTs were identified in the conceptual proteome of Drosophila 
melanogaster based on the genomic sequence release 3 (FlyBase, 2003). A search for protein 
domains in the InterPro database (Zdobnov and Apweiler, 2001) revealed that all of these 
proteins shared a SAM binding motif, which is essential for the function of 
methyltransferases. An alignment of these domains was performed using the clustal alignment 
algorithm of MegAlign software (DNASTAR Inc.; Higgins and Sharp, 1989) showing the 
similarity of this motif in the potential Drosophila PRMTs (Fig. 3.20A). Interestingly, 
comparison of the PRMT protein sequences revealed that CG9882 only showed about 10% 
sequence similarity to the other potential Drosophila PRMTs (Fig. 3.20B). However, the 
SAM binding motif of CG9882 showed a much higher similarity (about 33%) to the other 
PRMTs (Fig. 3.20C). Drosophila PRMTs were described recently (Boulanger et al., 2004) 
and called Drosophila arginine methyltransferases (Dart). On the basis of its closest homolog 
PRMT7, CG9882 was called Dart7. 
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Fig. 3.20: Potential Drosophila Protein Arginine Methyltransferases (Darts). Identical 
amino acids are shaded black. Protein sequence identities are listed in Material & Methods 
2.6. (A) Alignment of the predicted SAM binding motifs of mouse PRMT1 and potential 
Darts. (B) Calculated divergence and similarity of mouse PRMT1 and potential Darts (in %). 
(C) Calculated divergence and similarity of the SAM binding motifs shown in (A) of mouse 
PRMT1 and potential Darts (in %). 
 
3.3.6 The role of Darts in JAK/STAT signaling in cultured cells 
To examine the role of the identified predicted Darts in Drosophila JAK/STAT signaling, 
RNAi experiments were performed in the context of the luciferase reporter system (see 
Material & Methods 2.4.4). As shown in Fig. 3.9, it is possible to identify genes that interact 
with JAK/STAT signaling by using RNAi. 
Cultured cells were transiently transfected with a construct that expresses Upd-GFP to 
activate JAK/STAT signaling. In these cells Darts were knocked down by treatment with 
dsRNA covering about 500bp of the ORF of the respective Darts. Expression of Upd-GFP 
resulted in an eight-fold induction of luciferase reporter activity (Fig. 3.21A, column 2). As 
expected, addition of stat92E dsRNA resulted in a reduction of the JAK/STAT-dependent 
reporter activity to a value, comparable to non-stimulated cells (Fig. 3.21A, column 3). 
Addition of dsRNA to specifically degrade CG6554/Dart1, CG6563/Dart3, CG5358/Dart4, 
CG9929/Dart9 and CG32152 mRNA did not have a significant effect on the relative 
luciferase reporter activity (Fig. 3.21A, columns 4, 6, 7, 11 & 12). Furthermore, simultaneous 
knockdown of all potential Darts only reduced JAK/STAT activity slightly (Fig. 3.21A, 
column 13). A similar effect was observed by knocking down the S-adenosylmethionine 
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synthetase (SamS) (Fig. 3.21A, column 14). SamS, also called M(2)21AB, catalyses the 
biosynthesis of SAM, the major methyl donor in methylation reactions (reviewed in Chiang et 
al., 1996). 
 
 
Fig. 3.21: Effects of knocking down potential Darts by RNAi on JAK/STAT signaling in 
cultured cells. S2 cells (Schneider, 1972) co-expressing the indicated proteins, the 
2xDrafSTATwt-TATA-luc reporter (Kwon et al., 2000) and Renilla luciferase as 
normalization control. Cells were incubated with the indicated dsRNA (1.5 µg/105 cells) for 
three days until lysis. Lysates were used for dual luciferase reporter assays as described in 
Material & Methods 2.4.3.2. (A) Relative activity (Firefly luciferase reporter activity / Renilla 
luciferase activity) is plotted. Mock-transfected cells were allocated the relative activity 1. 
Error bars represent standard deviations of three experiments. Expression of Upd-GFP 
resulted in an eight-fold induction of luciferase reporter activity (column 2), which could be 
reduced to an almost non-stimulated level by addition of stat92E dsRNA (column 3). 
Treatment with CG6554, CG6563, CG5358, CG9929 and CG32152 dsRNA did not have an 
effect (columns 4, 6, 7, 11 & 12), whereas addition of CG3675 dsRNA resulted in a decrease 
(column 5) and addition of CG9927, CG9882 and CG16840 dsRNA resulted in an increase of 
3. Results 
 
 
68 
relative reporter activity (columns 8 - 10). Simultaneous knockdown of all Darts or SamS 
only resulted in a slight decrease of relative reporter activity (columns 13 & 14). (B) Absolute 
luciferase activity values (in RLU = relative light unit) of the same experiment as shown in 
(A) are plotted. Firefly luciferase activity is shown in blue, Renilla luciferase activity in red. 
Error bars represent standard deviations of three experiments. Addition of CG9882 dsRNA 
affected both JAK/STAT-dependent and -independent luciferase activities (column 9). 
Simultaneous knockdown of all Darts had a similar effect (column 13), whereas treatment 
with SamS dsRNA did not have a strong influence on luciferase activities (column 14). 
 
Addition of dsRNA targeting sequence-specific for CG3675/Dart2 resulted in a slight 
reduction of relative luciferase activity (Fig. 3.21A, column 5) suggesting a potential role as 
positive pathway regulator. Knockdown of CG9927/Dart6 and CG9882/Dart7 has a 
stimulating effect on relative luciferase reporter activity (Fig. 3.21A, columns 8 & 9). 
Therefore, a role as potential negative pathway regulator is possible. In comparison, addition 
of dsRNA to degrade CG16840/Dart8 mRNA had a stronger stimulating effect on reporter 
activity. Inhibition of its expression doubled luciferase reporter activity from eight-fold to 16-
fold (Fig. 3.21A, compare column 2 to 10). This indicated a stronger negative regulatory 
influence on JAK/STAT signaling than carried out by CG9927/Dart6 or CG9882/Dart7. 
However, a closer look at the absolute values of luciferase activities revealed that addition of 
CG9882/Dart7 dsRNA caused a strong reduction in both firefly reporter and JAK/STAT-
independent Renilla luciferase activity (Fig. 3.21B, column 9). This effect was aggravated 
when expression of all potential Darts was inhibited (Fig. 3.21B, column 13). Therefore, a 
general effect on transcription or translation caused by CG9882/Dart7 is more likely than a 
specific involvement in JAK/STAT signaling. Reducing expression levels of SamS should 
decrease the synthesis of the methyl donor SAM resulting in a lack of the substrate of Darts. 
As a consequence, methylation events were disturbed, which, in principal, should have a 
similar effect like simultaneously knocking down all Darts. However, knocking down the 
expression of SamS had only little effect on expression of both the firefly luciferase reporter 
and the Renilla luciferase control (Fig. 3.21B, column 14). 
 
3.3.7 Interaction of arginine methylation and JAK/STAT signaling in vivo 
The results of cell culture based assays described above suggested non-specific effects of 
arginine methylation on JAK/STAT signaling. At least, the apparently contradictory results of 
simultaneously knocking down all Darts and knocking down SamS made an interpretation of 
this data difficult. Therefore, the role of Darts and SamS in JAK/STAT signaling was 
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analyzed in vivo. For these studies mutants in the Drosophila PRMT1 homolog 
Dart1/CG6554 and SamS/M(2)21AB were tested for their interaction with the JAK/STAT 
pathway. Unfortunately, no mutants for Dart7/CG9882 or other Darts were available. 
 
 
Fig. 3.22: Interaction of JAK/STAT signaling with Dart1 and SamS/M(2)21AB in the 
developing Drosophila eye. (A) P{w+, GMR-updΔ3´}/+ eyes were overgrown, particularly 
on the dorsal side. (B) Removing one gene copy of the SAM synthetase M(2)21AB did not 
interact with ectopic Upd expression in the developing eye (P{w+, GMR-updΔ3´}/+ ; 
M(2)21AB1/+). (C) Removing one gene copy of CG6554/Dart1 did not interact with ectopic 
Upd expression in the developing eye (P{w+, GMR-updΔ3´}/+ ; Art1KG09631/+). 
 
The Drosophila eye was used as a model system to identify genetic interactions in vivo (see 
Material & Methods 2.7.3). To ectopically activate JAK/STAT signaling, the ligand Upd was 
expressed in the developing eye using the transgenic strain P{w+, GMR-updΔ3´} (Bach et al., 
2003). In this transgene binding sites for the eye-specific transcription factor Glass (Ellis et 
al., 1993) were multimerized and used for Upd expression posterior to the morphogenetic 
furrow in the eye imaginal disc. Upd expression by this Glass multimerized response (GMR) 
promoter ectopically activated the JAK/STAT pathway in the developing eye (see Fig. 3.15). 
This resulted in increased levels of cellular proliferation (Bach et al., 2003), causing an 
overgrowth of the adult eye compared to the wild type eye, particularly observable in the 
dorsal regions of the eye (Bach et al., 2003, see also Fig. 3.15). Removing positive regulators 
of the JAK/STAT pathway suppressed the eye overgrowth caused by Upd over-expression. 
Removal of one copy of stat92E, for example, counteracted the over-activation of the 
pathway and resulted in significant reduction in eye overgrowth (Mukherjee et al., 2006). 
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However, neither suppression nor enhancement of the overgrown eye phenotype could be 
observed when a P-element insertion in the first exon of CG6554 and the mutant SamS allele 
M(2)21AB1 were tested for genetic interaction with P{w+, GMR-updΔ3´} (compare Fig. 3.22A 
with B & C). These results showed that the Upd dependent overgrowth phenotype is not 
sensitive to the gene dosage of Dart1 and SamS. Additionally, this suggested that either 
methylation is not necessary for JAK/STAT signaling during eye development or that the 
methylation machinery is redundant with other components taking over the function of the 
affected genes. Furthermore, it is possible that one gene copy is still sufficient to produce 
enough protein activity to fulfill its entire function. A specific involvement of arginine 
methylation in JAK/STAT signaling thus remained unknown. 
 
3.4 Identification of the potential target for methylation in STAT92E 
Methylation affects a variety of different cellular processes (reviewed in Chiang et al., 1996). 
Hence, inhibition of methylation events also affects innumerable processes in cells and thus is 
not an appropriate appliance to determine the role of methylation specifically in JAK/STAT 
signaling. 
 
 
Fig. 3.23: Alignment of the N-terminal region of several STAT proteins. Identical amino 
acids are shaded black. Protein sequence identities are listed in Material & Methods 2.6. The 
asterisk marks the conserved arginine residue (R30 of Drosophila STAT92E). Hu = Homo 
sapiens, Mm = Mus musculus, Gg = Gallus gallus, Dr = Danio rerio, Xl = Xenopus laevis, Sf 
= Spodoptera frugiperda, Dm = Drosophila melanogaster, Ag = Anopheles gambiae, Ce = 
Caenorhabditis elegans. 
 
To differentiate between the broad effects caused by inhibition of methylation in general and 
the specific involvement of arginine methylation in JAK/STAT signaling, the potential target 
residue for methylation of STAT92E was identified. It was reported that STAT1 was 
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methylated at an arginine residue conserved throughout the STAT family (Mowen et al., 
2001). Alignments of various STAT proteins using the clustal alignment algorithm of 
MegAlign software (DNASTAR Inc.; Higgins and Sharp, 1989) showed that in Drosophila 
melanogaster this residue within the N-terminal domain is an arginine at position 30 (R30). 
This residue is highly conserved in all STAT proteins (Fig. 3.23; Mowen et al., 2001; and not 
shown). Analysis of STAT92E variants carrying a mutation in this residue should help to 
directly identify the influence of STAT methylation on signal transduction. 
 
3.4.1 Generation and analysis of STAT92ER30mut-GFP mutants 
To examine the function of the conserved R30 and to directly affect its potential methylation, 
various STAT92ER30mut-GFP mutants were generated on basis of previous reports (Mowen et 
al., 2001; Komyod et al., 2005). Arginine to alanine (R31A) and arginine to glutamic acid 
(R31E) substitutions were shown to increase the ability of mouse STAT1 to promote 
transcription by potentially mimicking arginine methylation (Mowen et al., 2001). Therefore, 
the corresponding mutations R30A and R30E were introduced in Drosophila STAT92E-GFP. 
Additionally, R30 was substituted with lysine (R30K) to minimize potential structural effects 
on the N-terminal domain caused by R30 disruption (Komyod et al., 2005). Furthermore, 
STAT92ER30mut,M647H-GFP double mutants were generated to assess if a potential mutation 
mimicking methylation was sufficient to rescue the dominant-negative effect of 
STAT92EM647H-GFP. This should be the case, if R30 methylation was missing for complete 
activation of STAT92EM647H-GFP. R30mut, Y704F double mutants were also generated for 
negative control experiments as it was shown that Y704F mutation is sufficient to abolish 
STAT92E function (see Fig. 3.11 - Fig. 3.14). 
 
3.4.2 Arginine methylation of STAT92E-GFP 
Cell culture experiments were carried out to assess the methylation state of STAT92E-GFP. 
Whole cell lysates were examined by Western Blotting using an anti-Mono/Di-methyl-
arginine antibody (see Material & Methods 2.5.2). 
Although proteins that were arginine methylated were present in lysates of cells expressing 
STAT92E-GFP without or with Hop, only a faint band of the correct size was detectable (Fig. 
3.24A, lanes 1 & 2, marked by dots). However, a protein of the same size could also be 
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detected in non-transfected cells used as negative control (Fig. 3.24A, lane 3, marked by 
dots). Therefore, this protein could not correspond to STAT92E-GFP. 
 
 
Fig. 3.24: Arginine methylation of STAT92E-GFP variants. (A) S2R+ cells (Yanagawa et 
al., 1998) co-expressing the indicated proteins. Whole cell extracts were analyzed by Western 
Blotting using anti-Mono/Di-methyl-arginine antibody (see Material & Methods 2.5.2). In 
lysates of cells expressing STAT92E without or with Hop a band potentially corresponding to 
STAT92E-GFP was detected (lanes 1 & 2). However, this band was also detected in mock-
transfected lysates (lane 3; respective bands are marked by dots). (B) Stability of 
STAT92ER30mut-GFP variants. Lysates of S2R+ cells (Yanagawa et al., 1998) expressing the 
STAT92ER30mut-GFP variants were analyzed by Western Blotting using anti-GFP antibody. 
No degradation products could be detected indicating full length fusion proteins (lanes 2 - 4). 
(C) STAT92E-GFP was purified by IP using anti-GFP antibody (see Material & Methods 
2.5.1) and analyzed by Western blotting using anti-Mono/Di-methyl-arginine antibody. A 
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band potentially corresponding to STAT92E-GFP was detected in purified lysates of cells 
expressing STAT92E-GFP or STAT92EM647H-GFP (lanes 1 & 2, 9 &10). However, this band, 
albeit weaker, was also detected in purified STAT92ER30mut-GFP samples (lanes 3 - 8; 
respective bands are marked by dots). Proteins of size between 47,5 and 62 kDa most likely 
corresponded to antibody polypeptide chains. 
 
To assess possible differences between the methylation status of STAT92E-GFP and the 
mutated STAT92E-GFP variants, these proteins were expressed in cultured cells and purified 
from whole cell lysates in IP experiments with an anti-GFP antibody (see Material & Methods 
2.5.1). First, STAT92ER30mut-GFP variants were tested for their stability by Western blotting. 
No degradation products could be detected indicating full length and stable fusion proteins 
(Fig. 3.24B, lanes 2 - 4). After STAT92E-GFP IP, in immuno-precipitated lysates of cells 
expressing STAT92E-GFP or STAT92EM647H-GFP a protein of the correct size could be 
detected by an anti-Mono/Di-methyl-arginine antibody (Fig. 3.24C, lanes 1, 2, 9 & 10, 
marked by dots). Yet, this band was also present, albeit weaker, in immuno-precipitated 
lysates containing STAT92ER30mut-GFP variants (Fig. 3.24C, lanes 3 – 8, marked by dots) 
suggesting that either another arginine than R30 was methylated or that unspecific antibody 
binding has occurred. Repetitions of this experiment did also not lead to a conclusive result. 
In summary, arginine methylation of STAT92E-GFP could not be verified in these assays. 
Although the results of the Western Blotting experiment did not indicate R30 methylation of 
STAT92E-GFP, the conservation of this residue among the STAT protein family suggested 
that this arginine held an essential role. Therefore, STAT92ER30mut-GFP variants were 
expressed in cultured cells and in vivo and were functionally characterized. Examination of 
these mutant proteins included analysis of their sub-cellular localization, DNA binding 
ability, transcriptional activation and their effect in vivo as it was performed for 
STAT92EM647H-GFP. 
 
3.4.3 Sub-cellular localization of STAT92ER30mut-GFP variants 
STAT92ER30mut-GFP mutant proteins were expressed in Kc167 cells (Cherbas et al., 1977) and 
activated by co-expression of HopTuml. 
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Fig. 3.25: Sub-cellular localization of STAT92ER30mut-GFP variants. Kc167 cells (Cherbas 
et al., 1977) co-expressing the indicated proteins. Columns 1 & 3 show GFP fluorescence and 
DAPI staining of DNA reflecting the localization of GFP fusion proteins (green) and the 
nuclei (blue), respectively. Columns 2 & 4 show columns 1 & 3 overlaid on a brightfield 
image of the cells. Scale bars represent 20 µM. (A), (C) & (E) STAT92ER30mut-GFP single 
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mutants are distributed throughout the cell including the nucleus under non-stimulated 
conditions. (B), (D) & (F) STAT92ER30mut-GFP single mutants accumulated in the nucleus 
upon stimulation by HopTuml (arrows). (G) & (I) STAT92ER30mut,M647H-GFP double mutants 
seemed to accumulate in the nucleus under non-stimulated conditions (arrows in G) with the 
exception of STAT92ER30K,M647H-GFP, which is distributed throughout the cell (arrows in I). 
(H) & (J) Upon stimulation by HopTuml STAT92ER30mut,M647H-GFP double mutants 
accumulated in the nucleus. (K) & (L) STAT92ER30K,Y704F-GFP double mutant was 
distributed throughout the cell under both non-stimulated (K) and stimulated (arrows in L) 
conditions. (M) - (P) STAT92ER30mut,M647H,Y704F-GFP triple mutants were distributed 
throughout the cell under both non-stimulated (M & O) and stimulated (arrows in P) 
conditions. The STAT92ER30E,M647H,Y704F-GFP triple mutant protein was presumably degraded 
upon stimulation with degradation products accumulating in the lysosome recognizable with 
GFP fluorescence in defined small areas (arrows in N). 
 
All STAT92ER30mut-GFP single mutants showed a behavior similar to STAT92E-GFP (see 
Fig. 3.5). Under non-stimulated conditions these variants were distributed throughout the cell 
including the nucleus (Fig. 3.25A, C & E). After stimulation with HopTuml the fluorescence 
accumulated in the nucleus (arrows in Fig. 3.25B, D & F) indicating the translocation of 
STAT92ER30mut-GFP variants from the cytoplasm into the nucleus. However, expression 
levels of STAT92ER30A-GFP and STAT92ER30E-GFP seemed to be reduced as compared to 
STAT92ER30K-GFP or STAT92E-GFP as judged by the detectable amount of GFP signal. The 
double mutant proteins STAT92ER30A,M647H-GFP and STAT92ER30E,M647H-GFP seemed to 
accumulate in the nucleus even without stimulation by co-expressed HopTuml (arrows in Fig. 
3.25G). However, nuclear accumulation of non-stimulated STAT92EM647H-GFP was more 
obvious (see Fig. 3.11). STAT92ER30K,M647H-GFP did not accumulate in the nucleus under 
non-stimulated conditions (arrows in Fig. 3.25I). Nuclear accumulation was observable only 
after stimulation (Fig. 3.25J). Again, the R30K mutant showed the highest level of GFP 
fluorescence of the mutant proteins. Disruption of Y704 in the double mutant 
STAT92ER30K,Y704F-GFP prevented nuclear accumulation (Fig. 3.25K & arrows in L). 
STAT92ER30A/E,Y704F-GFP double mutant proteins appeared to be degraded after stimulation 
(data not shown). Triple mutant proteins STAT92ER30mut,M647H,Y704F-GFP showed low level of 
GFP fluorescence and were distributed throughout the cell (Fig. 3.25M & O). Similar to the 
double mutants, R30A and R30E triple mutants seemed to be degraded after stimulation by 
co-expressed HopTuml judged by the GFP signal in the cells. The degradation products 
presumably accumulated in the lysosome recognizable with GFP fluorescence within this 
cellular compartment (arrows in Fig. 3.25N). The R30K triple mutant protein was the most 
stable of the STAT92E-GFP variants as judged by detectable GFP fluorescence (arrows in 
Fig. 3.25P). 
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3.4.4 DNA binding ability of STAT92ER30mut-GFP variants 
STAT92ER30mut-GFP mutant proteins were expressed in S2R+ cells (Yanagawa et al., 1998) 
alone or together with Hop for JAK/STAT stimulation. Lysates generated from these cells 
were tested for the DNA binding activity by EMSA as described before (see 3.1.3.3). 
 
 
Fig. 3.26: DNA binding ability of STAT92ER30mut-GFP variants. S2R+ cells (Yanagawa et 
al., 1998) co-expressing the indicated proteins. Crude cell lysates were tested for DNA 
binding ability to radio-labeled oligonucleotides containing the STAT92E consensus DNA 
recognition site TTCCCGGAA (see Material & Methods 2.5.3). Expression of Hop alone 
presumably activated endogenous non-tagged STAT92E, recognizable with a faint band (lane 
2, marked by dots) that ran faster than stimulated STAT92E-GFP (lane 4). Non-stimulated 
STAT92ER30mut-GFP mutant proteins did not bind to DNA (lanes 5, 7 & 9). Co-expression 
with Hop (lanes 6, 8 & 10) resulted in a shifted band similar to that of activated STAT92E-
GFP (lane 4). 
 
No shifted bands were detectable in lysates of mock-transfected cells (Fig. 3.26, lane 1). 
However, in lysates of cells expressing Hop alone a faint shifted band was detectable (Fig. 
3.26, lane 2, marked by dots), which ran faster than that produced by activated STAT92E-
GFP (Fig. 3.26, lane 4). Most likely, this band corresponded to endogenous non-tagged 
STAT92E. Lysates of non-stimulated cells only expressing STAT92ER30mut-GFP proteins did 
not display DNA binding activity (Fig. 3.26, lanes 5, 7 & 9), whereas co-expression of 
STAT92ER30mut-GFP variants together with Hop resulted in a detectable DNA binding 
activity, visible by clear shifted bands (Fig. 3.26, lanes 6, 8 & 10). However, these mutant 
proteins bound significantly weaker than the wild type control (Fig. 3.26, compare lanes 6, 8 
& 10 to lane 4), possibly due to their lower expression level (see 3.4.3). These results showed 
that STAT92ER30mut-GFP mutants are capable of DNA binding upon activation by Hop, 
similar to STAT92E-GFP. Band shifts in non-stimulated lysates (e. g. non-stimulated 
STAT92E-GFP in lane 3) were only detectable in rare cases and were most likely non-
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specific binding events due to protein over-expression using the Gal4/UAS system (Brand and 
Perrimon, 1993). 
 
3.4.5 Transcriptional activation by STAT92ER30mut-GFP variants 
In principle, the STAT92ER30mut-GFP single mutant proteins acted in a similar way as 
STAT92E-GFP, although differences in the expression level could be observed between the 
various arginine mutant proteins judged by the GFP fluorescence detected (see 3.4.3). R31A 
and R31E substitutions of mouse STAT1 were shown to increase signaling activity in a 
detectable amount under non-stimulated conditions (Mowen et al., 2001). Therefore, 
homologous mutations of Drosophila STAT92E were tested in luciferase activity assays for 
the ability to elicit reporter gene expression (see Material & Methods 2.4.3.2). 
The Kc167 cells used in this assay appeared to express endogenous STAT92E that can be 
activated by expression of the constitutive active kinase HopTuml. Expression of HopTuml alone 
resulted in approximately 4-fold induction of luciferase reporter activity (Fig. 3.27, column 1, 
red bar). STAT92E-GFP expression alone did not have an effect on reporter activity (Fig. 
3.27, column 2, blue bar). Thus, endogenous pathway activity, able to activate STAT92E-
GFP, was not present in these cells. Co-expression of STAT92E-GFP and HopTuml resulted in 
an almost 25-fold increase in relative luciferase activity (Fig. 3.27, column 2, red bar). 
STAT92ER30mut-GFP single mutants did not differ from the effect of STAT92E-GFP under 
non-stimulated conditions (Fig. 3.27, columns 3 - 5, blue bars). However, activation by 
HopTuml only led to 8-fold induction of luciferase reporter activity (Fig. 3.27, columns 3 - 5, 
red bars). This was a higher level than the induction by HopTuml alone indicating that 
STAT92ER30mut-GFP mutant proteins were still able to induce reporter gene expression to 
some extent. However, in comparison to STAT92E-GFP this ability was strongly impaired. 
For STAT92ER30mut,M647H-GFP double mutant proteins a similar effect could be observed (Fig. 
3.27, columns 6 - 8). Mutant proteins, in which the conserved tyrosine residue Y704 was 
disrupted, did not show any transactivation activity that exceeded the reporter activation by 
HopTuml alone, as shown for the double mutant STAT92ER30K,Y704F-GFP and the triple mutant 
STAT92ER30K,M647H,Y704F-GFP (Fig. 3.27, columns 9 & 10). The choice of the amino acid 
substituting the conserved R30 did not have a strong influence on the activity of the mutated 
STAT92E-GFP proteins, although R30K mutant proteins showed a slightly higher 
transcriptional activity than the other R30 mutants. However, I could not find evidence for 
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any of the STAT92ER30mut-GFP variants acting as gain-of-function proteins as it was 
described for mouse STAT1 mutants in a previous report (Mowen et al., 2001). 
 
 
Fig. 3.27: Transcriptional activation by STAT92ER30mut-GFP variants. Kc167 cells 
(Cherbas et al., 1977) co-expressing the indicated proteins, the 2xDrafSTATwt-TATA-luc 
reporter (Kwon et al., 2000) and Renilla luciferase as normalization control. Lysates were 
used for dual luciferase reporter assays as described in Material & Methods 2.4.3.2. Relative 
fold activation of the luciferase reporter (Firefly luciferase reporter activity / Renilla 
luciferase activity) in lysates of cells not expressing HopTuml is shown in blue, relative 
activation in lysates of cells co-transfected with an expression construct for HopTuml is shown 
in red. Mock-transfected cells were allocated the relative activity 1. Error bars represent 
standard deviations of six experiments. STAT92ER30mut-GFP variants were not able to induce 
luciferase reporter gene expression to the same extent as STAT92E-GFP (compare column 2 
to colums 3 - 10). 
 
The results of the cell culture experiments described above suggested that STAT92ER30mut-
GFP mutant proteins were able to react properly on JAK/STAT activity by the criteria of sub-
cellular localization and DNA binding, indicating proper Y704 phosphorylation. However, 
these mutants showed impaired transactivation activity in luciferase reporter assays (Fig. 
3.27). To reveal the functional consequences of R30 substitutions in vivo, the effects of 
STAT92ER30mut-GFP variants on the developing eye and on trh target gene expression were 
analyzed as described above (see 3.2.6.1 & 3.2.6.2). 
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3.4.6 Analysis of STAT92ER30mut-GFP variants in vivo 
3.4.6.1 Mis-expression of STAT92ER30mut-GFP variants during eye development 
To assess the effect of the STAT92ER30mut-GFP variants on JAK/STAT signaling in vivo, the 
Drosophila eye was used as a model (see also 3.2.6.1). STAT92ER30mut-GFP variants were 
expressed in the developing Drosophila eye using the ey-Gal4 driver (Halder et al., 1995). 
 
 
Fig. 3.28: Effect of mis-expression of STAT92ER30mut-GFP variants on the developing 
Drosophila eye. Adult eyes emanating from eye imaginal discs expressing the indicated 
STAT92E-GFP fusion proteins under the control of ey-Gal4 (Halder et al., 1995). All eyes 
are anterior to the left and show the lateral view. (A) Expression of STAT92E-GFP did not 
alter the size or morphology of the eye. (B) Expression of STAT92ER30A-GFP resulted in a 
small and rough eye. (C) Expression of STAT92ER30E-GFP resulted in a small and rough eye, 
occasionally in an almost complete loss of the eye. (D) Expression of STAT92ER30K-GFP led 
to a small and rough eye. (E) - (F) Expression of STAT92ER30mut,M647H-GFP double mutants 
also resulted in a small and rough eye. (H) Expression of STAT92ER30A,Y704F-GFP did not 
alter eye size or morphology. 
 
Expression of STAT92ER30mut-GFP single mutants in the developing eye produced a 
roughening and decrease of adult eye size (Fig. 3.28), similar to the dominant-negative alleles 
of the pathway receptor Dome∆Cyt and STAT92EM647H-GFP (see Fig. 3.16B & F). 
Expression of STAT92ER30A-GFP and STAT92ER30K-GFP in the eye imaginal disc resulted in 
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a consistent small and roughened eye phenotype (Fig. 3.28B & D). Expression of 
STAT92ER30E-GFP resulted in phenotypes varying from a small reduction in eye size to an 
almost complete loss of an eye (Fig. 3.28C). Additionally, the eyes of the same fly could be 
affected to a different extent. Over-expression of STAT92ER30mut,M647H-GFP double mutants 
produced a small eye phenotype, comparable to the STAT92ER30mut-GFP single mutant 
phenotype (Fig. 3.28E - G). Disruption of Y704 resulted in the loss of the phenotype as 
shown for STAT92ER30A,Y704F-GFP (Fig. 3.28H), suggesting that this residue and most likely 
its phosphorylation is important for STAT92ER30mut-GFP mutants to exert their dominant-
negative phenotype. These results were consistent in multiple independent transgenic lines. 
 
3.4.6.2 The effect of mis-expression of STAT92ER30mut-GFP variants on the 
expression of the pathway target gene trh 
To assess the function of STAT92ER30mut-GFP variants on a molecular level, the effect of 
these mutants on the expression of the JAK/STAT target gene trh (Isaac and Andrew, 1996; 
Wilk et al., 1996) was analyzed (see also 3.2.6.2). For this purpose, STAT92ER30mut-GFP 
variants were expressed ubiquitously in developing Drosophila embryos using the nullo-Gal4 
driver line (Kunwar et al., 2003). 
 
 
Fig. 3.29: Effect of STAT92ER30mut-GFP variants on the expression of JAK/STAT 
pathway target gene trh. trh RNA in situ hybridization using a DIG labeled antisense probe 
(see Material & Methods 2.8.1.2). Embryonic staging was carried out according to Campos-
Ortega and Hartenstein (1997). (A) At stages 10/11 trh expression in w; P{w+, Nullo-Gal4} / 
w; P{w+,UAS-STAT92E-GFP} embryos was strong and localized within the ten tracheal 
placodes and in the presumptive salivary glands. (B) – (D) By contrast, trh expression was 
almost completely ablated in w; P{w+, Nullo-Gal4} / w; P{w+,UAS-STAT92ER30mut-GFP} 
embryos of the same stage. In (B) - (D) the salivary gland primordium was brought into focus 
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to show that ubiquitous mis-expression of dominant negative STAT92ER30mut-GFP variants 
was also sufficient to prevent STAT92E independent trh expression in this tissue (Brown et 
al., 2001). 
 
As shown before, STAT92E-GFP did not affect the expression of the JAK/STAT target gene 
trh (Fig. 3.29A). However, expression of each of the three different STAT92ER30mut-GFP 
single mutant proteins during embryogenesis was sufficient to strongly reduce trh expression 
levels (Fig. 3.29B - D). This indicated that STAT92ER30mut-GFP variants act as dominant-
negative alleles of STAT92E-GFP in vivo, similar to STAT92EM647H-GFP and ∆NSTAT92E 
(see Fig. 3.17). 
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4 Discussion 
 
JAK/STAT signaling is involved in many different developmental processes including 
hematopoiesis and the immune response (reviewed in O'Shea et al., 2002). A wide variety of 
ligands are known in mammals to activate this signaling cascade by binding to their 
respective receptors (reviewed in Kisseleva et al., 2002). Four JAK proteins (reviewed in 
Yamaoka et al., 2004) transduce the signal via phosphorylation of a conserved tyrosine 
residue of seven STAT proteins (reviewed in Brierley and Fish, 2005). Phosphorylated STAT 
proteins dimerize, translocate to the nucleus and act as transcription factors by binding to 
specific sites in enhancers of their target genes and by subsequently activating their 
transcription (reviewed in Brierley and Fish, 2005). Specific combinations of receptors and 
JAK proteins ensure signal transduction through specific STAT dimers. As such, an external 
signal is transduced from the outside of a cell across the membrane, through the cytoplasm 
and finally into the nucleus. 
In Drosophila, only three ligands (Unpaired (Upd) 1 - 3), one receptor (Domeless (Dome)), 
one JAK kinase (Hopscotch (Hop)) and one STAT protein (STAT92E) are known so far. Due 
to the lower complexity and redundancy of the pathway, Drosophila melanogaster is an 
excellent model organism for the analysis of the detailed mode of JAK/STAT signal 
transduction. Additionally, Drosophila is a genetic model organism with a long history. In 
combination with modern techniques it can be used as a powerful tool to investigate 
biological pathways in vivo. Classical genetic approaches to test gene interactions allow the 
identification of genes cooperating in a particular process. Furthermore, the relatively easy 
way of generating transgenic flies (Rubin and Spradling, 1982) in combination with the 
Gal4/UAS-system (Brand and Perrimon, 1993) allows the expression of a transgene in many 
different tissues and time points. This enables the analysis of mis-expression effects of mutant 
proteins in vivo. In this study, Drosophila STAT92E and mutant variants of STAT92E have 
been analyzed for their function in JAK/STAT signaling using cell culture and in vivo assays. 
 
4.1 Tools for the analysis of Drosophila JAK/STAT activity 
To visualize and to analyze Drosophila JAK/STAT activity in general and the function of 
STAT92E variants in particular, cell culture and in vivo assays were established. 
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4.1.1 A reporter for JAK/STAT activity 
4.1.1.1 Expression pattern of socs36e-lacZ constructs 
Activation of JAK/STAT signaling results in the change of expression of multiple genes. In 
Drosophila socs36E is one of these target genes (Callus and Mathey-Prevot, 2002; Karsten et 
al., 2002). In the genomic region of socs36E 22 potential STAT92E DNA binding sites were 
identified (see Fig. 3.2; Karsten et al., 2002), which all share the consensus recognition 
sequence TTCNNNGAA (Yan et al., 1996). However, it was not known which binding sites 
are occupied in vivo by STAT92E dimers. To determine the minimal region containing all 
regulatory sequences for socs36E expression in vivo, lacZ reporter constructs including four 
different genomic regions with three to five clustered putative STAT92E binding sites (see 
Fig. 3.2) were engineered. These constructs were shown to be sufficient to activate lacZ 
reporter gene expression in patterns almost completely matching endogenous socs36E 
expression (see Fig. 3.3). Only very early aspects of the socs36E expression pattern, namely 
during stages 5 to 7 of embryogenesis, could not be reproduced. It is possible that under wild 
type conditions STAT92E dimers are bound to recognition sites of distinct enhancer regions. 
Interaction of these dimers might be required to produce the complete socs36E expression 
pattern. Cooperative binding of two STAT5 dimers to neighboring recognititon sites as 
tetramers, for example, is important for interleukin-2 induced target gene expression (Meyer 
et al., 1997). In transgenic Drosophila embryos potential interactions between STAT92E 
dimers, bound in genomic regions that were separated by their cloning into the lacZ reporter 
construct, would have been disrupted and thus adversely affect reporter gene expression. In 
addition, binding sites of unknown STAT92E co-factors might have been also affected, thus 
interfering with the recapitulation of the endogenous socs36E expression pattern. 
 
4.1.1.2 Luciferase reporter 
The lacZ reporter construct including region I, which contains 5 putative STAT92E binding 
sites (see Fig. 3.2), was shown to be capable of activating lacZ reporter gene expression in 
vivo. The expression pattern particularly recapitulated the aspects of endogenous socs36E 
expression from stage 9 of embryogenesis (see Fig. 3.3). Furthermore, a bioinformatics 
survey concerning the number and spacing of the putative binding sites within the genomic 
region of socs36E resulted in a high probability for the sites of region I to contribute to 
endogenous socs36E expression in vivo (Ho-Ryun Chung, personal communication). 
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Therefore, a luciferase reporter construct based on region I was designed to monitor 
JAK/STAT activity in cell culture assays. Surprisingly, it was not possible to detect pathway 
activity in S2 cells using this reporter construct (see Fig. 3.4). S2 cells are derived from 
Drosophila embryos in late embryogenesis and are thought to represent a haemocyte- or 
macrophage-like cell type (Schneider, 1972). However, in vivo lacZ reporter expression was 
not detectable in haemocyte- or macrophage-like cells, but present in ectodermal tissues like 
the fore- and hindgut and the tracheal system (see Fig. 3.3). It is therefore possible that the 
luciferase reporter based on region I was not able to respond to STAT92E activity in S2 cells, 
because other tissue-specific or STAT independent control mechanisms were missing in these 
cells. However, using the reporter 2xDrafSTATwt-TATA-luc, which contains two STAT92E 
binding sites from the promoter of the JAK/STAT target gene Draf, JAK/STAT activity was 
detectable in S2 cells (see Fig. 3.4; Kwon et al., 2000). Therefore, this reporter and its 
modified version 6x2xDrafLuc (Müller et al., 2005) were used for further experiments. 
 
4.1.2 Characteristics of STAT92E activation 
To visualize the sub-cellular localization of Drosophila STAT92E and to analyze STAT92E 
function in general, a fluorescently tagged STAT92E fusion protein (STAT92E-GFP) was 
generated. Upon activation of the JAK/STAT cascade, this fusion protein was phosphorylated 
on a highly conserved tyrosine residue at position 704 (Y704) by the tyrosine kinase 
Hopscotch (Hop) as tyrosine phosphorylation was not detectable for STAT92EY704F-GFP 
mutants (see Fig. 3.6 & Fig. 3.12). Several other findings also suggest that the GFP fusion 
protein is really functional. It could be shown that activated STAT92E-GFP accumulates in 
the nucleus (see Fig. 3.5), binds a consensus STAT92E recognition site in an EMSA (see Fig. 
3.7) and is able to induce luciferase reporter gene expression in cultured cells (see Fig. 3.8). 
However, over-expression of STAT92E-GFP during Drosophila development did not have an 
effect on JAK/STAT activity. On neither eye development (see Fig. 3.16) nor JAK/STAT 
target gene expression (see Fig. 3.17) a visible effect could be observed. Thus, elevated 
expression levels were not sufficient for an induction or inhibition of pathway activity in 
Drosophila. In contrast, it was shown that over-expression of a wild type STAT5 fusion 
protein in transgenic mice results in tumor growth similar to the one produced by over-
expression of constitutively active STAT5 (Iavnilovitch et al., 2004). This fact revealed 
potential functional differences between STAT proteins in various organisms and has to be 
considered when results of this study are discussed. 
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Taken together, it could be demonstrated that the STAT92E-GFP fusion protein is completely 
functional in cell culture assays in terms of sub-cellular localization, DNA binding ability and 
transcriptional activation of a luciferase reporter gene. Therefore, it was possible to use 
STAT92E-GFP in further assays to test STAT92E function. 
Analysis of the characteristics in cultured cells and in vivo as described above provided a 
potent tool to analyze STAT92E mutants at different steps in their function. In addition, 
RNAi screens using luciferase reporter assays (see Fig. 3.9; Baeg et al., 2005; Müller et al., 
2005) and assays for genetic interaction (for example, based on size alteration of the 
Drosophila eye (see Fig. 3.16; Bach et al., 2003)) helped to characterize STAT92E variants 
and to identify components modulating JAK/STAT activity. 
 
4.2 Functional analysis of STAT92E-GFP mutants 
4.2.1 STAT92EM647H-GFP 
Constitutive activation of JAK/STAT signaling, often caused by gain-of-function mutations in 
JAK proteins, is implicated in the onset of several severe human diseases (reviewed in 
Schindler, 2002; Valentino and Pierre, 2006). Recently, the first disease-associated mutation 
in a STAT protein has been identified (Rosenfeld et al., 2005). A patient with a lack-of-
function mutation in the SH2 domain of STAT5b displayed a combination of severe growth 
retardation and immunodeficiency caused by affected growth hormone and cytokine signaling 
(Rosenfeld et al., 2005). Although no natural gain-of-function allele of STAT proteins has 
been identified yet, constitutively active STAT variants were generated and analyzed 
(Bromberg et al., 1999; Ariyoshi et al., 2000). Functional analysis of these mutant STAT 
variants and the effects and mechanisms of STAT activation independent of stimulation by 
upstream pathway components could give an insight into the function of STAT proteins. It 
was shown that introduction of cysteine residues in the SH2 domain of murine STAT3 causes 
the formation of a sulfhydryl bond between STAT3 monomers resulting in covalent 
dimerization. These mutant STAT3 dimers translocate to the nucleus, bind DNA and activate 
transcription (Bromberg et al., 1999). Furthermore, a mutation in the SH2 domain of mouse 
STAT5A, in which the amino acid asparagine at position 642 (N642) was substituted with a 
histidine (STAT5AN642H), showed similar gain-of-function characteristics (Ariyoshi et al., 
2000). This mutant STAT5A-Flag fusion protein was constitutively phosphorylated resulting 
in a DNA bound STAT5A dimer that was able to induce target gene expression and was 
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sufficient to confer autonomous cell growth on interleukin-3-dependent Ba/F3 cells (Ariyoshi 
et al., 2000). In summary, these results showed that STAT phosphorylation, dimerization and 
DNA binding together is sufficient to mediate transcriptional activation. 
In the present study, a methionine at position 647 (M647) within the SH2 domain of 
Drosophila STAT92E was identified as the residue corresponding to N642 of mouse 
STAT5A (see Fig. 3.10). The accordant substitution of M647 to a histidine (M647H) led to 
constitutive Y704 phosphorylation of STAT92E-GFP (see Fig. 3.12), which was sufficient to 
cause nuclear accumulation (see Fig. 3.11) and constitutive DNA binding (see Fig. 3.13) 
similar to STAT5AN642H-Flag (Ariyoshi et al., 2000). STAT92E-GFP expression alone in 
contrast was not sufficient for its phosphorylation, nuclear accumulation and DNA binding 
(see Fig. 3.6, Fig. 3.5 & Fig. 3.7). Thus, endogenous JAK/STAT activity was not detectable 
in these assays suggesting that activation of STAT92EM647H -GFP under non-stimulated 
conditions was independent of specific Hop activity. 
A possible explanation for this non-specific activation could be a balance of continuous 
STAT phosphorylation and dephosphorylation at low levels under non-stimulated conditions 
proposed in a recent report (Liddle et al., 2006). According to this working hypothesis, 
inhibition of phosphatases results in an unbalance causing constitutive STAT 
phosphorylation. Most likely, a similar mechanism was also responsible for Drosophila 
STAT92EM647H-GFP phosphorylation under non-stimulated conditions. This model is 
supported by the fact that inhibition of protein phosphatases in cultured Drosophila cells by 
sodium-ortho-vanadate was sufficient to induce DNA binding of STAT92E-GFP independent 
of JAK/STAT activity (see Fig. 3.13). The intensity of the detected shifted band of non-
stimulated STAT92EM647H-GFP was comparable to that of STAT92E-GFP treated with 
sodium-ortho-vanadate. This suggested a similar way of activation via low levels of kinase 
activity for STAT92EM647H-GFP. 
It was hypothesized that dephosphorylation of activated STAT1 occurs after its release from 
DNA and is necessary for nuclear export of STAT1 (Meyer et al., 2003). Although whole cell 
extracts were used to assay the DNA binding activity of STAT92EM647H-GFP, it is very likely 
that the independently identified nuclear accumulation of this mutant variant coincides with 
constitutive DNA binding. It is possible that its higher affinity to DNA can slow down or 
prevent dephosphorylation of STAT92EM647H-GFP in the nucleus and its transport back into 
the cytoplasm. The enhanced DNA binding activity I observed for STAT92EM647H-GFP (see 
Fig. 3.13) thus could also contribute to the persisting phosphorylation and nuclear 
accumulation of this mutant. 
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The conserved tyrosine residue is essential for other mutant STAT proteins to fulfill their 
constitutive active function (Ariyoshi et al., 2000; Liddle et al., 2006). My results also 
indicated that corresponding Y704 is necessary in the process of STAT92EM647H-GFP 
activation. The double mutant STAT92EM647H,Y704F-GFP could not be phosphorylated (see 
Fig. 3.12). As a result, the protein lost its ability to accumulate in the nucleus (see Fig. 3.11) 
and to bind to DNA (see Fig. 3.13). This emphasized the essential role of the Y704 for 
STAT92EM647H-GFP to exert its gain-of-function phenotype. In general, the highly conserved 
tyrosine residue plays a key role for the activation of STAT proteins. 
 
4.2.1.1 Structural aspects of the M647H mutation 
Phosphatases were incapable of counteracting the phosphorylation of STAT92EM647H-GFP 
(see 4.2.1) and STAT5AN642H-Flag mutants (Ariyoshi et al., 2000) under non-stimulated 
conditions. One explanation for this is that the histidine substitution in these STAT variants 
increases the affinity of the mutated SH2 domains for the phosphorylated tyrosine in the 
dimer partner. This scenario would be consistent with molecular modeling of STAT92E based 
on the known structures of homo-dimerized mouse STAT3 (Becker et al., 1998). Such a 
model suggests that in both vertebrate STAT5AN642H-Flag and Drosophila STAT92EM647H-
GFP residues within the SH2 domains were substituted that have the potential to physically 
interact with the phospho-tyrosine residue of the dimerized partner (Fig. 4.1). In this model, 
M647 of Drosophila STAT92E is located near the pocket that binds the phosphorylated 
tyrosine of the STAT92E dimer partner. Substitution of this methionine with histidine 
(M647H) increases the positive charge in this pocket, potentially resulting in an increased 
affinity of the SH2 domain for the negatively charged phosphorylated tyrosine residue (Pierre 
Montaville & Stefan Becker (MPIbpc, Göttingen), personal communication; Ariyoshi et al., 
2000). This way, binding between the phosphorylated tyrosine and the SH2 domain is 
strengthened. The resultant enhanced interaction between STAT dimer partners, in turn, could 
restrict the access for cytoplasmic phosphatases under non-stimulated conditions preventing 
dephosphorylation. Consequently, a pool of phosphorylated STAT92EM647H-GFP would 
gradually accumulate in the cell, which would result in constitutive dimerization and DNA 
binding of STAT92EM647H-GFP similar to STAT92E-GFP activation by phosphatase 
inhibitors (see Fig. 3.13). 
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Fig. 4.1: Surface model of the phospho-tyrosine binding pocket of the STAT3 SH2 
domain. Image kindly provided by P. Montaville (MPIbpc, Göttingen). Negatively charged 
residues are depicted in red, positively charged residues in blue. Corresponding residues of 
Drosophila STAT92E are listed below residues of mouse STAT3. The phosphorylated 
tyrosine is bound in a negatively charged pocket. Residue S636 of mouse STAT3 (or M647 of 
Drosophila STAT92E) is located near this binding pocket with the potential to interact with 
the phosphorylated tyrosine residue. 
 
4.2.1.2 Transcriptional activation by STAT92EM647H-GFP 
Mouse STAT5AN642H-Flag was reported to induce luciferase reporter and target gene 
expression independently of cytokine stimulation to a level equivalent to activated wild type 
STAT5A-Flag (Ariyoshi et al., 2000). Therefore, the corresponding Drosophila mutant 
protein STAT92EM647H-GFP was expected to permanently activate reporter gene expression. 
Surprisingly, this was not the case (see Fig. 3.14). Even co-expression of STAT92EM647H-GFP 
together with Hop was not sufficient to induce luciferase reporter gene expression. In contrast 
to mouse STAT5AN642H-Flag, constitutive phosphorylation of Y704 was not sufficient to 
completely activate Drosophila STAT92EM647H-GFP in cultured cells. As proposed above 
(see 4.2.1), treatment of STAT92E-GFP with phosphatase inhibitors should mimic 
STAT92EM647H-GFP activation by low levels of kinase activity under non-stimulated 
conditions. Therefore, it was tested whether phosphorylation of wild type STAT92E-GFP 
under such conditions is also insufficient for reporter gene expression. Unfortunately, it was 
not possible to address this question in a luciferase reporter assay. Short-time treatment of 
cultured cells with the phosphatase inhibitor was not sufficient for reporter gene expression to 
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an extent detectable in this assay. Prolonged treatment, however, resulted in cell death, 
making interpretations of such STAT92E activation impossible. 
Taken together, these results suggested that STAT92EM647H-GFP was phosphorylated by low 
levels of kinase activity. Its function under non-stimulated conditions appeared to be 
mimicked by STAT92E-GFP treated with phosphatase inhibitors. However, this 
phosphorylation, presumably occurring in the cytoplasm, was not sufficient for complete 
activation of STAT92E-GFP. Alternatively, it is also possible that the M647H mutation 
rendered STAT92E-GFP non-functional in terms of transcriptional activation while positively 
affecting its phosphorylation, sub-cellular localization and DNA binding. 
 
4.2.1.3 STAT92EM647H-GFP acts as a dominant-negative allele 
Previous results identified the STAT5AN642H-Flag mutant as a constitutively active allele of 
mouse STAT5A (Ariyoshi et al., 2000) with the ability to confer autonomous cell growth on 
cytokine-dependent Ba/F3 cells. However, the proliferation rate was much slower as 
compared to cells that were treated with external cytokines. Additionally, levels of STAT5A 
target genes expression appeared to be similar or only modestly increased in cells expressing 
STAT5AN642H-Flag as compared to cells expressing wild type STAT5A-Flag. However, 
autonomous growth of Ba/F3 cells expressing STAT5AN642H-Flag did imply a gain-of-
function effect for this mutant STAT protein. 
The analysis of mutations in the context of an entire organism provides a potentially more 
accurate system than cultured cells, which often represent transformed cells differing in their 
behavior from wild type cells. In addition to cell culture assays, the function of the 
transactivational inactive Drosophila mutant protein corresponding to the constitutively active 
mouse STAT5AN642H-Flag was therefore also analyzed in vivo. Expression of STAT92EM647H-
GFP in the developing Drosophila eye was sufficient to inhibit endogenous JAK/STAT 
activity, resulting in a small and rough eye phenotype. Expression of a dominant-negative 
form of the pathway receptor Domeless caused a similar phenotype (see Fig. 3.16). 
Additionally, expression of STAT92EM647H-GFP during embryonic development was 
sufficient to prevent endogenous expression of the JAK/STAT pathway target gene trh (see 
Fig. 3.17). Taken together, STAT92EM647H-GFP acted as a dominant-negative allele of 
STAT92E in vivo. 
An explanation for the diverging behavior of the corresponding mutations of Drosophila and 
mouse STATs may be the redundancy of STAT proteins in mammalian cells. 
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Transcriptionally competent, but non-phosphorylated endogenous STAT proteins present in 
these cells may be able to hetero-dimerize with the constitutively phosphorylated 
STAT5AN642H-Flag. These half-activated dimer complexes might be capable of inducing 
target gene expression at low levels, sufficient for the survival of the Ba/F3 cells. An 
explanation for the existence of such half-activated dimers might be provided in a recent 
report, in which non-phosphorylated STAT1 has been described to exist in an antiparallel 
dimeric structure (Zhong et al., 2005). After phosphorylation a conformational rearrangement 
takes place and the SH2 domains bind the phosphorylated tyrosine of the respective dimer 
partner. In this model, half-activated hetero-dimers may form that possess the ability to 
activate target gene expression to a minor degree. The relative high expression levels in 
Drosophila cells that result from the Gal4/UAS system (Brand and Perrimon, 1993) increases 
the likelihood that STAT92EM647H-GFP homo-dimers form. As such, a scenario in which 
transcriptionally incompetent STAT92EM647H-GFP homo-dimers compete with half-activated 
hetero-dimers for STAT92E binding sites may represent the more accurate description of this 
particular mutation in vivo. 
Additionally, it cannot be ruled out that different functions of Drosophila STAT92E and 
mouse STAT5A contribute to the diverging behavior of the respective mutant variants. Over-
expression of a wild type STAT5 fusion protein was sufficient to induce tumor growth in 
mice, similar to a constitutively active chimeric STAT5 variant (Iavnilovitch et al., 2004; see 
also 4.1.2). In contrast, no gain-of-function phenotype could be detected for Drosophila 
STAT92E-GFP over-expression (see Fig. 3.16). 
Furthermore, it was reported that inactivation of STAT1 induced transcription appeared to be 
primarily governed by the dissociation rate of the STAT1-DNA complex, a frequency 
dictated by the particular recognition site and the affinity of STAT1 binding to this site 
(Meyer et al., 2003). Most likely, STAT92EM647H-GFP dimers competed against endogenous 
wild type STAT92E dimers for STAT recognition sites in enhancers of target genes. An 
enhanced binding of STAT92EM647H-GFP to DNA might have changed the dissociation rate 
resulting in constitutive DNA binding (see Fig. 3.13) providing an advantage for 
STAT92EM647H-GFP over wild type STAT92E. Hence, the access to these enhancer elements 
for endogenous STAT92E would be blocked. Taken together, the dominant-negative effect 
observed (see Fig. 3.16 & Fig. 3.17) was possibly based on DNA-bound, transcriptionally 
incompetent STAT92EM647H-GFP dimers, preventing the expression of JAK/STAT pathway 
target genes. 
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In summary, Y704 phosphorylation was sufficient for translocation of STAT92E-GFP to the 
nucleus and its DNA binding (see Fig. 3.5 & Fig. 3.7). However, in the STAT92EM647H-GFP 
mutant protein Y704 phosphorylation was not sufficient for the induction of JAK/STAT 
pathway target gene expression (see Fig. 3.17). This mutant represents the first STAT protein, 
for which tyrosine phosphorylation, nuclear accumulation and DNA binding is not sufficient 
for complete STAT activation. However, the mechanism, by which it exerts its dominant-
negative phenotype, remains unclear. 
Strikingly, in less complex organisms such as C. elegans a histidine is found in the position 
corresponding to N642 of mouse STAT5A or M647 of Drosophila STAT92E (see Fig. 3.10), 
respectively. Therefore, it is very unlikely that this mutation in SH2 domains alters these 
STAT proteins to be utterly non-functional. However, it is possible that STAT-like molecules 
of these organisms are constitutively phosphorylated and DNA-bound. Furthermore, no JAK-
like molecules have been identified in the C. elegans genome (The C. elegans Sequencing 
Consortium, 1998). Therefore, it might be that STAT activity in C. elegans is controlled by 
additional mechanisms independent of tyrosine phosphorylation, conceivably via the 
modulation of transactivation activity. Thus, it appears possible that signaling via STAT is 
controlled on levels other than phosphorylation. In organisms where JAK proteins mainly 
impart pathway activation, this additional control mechanism could be necessary for full 
STAT activation. STAT92EM647H-GFP might lack this control mechanism explaining the 
inability to be completely activated and to induce target gene expression. 
 
4.3 Arginine methylation of STAT92E 
As discussed above, STAT92EM647H-GFP was constitutively phosphorylated, which was 
originally thought to be sufficient for complete activation of this protein. However, this 
STAT92E variant acted as a dominant-negative allele in vivo. The mechanism causing the 
dominant-negative phenotype remains to be elucidated. One possibility is that low level of 
kinase activities mediated constitutive STAT92EM647H-GFP phosphorylation (see 4.2.1) in the 
cytoplasm. Yet, it is also possible that STAT92E have to receive another modification at the 
receptor/JAK complex for its complete activation. Data of Dr. Steve Brown (University of 
Manchester) support this hypothesis. He found a potential protein arginine methyltransferase 
(PRMT) bound to both the receptor Dome and the kinase Hop in Y2H screens. In addition, 
STAT1 arginine methylation was reported to modulate STAT activity by preventing 
interaction with the negative regulator PIAS (Mowen et al., 2001). Furthermore, PRMT1 
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binds to the intracytoplasmic domain of the type I interferon receptor (Abramovich et al., 
1997) indicating a role for arginine methylation in JAK/STAT signaling. Moreover, treatment 
of cultured cells with 5´-deoxy-5´(methylthio)adenosine (MTA), an inhibitor of 
methyltransferases, was reported to specifically inhibit JAK/STAT signaling by reducing 
STAT1 arginine methylation (Mowen et al., 2001). However, the specificity of this inhibition 
is unclear since another report demonstrated that MTA treatment adversely affects multiple 
biological processes (Williams-Ashman et al., 1982). In Drosophila cell culture experiments 
MTA treatment also resulted in a rather non-specific effect in the dual luciferase reporter 
system, since both JAK/STAT-dependent firefly luciferase reporter and JAK/STAT-
independent Renilla luciferase expression levels were affected (see Fig. 3.19). Meissner and 
colleagues obtained similar results showing a negative effect of MTA on STAT1 independent 
NF-κB reporter gene transcription (Meissner et al., 2004). Because of the broad effects of 
MTA on various processes, including general transcription, specific effects of STAT92E 
methylation could not be addressed with those experiments. Therefore, determination of the 
role of STAT92E arginine methylation during JAK/STAT signaling required a more specific 
inhibitor than MTA. 
 
4.3.1 Drosophila arginine methyltransferases 
In order to circumvent the broad effects of MTA treatment, a more specific way to inhibit 
arginine methylation was applied. To do so, the Drosophila genome was searched for 
potential enzymes mediating protein arginine methylation. A BLAST search (Altschul et al., 
1990) for Drosophila protein arginine methyltransferases (Dart) identified nine candidate 
proteins. Typically for methyltransferases, all these proteins contain a domain for the binding 
of the main methyl donor SAM (see Fig. 3.20). CG9882/Dart7 identified in Y2H assays by 
Steve Brown (University of Manchester) was also among those candidate proteins. However, 
the closest homolog to PRMT1, which was shown to be involved in modulating mammalian 
JAK/STAT activity (Mowen et al., 2001), was CG6554/Dart1. Actually, CG9882/Dart7 
shares only low similarity to mouse PRMT1 and the other Darts (see Fig. 3.20). 
Expression of Darts was detectable by Northern Blotting at various developmental stages 
suggesting that arginine methylation is essential during Drosophila development (Boulanger 
et al., 2004). Consistently, RNAi experiments undertaken in the present study indicated a 
potential role for several Darts in JAK/STAT signal transduction (see Fig. 3.21). 
CG9927/Dart6 and CG16840/Dart8 acted as negative regulators of JAK/STAT signaling. 
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Knocking down their mRNA resulted in an increase of luciferase reporter activity. The 
opposite effect was observed for CG3675/Dart2 suggesting a role as positive regulator. 
CG6554/Dart1, the closest homolog to PRMT1, which was shown to be involved in 
JAK/STAT signaling (Abramovich et al., 1997; Mowen et al., 2001), did not interact with the 
JAK/STAT pathway in this assay. However, as indicated by Y2H assays, the most promising 
candidate for an involvement in JAK/STAT signaling was CG9882/Dart7, identified as 
interaction partner of Dome and Hop. When the expression of this gene was knocked down in 
the dual luciferase reporter assay system, both luciferase reporter and control activity were 
strongly reduced. This result indicated a non-specific effect rather than a specific involvement 
of CG9882/Dart7 in JAK/STAT signaling. However, it is possible that off-target effects 
caused by CG9882/Dart7 dsRNA had an impact on these results, because knocking down the 
synthetase of the main methyl donor SamS to inhibit methylation in general surprisingly did 
not have a comparable effect. One possibility is that the SamS RNAi might have been 
inefficient, resulting in remaining SamS protein activity. Additionally, methylation of 
histones, for example, can have both positive and negative regulatory effects on transcription 
(Lee et al., 2005). Thus, the generalized effects on methylation caused by knocking down 
SamS might camouflage specific effects on the reporter assay. Furthermore, CG9882/Dart7 
might also affect other processes than arginine methylation explaining the differing effects 
observed for knocking down CG9882/Dart7 and SamS. Genetic interaction assays were 
performed to determine the role for methylation in JAK/STAT signaling in vivo. However, for 
neither a mutant allele of SamS nor a P-element insertion in CG6554/Dart1 an interaction 
with JAK/STAT signaling during eye development was detectable (see Fig. 3.22). 
Unfortunately, no mutant alleles of CG9882/Dart7 or other Darts were available. Thus, the 
effect of arginine methylation on JAK/STAT activity could not be readily addressed by these 
assays. 
Although these results do not exclude the possibility of STAT methylation, it appeared more 
likely that protein methylation is involved in general transcriptional regulation. Arginine 
methylation of several proteins of the transcriptional machinery is required for protein-protein 
interactions regulating transcriptional initiation (Stallcup et al., 2003). Inhibition of these 
modification events could affect these interactions resulting in a negative effect on 
transcriptional activation. The protein arginine methyltransferase CARM1, for example, was 
shown to be involved in transcriptional activation by methylating histone H3, the histone 
acetyltransferases CBP/p300 and possibly other proteins in the transcription initiation 
complex (reviewed in Lee et al., 2005). Additionally, arginine methylation of DNA 
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polymerase β was reported to stimulate polymerase activity by enhancing DNA binding and 
processivity (El-Andaloussi et al., 2006). A specific involvement in JAK/STAT signaling, in 
particular of STAT92E methylation, is therefore difficult to determine by the approaches 
described above. 
The protein arginine methyltransferase CG9882/Dart7 was not expressed during embryonic 
and larval development at a level detectable experimentally (see 3.3.2; Boulanger et al., 
2004). Therefore, an involvement in JAK/STAT signaling at this time point seemed unlikely. 
However, it is possible that low expression levels, not detectable by in situ hybridization, are 
sufficient for functional activity of CG9882/Dart7. Low levels of the transcript were detected 
in the ovaries by Northern Blotting (Boulanger et al., 2004). Additionally, CG9927/Dart6 and 
CG16840/Dart8 mRNA is predominantly found in ovaries (Boulanger et al., 2004). However, 
an interaction of these Darts, in particular of CG9882/Dart7, with JAK/STAT signaling 
during oogenesis remains to be determined. 
 
4.3.2 STAT92ER30mut-GFP mutants 
A function for arginine methylation specifically in JAK/STAT signaling or STAT92E 
arginine methylation itself could not be shown with the assays used (see Fig. 3.19, Fig. 3.21, 
Fig. 3.22 & Fig. 3.24). To differentiate between potential broad effects caused by inhibition of 
Darts and a specific involvement of arginine methylation in JAK/STAT signaling, the 
putative target residue for methylation of STAT92E was identified. STAT1 methylation at a 
highly conserved arginine residue within the N-terminal domain was reported recently 
(Mowen et al., 2001). Alignments of several STAT proteins identified the corresponding 
arginine residue of the Drosophila melanogaster STAT92E protein at position 30 (see Fig. 
3.23). Mutations of this residue did not alter the sub-cellular localization or the DNA binding 
ability of Drosophila STAT92E (see Fig. 3.25 & Fig. 3.26). However, expression levels of 
STAT92ER30mut-GFP variants compared to STAT92E-GFP seemed to be reduced as judged 
by GFP fluorescence detected in transfected cultured cells. This might indicate that 
STAT92ER30mut-GFP variants are less stable than STAT92E-GFP, a conclusion also made by 
others for STAT1 and STAT3 mutants (Meissner et al., 2004; Komyod et al., 2005). 
Consistently, STAT92ER30mut-GFP mutants were not able to activate reporter gene expression 
to an extent similar to STAT92E-GFP (see Fig. 3.27). However, in vivo mis-expression of 
these mutant proteins resulted in dominant-negative phenotypes (see Fig. 3.28 & Fig. 3.29). It 
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is possible that these effects caused by STAT92ER30mut-GFP variants was based on the 
binding at enhancer sites and the inability of subsequent activation of target gene expression. 
These mutant proteins might have lost the ability to interact with a subset of proteins resulting 
in the dominant-negative phenotype. Arginine methylation, for example, is often involved in 
protein-protein interactions. Therefore, disruption of the potential methylation target 
abolishing its modification might impede important interactions of STAT92E with the 
transcriptional machinery. As a result, target gene expression could not be activated to its full 
extent and DNA-bound STAT92ER30mut-GFP dimers blocked the binding of endogenous wild 
type STAT92E. An alternative model suggests that arginine methylation of STAT1 prevents 
the binding of the negative regulator PIAS1 (Mowen et al., 2001). Inhibition of arginine 
methylation led to an increased interaction of STAT1 with PIAS1 and resulted in reduced 
transcriptional response upon pathway stimulation (Mowen et al., 2001). PIAS proteins can 
negatively regulate STAT activity at different levels in vertebrates. For example, PIAS1 
specifically inhibits DNA binding of activated STAT1 (Liu et al., 1998). However, 
Drosophila STAT92ER30mut-GFP proteins were still able to bind to DNA (see Fig. 3.26). 
Another PIAS protein, PIASy, does not affect the DNA binding activity of STAT1. It rather 
acts as a transcriptional co-repressor of STAT1 (Liu et al., 2001). In principal, a model, in 
which mutant STAT92E-GFP dimers are DNA-bound and negatively regulated by associated 
Drosophila PIAS, is therefore possible. 
Beside reduced stability, structural changes in the STAT92ER30mut-GFP mutant proteins 
independent of arginine methylation might have impaired interactions with co-factors. This 
could also have contributed to the inability of these mutant proteins to act as transcriptional 
activators. STAT92E-GFP variants were still able to translocate to the nucleus and bind to 
DNA following stimulation (see Fig. 3.25 & Fig. 3.26) regardless of these potential structural 
changes. Therefore, it seems possible that interactions with the transcriptional machinery are 
disturbed in these mutants, adversely affecting transcriptional initiation. It was shown, for 
example, that interaction of STAT2 or STAT1 with the histone acetyltransferases CBP/p300 
(Bhattacharya et al., 1996; Zhang et al., 1996) is required for JAK/STAT-dependent 
transcriptional activation. 
Structural changes in the N-terminal domain of STAT92ER30mut-GFP variants could also 
affect important interaction between STAT dimer partners. It has been proposed that a 
conformational change of activated STAT dimers facilitate their dephosphorylation by 
presenting the phosphorylated tyrosine residue to phosphatases (Fig. 4.2; Zhong et al., 2005). 
In this model, phosphorylated STAT dimers exist in a parallel structure. The conformational 
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rearrangement to an antiparallel dimeric structure after translocation from the DNA results in 
the exposure of the phosphorylated tyrosine to nuclear phosphatases (Zhong et al., 2005). 
Mutation of the conserved R30 of Drosophila STAT92E may alter the structure of the N-
terminal domain of this mutant protein. This, in turn, could affect the ability of 
STAT92ER30mut-GFP proteins to form the antiparallel dimeric structure, which would interfere 
with dephosporylation. Phosphorylated STAT92ER30mut-GFP dimers would remain in the 
nucleus and be again able to bind to DNA. Indeed, it was reported that the conserved arginine 
residue is located within an evolutionary conserved salt bridge network in the N-terminal 
domain (Vinkemeier et al., 1998; Meissner et al., 2004), which indicated an important 
structural role. The amino acids contributing to this network are conserved throughout most 
STAT proteins including Drosophila STAT92E. Therefore, it is very likely that R30 of 
STAT92E occupies a similar structural role. 
 
 
Fig. 4.2: Possible scenario for STAT inactivation (modified after Zhong et al., 2005). 
Inactivation of STAT dimers requires translocation from the DNA. Interaction between the N-
terminal domains (N) then disrupts the interaction between SH2 domains (SH2) and the 
phosphorylated tyrosine (P or pY) of the dimer partner. This structural rearrangement results 
in an anti-parallel structure of the dimer presenting the phosphorylated tyrosine residues to 
phosphatases (P´ase). Interactions between the coiled-coil (CC) and the DNA binding (DBD) 
domain are also required for this structural rearrangement.  L: Linker domain. 
 
A previous report suggested that R31A and R31E mutations of STAT1 resulted in increased 
JAK/STAT activity (Mowen et al., 2001). However, STAT92E-GFP mutants carrying the 
mutations R30A, R30E or R30K did not have a positive regulatory effect on JAK/STAT 
signaling. R30 mutations of Drosophila STAT92E-GFP reduced the induction of reporter 
gene expression (see Fig. 3.27) and resulted in molecules that exhibited dominant-negative 
phenotypes in vivo (see Fig. 3.28 & Fig. 3.29). Although arginine mutations of STAT1 and 
STAT6 have been reported not to result in gain-of-function proteins (Chen et al., 2004; 
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Meissner et al., 2004; Komyod et al., 2005) contrary to a previous report (Mowen et al., 
2001), these vertebrate STAT mutant proteins also behave differently from Drosophila 
STAT92E variants. Substitution of the conserved arginine residue resulted in vertebrate 
STAT proteins that were not able to accumulate in the nucleus upon pathway stimulation. In 
addition, no DNA binding of these mutants was detectable (Chen et al., 2004; Meissner et al., 
2004; Komyod et al., 2005). Drosophila STAT92ER30mut-GFP variants showed a different 
functional behavior. These mutant proteins were able to translocate to the nucleus and bind to 
DNA under stimulated conditions (see Fig. 3.25 & Fig. 3.26). Sequence variations in the N-
terminal domain between Drosophila STAT92E and vertebrate STATs could potentially 
reflect different demands on these proteins contributing to the observed functional deviation. 
In addition, this could also be an explanation for the dominant-negative phenotype of 
Drosophila STAT92ER30mut-GFP compared to vertebrate STAT arginine mutants. Drosophila 
STAT92ER30mut-GFP variants have the potential to directly interfere with transcriptional 
initiation, since they are still able to accumulate in the nucleus and to bind DNA, in contrast 
to vertebrate STAT mutants, which remain in the cytoplasm. 
The results obtained in the present study suggest a general role for arginine methylation in 
transcriptional or translational regulation rather than a specific involvement in JAK/STAT 
signaling. Consistently, arginine methylation of STAT92E could not be detected by 
immunoprecipitation and Western blotting experiments (see Fig. 3.24). Recently, several 
reports investigated STAT protein methylation of the N-terminal conserved arginine residue 
(Meissner et al., 2004; Komyod et al., 2005). The utilized assays, including Mass 
spectroscopy, could not reveal a methylated arginine at the proposed position (Meissner et al., 
2004). Furthermore, 3D structural analysis is arguing against a post-translational modification 
of this arginine residue (Komyod et al., 2005), because it is part of a salt bridge network that 
is conserved between distinct members of the STAT family (see above; Vinkemeier et al., 
1998). 
 
Taken together, these results imply an important role of R30 within Drosophila STAT92E. 
However, it seems that methylation of this residue does not occur and thus does not contribute 
to full activation of STAT92E. Therefore, missing of R30 methylation cannot be the reason 
for STAT92EM647H-GFP acting as a dominant-negative allele. This mutant protein has lost its 
ability to activate transcription due to a single amino acid substitution in its SH2 domain. 
Structural effects on the transactivation domain or interaction surfaces of STAT92E caused by 
this substitution might have contributed to its function as dominant-negative allele of 
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STAT92E. Recently, other modifications of STAT proteins have been described. 
Glycosylation of a N-terminal located threonine residue of STAT5 was shown to to be 
required for binding to the transcriptional co-activator CBP (Gewinner et al., 2004). 
Additionally, this co-activator CBP was reported to acetylate a lysine residue in the 
transactivation domain of STAT3 (Wang et al., 2005) stimulating sequence-specific DNA 
binding and transactivation activity of STAT3. Thus, STAT activation is not only controlled 
by its state of phosphorylation, but cooperation of different modifications of STAT proteins is 
necessary for complete activation and recruitment of co-factors. Although it is not known if 
Drosophila STAT92E is modified in a similar way, it is possible that both R30 and M647 
substitutions interfere with potential modifications and thus affect the recruitment and 
interaction with positively or negatively regulating co-factors. This, in turn, could have an 
impact on transcriptional activation mediated by Drosophila STAT92E resulting in dominant-
negative over-expression phenotypes in vivo. 
 
4.4 Outlook 
The regulation of JAK/STAT signal transduction is an important step in the development of 
an organism. Additionally, mis-regulation has been shown to be involved in multiple diseases. 
Analysis of post-translational modifications of STAT proteins, in addition to tyrosine 
phosphorylation, in the context of the regulation of JAK/STAT activity has not been a major 
focus up to now. However, several modifications of STAT, including acetylation (Wang et 
al., 2005) and glycosylation (Gewinner et al., 2004), have recently been described to affect 
JAK/STAT pathway activity. The present as well as further studies examining the role of 
STAT modifications in signaling will help to elucidate their respective effects on signal 
transduction by JAK/STAT. Additionally, generation and analysis of other mutant STAT 
proteins, in particular of constitutively active alleles, will add to the comprehension of STAT 
function. Furthermore, such mutants would also be a potentially valuable tool for in vivo 
epistatic analysis of JAK/STAT signaling regulators and inter-pathway crosstalk. Ultimately, 
these findings will also contribute to the understanding of diseases caused by JAK/STAT mis-
regulation and could lead to novel approaches for the treatment of those diseases. 
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5 Summary 
The highly conserved JAK/STAT signal transduction cascade is required for multiple 
developmental and cellular processes. In mammals pathway activation by binding of a 
multitude of ligands to their respective receptors results in phosphorylation of STAT 
transcription factors at a highly conserved tyrosine (Y) by JAKs. This modification is 
essential and was thought to be sufficient for STAT activation, since Y mutation completely 
abolishes STAT function. 
In Drosophila the JAK/STAT pathway has a greatly reduced complexity and redundancy 
simplifying the functional analysis of STAT activation. Therefore, Drosophila STAT92E 
function in cell culture and in vivo assays was investigated by introducing mutations into 
STAT92E based on previously reported vertebrate alleles. Constitutive Y phosphorylation of 
the STAT92EM647H-GFP mutant is sufficient for nuclear accumulation and DNA binding even 
under non-stimulated conditions. However, no transcriptional activation could be detected. 
Additionally, STAT92EM647H-GFP causes dominant-negative phenotypes when over-
expressed in vivo. This data demonstrated that Y phosphorylation alone is not sufficient for 
complete STAT92E activation suggesting the presence of another regulatory step. A potential 
mechanism is the reported methylation of a conserved arginine (R) of murine STAT1. This is 
further supported by detected interactions of the annotated Drosophila Protein R 
Methyltransferase (Dart) 7 with JAK/STAT pathway components in yeast two-hybrid screens. 
To assess a regulatory role of methylation on STAT activity, putative Darts were targeted in 
RNAi knockdown experiments. Additionally, mutant STAT92ER30mut-GFP variants were 
generated, which caused dominant-negative over-expression phenotypes in vivo. However, 
since STAT92E R methylation could not be detected, it seems more likely that mutation of 
the conserved R affects interaction surfaces disrupting protein-protein interactions required 
for transcriptional initiation. Furthermore, the results of the RNAi experiments and cell 
culture assays and results of others suggest that protein methylation affects general 
transcriptional control, rather than that it has a specific effect on JAK/STAT components. 
The results of this study demonstrate the evolutionary conserved crucial role of Y 
phosphorylation for STAT activity. Nevertheless, this modification is not sufficient for 
activation suggesting additional regulatory mechanisms. Further analysis of STAT variants 
carrying mutations in potential modification sites will help to elucidate STAT functionality 
and thus provide useful information for the treatment of diseases caused by JAK/STAT 
pathway mis-regulation. 
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